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STUDIES TOWARD THE SYNTHESES OF  
TETRAHYDROSWERTIANOLIN AND PUNICEASIDE B 
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Major Professor: John A. Porco, Jr., Professor of Chemistry 
 
ABSTRACT 
 Tetrahydroxanthones are a family of natural products with chemically interesting 
functional groups and a diverse array of reported biological activities. The dissertation 
research described herein has been focused on the syntheses of tetrahydroswertianolin, a 
glycosylated tetrahydroxanthone, and puniceaside B, a heterodimeric, glycosylated 
tetrahydroxanthone. To the best of our knowledge, there have been no published reports 
on the total synthesis of either natural product. We have targeted tetrahydroswertianolin 
and puniceaside B in hopes of developing a divergent method to easily access a variety of 
tetrahydroxanthone cores for natural product and analogue synthesis.  
 Our efforts to develop a cascade reaction toward the tetrahydroxanthone core and 
the stepwise route that we simultaneously pursued will be presented. A scalable synthetic 
route to the tetrahydroxanthone core of tetrahydroswertianolin and the xanthone core of 
puniceaside B was accomplished. An asymmetric route to the tetrahydroxanthone 
precursor was also developed.  
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CHAPTER 1 
Tetrahydroswertianolin and Puniceaside B: Tetrahydroxanthone Natural Products 
 
1.1  Introduction and overview 
Tetrahydroswertianolin1–3 (1) is a glycosylated tetrahydroxanthone that was 
isolated in 1997 from Swertia japonica Makino, a Japanese herb used in folk medicine to 
reduce fever (Figure 1.1). Puniceaside B4  (2) is a heterodimer consisting of a glycosylated 
tetrahydroxanthone and a fully aromatic xanthone that was isolated more recently in 2010. 
Both 1 and 2 belong to a family of natural products known as the tetrahydroxanthones. 
Their challenging chemical motif lends itself to the opportunity of developing new 
synthetic methodologies. Tetrahydroxanthone natural products have shown a diverse array 
of biology, such as antimalarial, antibiotic, and anticancer activities.5,6 However, the 
biological mechanism of action of these compounds is still unknown. As a result, 
tetrahydroxanthone natural products have been targeted by a number of synthetic research 
groups in recent years.  
 
Figure 1.1   Tetrahydroswertianolin and Puniceaside B 
Tetrahydroxanthones are a subset of xanthone natural products which are classified 
based on the oxidation level of the C ring as follows: fully aromatic (3), dihydro- (4), 
tetrahydro- (5, 6, & 7), or hexahydro- (8) xanthones (Figure 1.2).  
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Figure 1.2   Classification of the Xanthone Motif 
Among the tetrahydroxanthones, there are three major subtypes: 1,2,3,4-
tetrahydroxanthones (5); 2,3,4,4a-tetrahydroxanthones (6); and 1,4,4a,9a-
tetrahydroxanthones (7). There have been synthetic studies of tetrahydroxanthones of the 
subtype 6, such as the work published by the Tietze,7–12 Nicolaou,13 Brӓse,14–20 and Porco21–
24 groups. There have also been synthetic studies on tetrahydroxanthones of the subtype 
7.25–29 The focus of this chapter will be on tetrahydroxanthones of the subtype 5.  
 
1.2  Tetrahydroswertianolin: Characterization and Structural Elucidation  
Kadota and coworkers used activity-guided fractionation to isolate a number of 
xanthone natural products from Swertia japonica Makino, a plant traditionally used in 
Japanese folk medicine for stomachaches, as a liver tonic, and febrifuge.1,30 Previously, 
Kadota and coworkers had shown that the aqueous EtOH soluble extract of Swertia 
japonica Makino exhibited hypoglycemic effects in streptozotocin (STZ)-induced diabetic 
rats.30 The authors determined that the xanthone bellidifoline (9) (Figure 1.3) was the key 
component in this fraction responsible for the hypoglycemic activity.31  
In 1997, Kadota and coworkers divided the n-BuOH soluble extract of Swertia 
japonica Makino into 8 fractions using column chromatography and tested each fraction 
in a D-GalN/LPS liver injury mouse model.2 Lipopolysaccharide (LPS) is derived from the 
cell wall of gram-negative bacteria and is known to induce multiorgan failure in animal 
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models. D-Galactosamine (D-GalN) sensitizes mice to LPS by selectively inhibiting 
transcription and protein synthesis in the liver. Thus, co-administering LPS and D-GalN to 
mice produces a liver injury model that can be used to evaluate hepatoprotective drugs. In 
this model, liver damage is measured in terms of alanine aminotransferase (ALT) levels.2  
Kadota and coworkers treated groups of mice with the 8 fractions from the n-BuOH 
soluble extract 18 h and 2 h before the D-GalN/LPS challenge. Fractions 4 and 5 showed 
significant reduction in ALT levels, indicating hepatoprotective activity. Further 
purification of these fractions gave three compounds: gentiopricroside (10a), sweroside 
(10b), and tetrahydroswertianolin (1). Compounds 10a and 10b had been isolated and 
characterized previously. Compound 1 was reported as a new tetrahydroxanthone and a 
yellow amorphous solid with [α]D20 = + 8.0° (c = 0.2, MeOH) and m/z [M+H]+ = 441.1389. 
This was the first report of a partially saturated xanthone compound being isolated from 
the Swertia species.1  
 
Figure 1.3   Compounds Isolated from Swertia japonica Makino 
The authors elucidated the structure of tetrahydroswertianolin (1) as follows.1 
Treatment of 1 with the β-glucosidase enzyme led to tetrahydrobellidifoline (11) and D-
glucose (12) (Figure 1.4 a.). Acidic hydrolysis of 1 with 5% HCl at 100 °C led to D-
glucose (12) and 1-hydro-3-methoxyxanthone (13) (Figure 1.4 b.). Nuclear Overhauser 
effect (nOe) correlations between the re hydrogen on C-7 with the hydrogen on C-8 and 
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with the hydrogen on C-5 led the authors to conclude that the relative stereochemistry of 
the hydroxyl groups were in the cis configuration (Figure 1.4 b.). The absolute 
stereochemistry of 1 was determined by Mosher’s ester analysis of the C-5 hydroxyl group 
(Figure 1.4 c.). The chemical shifts and HMBC correlations for tetrahydroswertianlin (1) 
reported by the isolation chemists are also shown below (Table 1.1). 
Further biological studies were conducted to show that tetrahydroswertianolin (1) 
induced the most significant ALT level decrease compared to control groups, compounds 
9, 10a, and 10b, and to glycyrrhizin (GCR) a known hepatoprotective agent.2 In a separate 
experiment, the authors concluded that tetrahydroswertianolin (1) blocked tumor necrosis 
factor-α (TNF-α) production and proposed this as a possible mechanism of action in the 
reduction of hepatic apoptosis observed.3 
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Figure 1.4   Structural Elucidation of Tetrahydroswertianolin by the Isolation Group 
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Table 1.1   Chemical Shifts and HBMC Correlations of Tetrahydroswertianolin Reported by 
Isolation Group 
 
Atom No. δH, J, integration (CD3OD) δC (CD3OD) HMBC  
1 -- 163.05 2-H 
1-OH 12.45 (s, 1H)  -- 
2 6.29 (d, J = 2.0 Hz, 1H) 99.16 -- 
3 -- 167.42 2-H, 4-H 
3-OMe 3.86 (s, 3H) 56.51 -- 
4 6.59 (d, J = 2.0 Hz, 1H) 93.50 -- 
4a -- 159.04 4-H 
4b -- 168.66 5-H, 8-H 
5 4.59 (dd, J = 9.5, 7.0 Hz, 1H) 67.50 -- 
6 2.11 (m, 2H) 27.35 8-H 
7 
1.79 (br tt, J = 13.5, 3.0 Hz, 1H, 7-Hax) 
2.30 (dq, J = 13.5, 3.0, 1H, 7-Heq) 
27.92 8-H 
8 4.95 (t, J = 3.0 Hz, 1H) 71.11 7-H 
8a -- 118.04 7-H, 8-H 
9 -- 183.09 8-H 
9a -- 106.22 2-H 
1′ 4.68 (d, J = 8.0 Hz, 1H) 105.18 8-H 
2′ 3.17 (dd, J = 9.0, 8.0 Hz, 1H) 75.66 -- 
3′ 3.41 (t, J = 9.0 Hz, 1H) 77.84 -- 
4′ 3.30 (m, 1H) 71.53 -- 
5′ 3.34 (m, 1H) 78.13 -- 
6′ 
3.70 (dd, J = 12.0, 5.0 Hz, 1H, 6′-Ha) 
3.89 (dd, J = 12.0, 2.0 Hz, 1H, 6′-Hb) 
62.76 -- 
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1.3  Puniceaside B: Characterization and Structural Elucidation  
Guo and coworkers isolated puniceaside B (2) along with puniceasides A (15) and 
C-E (16-18) (Figure 1.5) from Swertia punicea, a plant that has been used to treat fever, 
intoxication, jaundice, and cholecystitis in Chinese folk medicine.4   
 
Figure 1.5   Puniceaside A and C-E 
The structure of 2 was elucidated as follows. The proton signals at δ 1.68, 1.98, and 
2.18 along with their COSY and HMBC correlations suggested that 2 contained saturated 
carbons; these signals were also very similar to the methylene signals found in 
tetrahydroswertianolin (1). The nOe correlations observed between H-5 and H-8 led to a 
cis configurational assignment. Interestingly, the resonance for 6ʹ-H appeared as two 
singlets at ambient temperature (δ 7.10 and 7.12) which suggested that 2 could exist as a 
mixture of two atropisomers. However, heating the 1H NMR sample in (CD3)2SO to 120 
°C led to coalescence of the two signals (δ 7.10 and 7.12) to one singlet at δ 7.14. Finally, 
acid hydrolysis of puniceaside B (2) gave D-glucose. However, the isolation chemists did 
not determine the absolute stereochemistry of 2. The chemical shifts and key COSY and 
HMBC correlations for 2 are shown below (Table 1.2). 
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Table 1.2   Chemical Shifts and COSY and HBMC Correlations for Puniceaside B Reported by 
Isolation Group 
 
Atom No. δH, J, i ((CD3)2SO) δC ((CD3)2SO) COSY HMBC  
1 -- 159.1 -- -- 
2 -- 107.1 -- 4-H, 6′-H 
3 -- 162.3 -- -- 
4 6.54 (s, 1H) 93.3 -- -- 
4a -- 156.2 -- -- 
4b -- 167.3 -- 6-H 
5 4.55 (m, 1H) 65.5 6-H, 7-H, 8-H 6-H, 7-H 
6 1.98 (m, 2H) 26.5 5-H, 7-H, 8-H -- 
7 
1.68 (m, 1H) 
2.18 (m, 1H) 
27.1 
5-H, 6-H, 8-H 
-- 
8 4.89 (brt, J = 2.1 Hz, 1H) 68.6 5-H, 6-H, 7-H 7-H, 6-H, 1ʺ-H 
8a -- 116.4 -- 7-H 
9 -- 181.0 -- -- 
9a -- 103.4 -- 4-H 
1′ -- 162.3 -- 2′-H 
2′ 6.23 (brs, 1H) 98.5 -- 4′-H 
3′ -- 166.5 -- 2′-H 
4′ 6.44 (brs, 1H) 94.4 -- 2′-H 
4a′ -- 157.6 -- -- 
4b′ -- 142.9 -- 6′-H 
5′ -- 136.5 -- 6′-H 
6′ 7.10 (s), 7.12 (s) (1H) 126.7 -- -- 
7′ -- 114.6 -- -- 
8′ -- 150.1 -- 6′-H 
8a′ -- 108.0 -- -- 
9′ -- 183.9 -- -- 
9a′ -- 101.2 -- 2′-H, 4′-H 
1ʺ -- 162.3 -- 8-H 
2ʺ 2.92 (m, 1H) 74.0 -- -- 
3ʺ 3.15 (m, 1H) 76.6 -- -- 
4ʺ 3.05 (m, 1H) 70.1 -- -- 
5ʺ 3.16 (m, 1H) 77.0 -- -- 
6ʺ 
3.69 (brd, J = 12 Hz, 1H) 
3.44 (m, 1H) 
61.1 
-- 
-- 
 
  
9 
1.4  Related Tetrahydroxanthone Natural Products 
Glycosylated tetrahydroxanthone natural products related to tetrahydroswertianolin 
(1) and puniceaside B (2) are shown below (Figure 1.6). Campestroside (19)32 is a 
demethylated analogue of tetrahydroswertianolin (1); the unnamed THX 20 isolated in 
201333 is a regioisomer of 1 where the sugar moiety is attached to the secondary alcohol at 
C-4 rather than at C-1. Kigamicin A-D (21a-d) are glycosylated tetrahydroxanthone natural 
products with an annulated isoquinolinone moiety.34–36    
 
Figure 1.6   Related Glycosylated Tetrahydroxanthone Natural Products 
Several related tetrahydroxanthone natural products which lack the sugar moieties 
are shown below (Figure 1.7). Kibdelones A-C (22a-c) are hexacyclic tetrahydroxanthone 
natural products that were isolated from a rare Australian microbe.37 Simaomicin α (23) 
was isolated from actinomycete culture broth and has the same diol substitution as 
tetrahydroswertianolin (1) in its partially saturated tetrahydroxanthone ring but with trans 
stereochemistry. The compound showed promising anticoccidial activity when used in 
chicken feed.38–41 Actinoplanone (24)42 and albofungin (25) 43 are tetrahydroxanthone 
natural products that were isolated over 20 years ago, but their syntheses have not yet been 
reported in the literature. The hexacyclic cores found in both 24 and 25 map onto the 
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hexacyclic framework found in the kibdelones (22a-c) and simaomicin α (23) but vary in 
their functional decoration of the AB and F rings.  
 
Figure 1.7   Related Tetrahydroxanthone Natural Products 
 
1.5  Biosynthesis  
To our knowledge, the biosynthetic pathways of tetrahydroswertianolin (1) and 
puniceaside B (2) have not yet been reported in the literature. There have been reports on 
studies of the biosynthetic pathways of simaomicin α44 (Figure 1.7) and structurally related 
polycyclic xanthones, such as lysolipin X (26a)45 and I (26b),46 FD-594 (27),47,48 
arixanthomycin (28),49 citreamicin (29),50 and xantholipin (30)51,52 (Figure 1.8); 
oxygenated xanthones;53–59 and secalonic acids A and D,60–63 which are 2,3,4,4a-
tetrahydroxanthone natural products that were synthesized by Porco and coworkers.22 In 
this section, we describe the biosynthetic studies of simaomicin α by Borders and 
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coworkers in 1989 and the biosynthetic study of xantholipin by You and coworkers. 
 
Figure 1.8   Related Polycyclic Xanthone Natural Products 
Borders and coworkers extracted and analyzed the products that were produced 
when 13C labeled acetate and methionine were fed to Actimadura madurae, the bacteria 
from which simaomicin α (23) was isolated.50 The authors concluded that the vinyl methyl 
group and all of the carbons in the hexacyclic core of 23 were derived from acetates based 
on the incorporation of the 13C labeled acetate groups. Additionally, 18O labeling 
experiments indicated that the oxygen on C-12 was surprisingly from molecular oxygen. 
The authors also concluded that the -NCH3, -OCH3, and -OCH2O- (methylene bridge in 
the dioxane ring) groups were derived from the methionine based on the incorporation of 
the labeled 13CH3. From these results, the authors proposed that biosynthetically, 
simaomicin α (23) was derived from the cyclization of a single polyketide chain followed 
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by oxidative cleavage, loss of CO2, and further functionalization via condensation, 
dehydration, oxidation, reduction, and amination (Scheme 1.1).    
Scheme 1.1   Proposed Biosynthetic Pathway for Simaomicin α by Borders and Coworkers 
 In 2012, You and coworkers sequenced the entire biosynthetic gene cluster for 
xantholipin (52 kb xantholipin), conducted feeding experiments, and used bioinformatic 
analysis to propose a biosynthetic pathway for xantholipin (30).51 More recently, the 
authors published results from their in vitro isotopic labeling experiments and proposed a 
novel mechanism for xanthone formation that could be a general biosynthetic pathway for 
polycyclic xanthones.52 The authors proposed the following biosynthetic pathway for 
xantholipin (Scheme 1.2). Following the synthesis of a single polyketide chain 36, 
selective reduction at C-19 and C-17 gave 37 which then cyclized to the core of xantholipin 
(38). From this intermediate, the authors found that the CoA enzyme was cleaved and the 
intermediate was oxidized to anthraquinone 39. Selective methylation of the phenol at C-
17 mediated by S-adenosyl methionine (SAM) led to key intermediate 40. The authors 
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discovered through structural analysis that this methylation of the phenol is key to xanthone 
formation from the anthraquinone intermediate 39. 
The key mechanistic discovery You and coworkers reported relates to the 
enzymatic mechanism of XanO4, a monooxygenase that was suggested to be a member of 
the Baeyer-Villiger monooxygenases. Through their labeling experiments and detection of 
proposed intermediates via mass spectrometry, the authors proposed a double addition of 
the oxidized adenine dinucleotide (FAD) catalyzed by XanO4. Specifically, it was 
proposed that the first oxidized FAD (Fl-O-O-) added to C-17 to give enolate intermediate 
41. After epoxide formation and loss of FAD hydroxide (Fl-4a-OH), XanO4 was proposed 
to catalyze another addition of Fl-O-O- to the carbonyl at C-15 to initiate a Baeyer-Villiger 
oxidation to give carboxylic acid 45. The phenol that was expelled then opens the epoxide 
to give hemiacetal 46. A decarboxylation followed by loss of methanol gives the core (47) 
of xantholipin.   
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Scheme 1.2   Proposed Biosynthetic Pathway for Xantholipin by You and Coworkers 
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1.6  Previous Synthetic Studies of Tetrahydroxanthones 
Previous synthetic studies and biological evaluations of 1,2,3,4-tetrahydroxanthone 
natural products and analogues will be discussed herein.  
1.6.1  Porco Group: Synthesis of Kibdelones C and A 
Porco and coworkers reported the total synthesis of kibdelone C in 2011.64,65  
Kibdelones A – C (22a-c) and isokibdelone A (22d) were isolated from 
Kibdelosporangium sp. in 2006 by Capon and coworkers (Figure 1.9).37 This isolation 
group discovered that methanol equilibrated a mixture of kibdelone B and C to a mixture 
of kibdelones A, B, and C. They also showed that under aerobic conditions, kibdelone C 
(22c) oxidized to kibdelones A (22a) and B (22b). In the NCI’s 60-cell screen, kibdelone 
C showed a GI50 of <1 nM against SR tumor and SN12C carcinoma cell lines.  
 
Figure 1.9   Kibdelones A-C and Isokibdelone A 
A key step in the Porco group’s synthesis of 22c was a PtBr4 mediated arylation 
between quinone monoketal 48 and vinyl phenol 49 (Scheme 1.3). Irradiating the resulting 
biaryl compound to induce a 6π-electrocyclization followed by desilylation gave ABCD-
fragment 50 in a 34% overall yield (3 steps). Synthesis of the F ring 53 began with a halo-
Michael addition of iodide to benzyl-protected ynoate 51 by MgI2 followed by an aldol 
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condensation on the aldehyde. The diastereoselectivity of this iodo-Baylis-Hillman 
reaction66–73 was proposed to come from either chelation of the MgI2 with the benzyl ether 
α to the aldehyde,74–76 or equilibration to the thermodynamic product via a retro-halo-
Michael aldol reaction.77    
Subjecting the ABCD fragment 50 and F ring 52 to basic copper or palladium-
mediated coupling conditions showed no reactivity. Thus, fragment 52 was converted to 
acetonide 53. Porco and coworkers then found that Cu(I) was not necessary for the coupling 
of ABCD fragment 50 and acetonide 53 which proceeded with K3PO4 in DMSO at 50 °C 
in 44% yield. To cyclize ether 54 to tetrahydroxanthone 55, the methyl ester was saponified 
to the carboxylic acid in order to activate the acyl electrophile with cyanuric chloride. 
Kibdelone C methyl ether (55) was then finally elaborated to the natural product (22c).  
Scheme 1.3  Key Steps in the Porco Group’s Synthesis of Kibdelone C 
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Optical rotation was used to confirm that the absolute stereochemistry of the 
naturally isolated kibdelone C matched that of the synthetic sample as shown in Figure 
1.8. Additionally, several ABCD-ring fragments and intermediates were assessed in the 
NCI’s 60-cell screen. When this data was compared to the activity and selectivity that 
kibdelone C had against the same cell lines, it was found that the E and F rings of the 
natural product contributed significantly to cytotoxic activity.64    
Porco and coworkers then applied their convergent strategy to the synthesis of 
kibdelone A (22a) in 2013.78 The F ring precursor 58 was synthesized in collaboration with 
Professor Tomas Hudlicky and coworkers. Diol 57b was accessed via asymmetric 
dihydroxylation of methyl 2-iodobenzoate (56) using E. coli JM 109 (Scheme 1.4). The 
minor regioisomer 57 was then protected with 2,2-dimethoxypropane and a Markovnikov 
hydration employing Co(acac)2 afforded the desired F ring acetonide 53 in 48% yield (2 
steps). 
Scheme 1.4   F Ring Synthesis Employing E. coli JM 109 
 
The completely conjugated ABCD phenol 59 was synthesized by applying the 
synthetic route for the ABCD fragment 50 employed in the synthesis of kibdelone C with 
an oxidant in the 6π-electrocyclization. Unfortunately, phenol 59 did not show the same 
nucleophilic reactivity in coupling with F ring synthon 53, possibly due to the conjugation 
through the cyclohexane C ring found in phenol 59. Thus, the methyl ester 53 was 
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converted to the more reactive HFIP ester 58 via saponification and DCC coupling 
(Scheme 1.3).     
Scheme 1.5   Key Modifications in the Porco Group’s Synthesis of Kibdelone A 
 
Applying K3PO4 as the base in the coupling of HFIP ester 58 and ABCD-ring 59 in 
DMA as solvent gave ether 60. Unfortunately, the HFIP ester in compound 60 was not 
reactive enough for a direct cyclization. Thus, the previously employed (Scheme 1.3) 
strategy of saponifying the ester to the carboxylic acid followed by activation with cyanuric 
chloride was used to access kibdelone A methyl ether (61) which was further elaborated to 
the natural product kibdelone A (22a). 
1.6.2  Ready Group: Synthesis of Kibdelone C, Analogues, and Simaomicin α 
 Ready and coworkers have also been active in the field of tetrahydroxanthone 
synthesis and their biological evaluation. They published on the synthesis of kibdelone C 
in 201179 and applied their overall strategy to the synthesis of simaomicin α in 2013.80  
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The Ready group’s approach to synthesizing the tetrahydroxanthone core in 
kibdelone C started with the addition of vinyl iodide 63 to bromobenzaldehyde 62 via a 
diionic species generated by treating 63 with MeLi and t-BuLi (Scheme 1.6). After 
oxidizing the resulting secondary alcohol 64 with DMP, they then treated the resulting 
enedione with perchloric acid in acetone and t-BuOH. This removed the MOM and both 
TBS groups, cyclized the resulting compound to the tetrahydroxanthone core, and 
protected the diols as an acetonide which gave compound 66 in 66% yield (2 steps). The 
investigators observed that in the absence of acetone, the stereocenter at C-10 epimerized. 
They proposed that the likely mechanism was via the oxonium species 65 where the 
xanthone oxygen displaces the allylic alcohol at C-10.  
After reprotecting the alcohol at C-14, the AB-ring fragment was attached via 
coupling with alkyne 68 (Scheme 1.6). Hydrogenation of the alkyne bridge to an alkane, 
iodinating the B ring with I2 and Cu(I), and protecting the phenol with a Boc group gave 
intermediate 69 in 65% yield over 4 steps. The C ring was then formed using a Pd(0)-
mediated intramolecular C-H arylation process. The end game of the synthesis focused on 
chlorination and removal of the protecting groups which afforded (–)-kibdelone C (ent-
22c). The Ready group’s synthesis confirmed by optical rotation that the absolute 
stereochemistry of their synthetic sample was the enantiomer of natural kibdelone C.     
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Scheme 1.6   Key Steps in the Ready Group’s Synthesis of (-)-Kibdelone C   
 Ready and coworkers also applied this overall strategy toward the synthesis of 
simaomicin α (Scheme 1.7).80 They obtained tetrahydroxanthone 72 through acidic 
treatment of the enedione obtained from DMP oxidation of alcohol 71. In this case, they 
obtained tetrahydroxanthone 72 as a mixture of epimers at C-10 due to the fact that there 
is no α stereocenter to which an acetonide group can be anchored to retain stereochemistry. 
The stereocenter was then corrected via an oxidation with Dess-Martin periodinane (DMP) 
and a catalyst-controlled, asymmetric Noyori reduction. After further decoration of the 
aromatic ring with an acetaldehyde moiety, the AB-ring was tethered to the aldehyde to 
give intermediate 76. Excitingly, Ready and coworkers were then able to perform an direct 
dehydrogenative, biaryl coupling on the further elaborated dioxane 77 using stoichiometric 
Pd(OAc)2 in 61% yield. They proposed that the dioxane ring in 77 biased the structure 
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toward the dehydrogenative coupling. In the case of their route to kibdelone C (Scheme 
1.6), this dioxane ring is absent, and they were forced to iodinate one of the aromatic rings 
before being able to successfully form the biaryl bond through C-H arylation. With 
compound 78 in hand, global deprotection lead to (–)-simaomicin α (ent-23) (Scheme 1.7).  
Scheme 1.7   Key Steps in the Ready Group’s Synthesis of (-)-Simaomicin α  
 
The Ready group’s synthesis confirmed the structure and absolute stereochemistry 
of simaomicin α by NMR spectroscopy, UV/vis spectra, and optical rotation to be as shown 
in Figure 1.4. The natural sample of simaomicin α (23) showed G1 arrest at low nanomolar 
concentrations, had an IC50 of 11.0 nM against HCT116, a colon cancer cell line, and 
showed a minimum inhibitory concentration (MIC) of 280 nM against Bacillus subtilis.38 
Ready and coworkers tested their synthetic (–)-simaomicin α (ent-22) against HCT116 and 
found the IC50 value (21 nM) to be comparable to that of the natural sample. Their synthetic 
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ent-23 showed a similar MIC against B. subtilis as well. These data lead them to conclude 
that both enantiomers of simaomicin α have similar biological activity.   
Most recently, Ready and coworkers published on the synthesis of several 
kibdelone C derivatives and extensive biological evaluation of the natural and synthetic 
enantiomers of kibdelone C and their synthesized analogues.81 They found that both 
enantiomers of kibdelone C showed similar nM activity against the colon cancer cell line 
HCT116.80 They concluded that the nPr and chlorine groups in the A ring can be substituted 
with other alkyl groups and that the phenol in ring B on the convex face of the molecule 
can be protected with a methyl group (Figure 1.10). This methyl group stabilized the 
analogue from spontaneously oxidizing from the hydroquinone to the quinone as was first 
shown by the Porco laboratory in their synthesis of kibdelone C.65  
 
Figure 1.10  Ready Group’s Key Modifications of Kibdelone C Methyl Ether for Biological Evaluation 
Most importantly, Ready and coworkers found that the key biologically active 
motif is the biphenol core on the concave side of the molecule spanning the A, B, D, and 
E rings. Finally, they concluded that the hydroxyl groups on C-11 and C-13 in the F ring 
were not vital to the biological activity (Figure 1.10).  
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1.6.3  Shipman Group: Synthesis of Tetrahydroxanthones 
Shipman and coworkers published their Pd-catalyzed synthesis of 
tetrahydroxanthone cores in 2011.82 They synthesized a number of benzophenones such as 
79a and subjected them to Pd2(dba)3
 with XPhos as an optimal ligand, cesium carbonate as 
the base, and heating at 101 °C in dioxane. Under these basic conditions, the cyclohexanone 
tautomerized to the enol form, then underwent a migratory insertion to the Pd(II) 
intermediate after oxidative insertion into the bromobenzene. Shipman and coworkers were 
able to synthesize a variety of differentially substituted tetrahydroxanthone derivatives 
(80a-h) with their methodology (Scheme 1.8 a.).  
By employing dibromobenzene cyclohexanone 81 and adding phenyl boronic acid 
82, the authors were then able to perform a sequential Suzuki coupling to access further 
decorated tetrahydroxanthones such as 83 (Scheme 1.8 b.). They were also able to 
derivatize the partially saturated ring by synthesizing substrate 84, applying their Pd-
catalyzed cyclization conditions to access enol ether 85, deprotect the enol ether to ketone 
86, and then conduct a Noyori reduction to give tetrahydroxanthone 86 in 79% yield and 
56% ee (Scheme 1.8 c.).83 
Shipman and coworkers then tested the THX analogues82 they synthesized against 
human pancreatic cancer (PANC-1) cells using a new “antiausterity” cancer screening 
strategy.84 Kigamicin C (21c), which is known to show activity against PANC-1 cells, was 
used as a positive control. The authors found that THX 83 displayed similar “antiausterity” 
activity as kigamicin C (21c) against PANC-1 cells that were deprived of nutrients. 
Unfortunately, THX 83 was > 100 fold less active than 21c against the PANC-1 cells 
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treated under normal nutrient conditions. This suggested that other structural moieties in 
kigamicin C (21c) contribute significantly to biological activity.82 
Scheme 1.8   Shipman Group’s Synthesis of Tetrahydroxanthones 
 
Shipman and coworkers have also been actively pursuing the synthesis of 
tetrahydroxanthone natural products. Recently, they also published on their studies toward 
the amicetose sugars attached to kigamicins A-D (22a-d),83 which will be described in 
chapter 2 of this dissertation. 
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1.6.4  Gao Group: Photo-induced Synthesis of Tetrahydroxanthones 
Gao and coworkers developed a photo-induced synthesis of tetrahydroxanthones 
and published their work in 2014.85 They synthesized a number of tetrahydroxanthone 
derivatives (89a-t) by irradiating the corresponding methylated chlorocyclohexenyl (88a-
t) with tetramethylpiperidine (TMP) in acetonitrile and water (Scheme 1.9). The conditions 
the investigators developed were milder than the basic, palladium conditions developed by 
Shipman and coworkers, which required heating at 101 °C (Scheme 1.8).82 Gao and 
coworkers were able to synthesize an impressive collection of tetrahydroxanthones 
(Scheme 1.9). However, further functionalization of the partially saturated ring beyond the 
installation of a heteroatom next to C-1 (89l-n, 89p, 89r, 89t) was not reported. 
Scheme 1.9   Gao Group’s Synthesis of Tetrahydroxanthones  
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The authors proposed the following mechanism for their photo-induced synthesis 
of tetrahydroxanthones. Irradiation of chlorocyclohexenyl 88a would give the radical anion 
91 which could then follow two mechanistic pathways. In the first pathway, radical anion 
91 could lose an electron and form a C-O bond to give cycle 94 (Scheme 1.10 a.). Then 
loss of chloromethane would give tetrahydroxanthone 89a. Alternatively, radical anion 91 
could cyclize with the aromatic ring to give the enolate radical 95 which could lose HCl 
and an electron to give fluorenone 90a (Scheme 1.10 b.). This fluorenone was a byproduct 
observed in many of the reactions reported.     
Scheme 1.10  Gao Group’s Proposed Mechanism for Photolysis 
 
1.6.5  Dake Group: Intramolecular oxa-Michael/Aldol to Tetrahydroxanthones 
As a final example, Dake and coworkers published their intramolecular oxa-
Michael/aldol strategy toward synthesizing tetrahydroxanthones in 2014.86 The authors 
synthesized six different ynones (96a-e) and subjected them to 30 mol% 4-
dimethylaminopyridine (DMAP) in dichloromethane at room temperature (Scheme 1.11). 
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This induced an oxa-Michael addition followed by aldol condensation on the aldehyde to 
give a mixture of both stereoisomers of the tetrahydroxanthone (97a-b, 98a-b) or the 
tetrahydroxanthone (97c-d) and a chromone byproduct (99a-e). The authors proposed a 
conjugate addition of DMAP to the ynone moiety which initiated a Baylis-Hillman/aldol 
sequence leading to the tetrahydroxanthone core.   
Scheme 1.11  Dake Group’s Synthesis of Tetrahydroxanthones  
 
 Although Dake and coworkers were able to develop an intramolecular oxa-
Michael/aldol method toward six different tetrahydroxanthone cores, they did not report 
further decoration of the partially unsaturated ring. 
 
1.7 Conclusion  
 Tetrahydroxanthone natural products are chemically and biologically interesting 
structures that merit continued study. Several different strategies aimed at synthesizing 
these compounds have been published in the past 10 years, but there is still a need for 
continued development of synthetic strategies to access tetrahydroxanthone core structures 
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efficiently and rapidly. There are still many tetrahydroxanthone natural products that have 
not been synthetically accessed. We sought to contribute to this exciting field by targeting 
the syntheses of tetrahydroswertianolin (1) and puniceaside B (2) which will be the subject 
of the following dissertation chapters. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
29 
CHAPTER 2 
Synthetic Studies Toward Tetrahydroswertianolin 
 
2.1   Overview and Introduction 
 This chapter describes our efforts toward the total synthesis of 
tetrahydroswertianolin (1). Our synthetic strategy sought to employ a novel cascade 
reaction to access the tetrahydroxanthone core found in compound 1. We report our key 
efforts to develop such a cascade reaction. We also report our development of a stepwise 
route which fortuitously led to an intramolecular, anionic Friedel–Crafts-type cyclization 
of an aromatic ring onto an unsaturated methyl ester.  
 
2.2   Cascade Process toward Tetrahydroxanthone Core 
In order to access the tetrahydroxanthone core found in tetrahydroswertianolin (1) 
and puniceaside B (2), we envisioned a base-promoted, cascade process (Figure 2.1). An 
intermolecular oxa–Michael addition of phenol 102 to lactol ynoate 100 (likely in 
equilibrium with hydroxyl aldehyde 101) followed by an intramolecular aldol condensation 
would yield diol 104. A final Friedel–Crafts-like cyclization would then afford the 
tetrahydroxanthone core structure 105 in an efficient, cascade process.  
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Figure 2.1   Proposed Cascade Reaction to Tetrahydroxanthone Core 
 
2.2.1   Literature Precedent: oxa–Michael Additions 
Although there is precedent for oxa–Michael additions of alcohols and phenols into 
enones,87,88 we focused our attention on examples of oxa–Michael addition of phenols into 
ynones in order to find Brønsted bases, nucleophilic promoters, and Lewis acids to initiate 
our desired intermolecular oxa–Michael addition (Figure 2.1). In particular, we sought 
examples of oxa–Michael addition of phenols into ynones and ynoates. Below are select 
examples of intramolecular and intermolecular variants of these reactions. 
In 1990, Detty and coworkers reported that ynone 116, obtained via acylation of 
phenol 115 with propiolic acid 111 using Eaton’s reagent at 0 °C,  could be treated with 
catalytic K2CO3 in acetone to induce an intramolecular oxa–Michael addition into the 
ynone moiety to yield chromone 117 in 88% yield (Scheme 2.1 b.).89 The discovery of this 
oxa–Michael addition allowed them to bypass a previously developed one-pot process 
which worked well for phenyl propiolic acid (107) but not for the desired methyl propiolic 
acid (111) (Scheme 2.1 a.). 
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In their synthesis of anthrapyran AH-1763, Tietze and coworkers showed that 
reacting cesium carbonate with ynone 122 initiated an intramolecular oxa–Michael 
addition of the phenol into the ynone (Scheme 2.1 c.).90  This reaction afforded the desired 
chromone 123 in 71% yield which was further elaborated to the natural product. 
Scheme 2.1   Intramolecular oxa–Michael Addition of Phenols into Ynones 
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 Several examples of intermolecular phenol additions into ynones include the 
Suzuki group’s report91 of a PBu3 and N,N-dimethylbenzylamine (BDMA) (126)-mediated 
addition of 4-methoxyphenol (125) into acetonide 124  to afford 127  in 46% yield (Scheme 
2.2 a.); the Parker group’s report92 of a DABCO-mediated addition of iodophenol 129 into 
ynone 128 in THF to afford 130 in 70% yield (Scheme 2.2 b.); and the Zhang group’s 
report93 of a K3PO4-mediated addition of phenol 132 into diaryl ynone 131 in acetonitrile 
to give a 1:1 mixture of both E and Z alkene isomers of 133 in quantitative yield (Scheme 
2.2 c.). In each of these examples, the authors were able to induce an oxa–Michael addition 
of a decorated phenol (125, 129, and 132) into an internal ynone (124, 128, and 131). 
Scheme 2.2   Intermolecular oxa-Michael Addition of Phenols into Internal Ynones 
 
 While precedent of phenol additions into internal ynoates exists in the reported 
literature, there are far more examples of additions into terminal ynoates. For example, 
Stork and coworkers employed trimethylamine in THF to induce the addition of acetal 
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phenol 134 into methyl propiolate (135) in 89% yield (Scheme 2.3 a.).94 Tang and 
coworkers employed N-methylmorpholine (NMM) in acetonitrile to add phenol 137 to 
ethyl propiolate (138), affording 139 exclusively as the E isomer in 92% yield (Scheme 
2.3 b.).95 Dai and coworkers utilized DMAP to synthesize protected catechol 142 from 
phenol 140 and tert-butyl propiolate (141) (Scheme 2.3 c.).96  
Scheme 2.3   Intermolecular oxa-Michael Addition of Phenols into Terminal Ynoates 
 
Several key examples of phenol additions into internal alkynoates are shown below 
(Scheme 2.4). In 2007, Li and coworkers reported97 a DABCO-catalyzed oxa–Michael 
addition of phenols 144a-j to dimethyl acetylenedicarboxylate (143) to access the 
corresponding E and Z adducts  (Scheme 2.4 a.). Selectivity for the E alkene was observed 
with electron-deficient phenols (i.e. 144c, d, e, and h). Cao and coworkers98 showed that 
using a catalytic amount of triethylamine in DMSO induced an oxa–Michael addition of 
salicylaldehydes 147a-i with fluorinated internal alkynes 148a-i followed by aldol 
condensation to give chromenes 149a-i in 85-93% yields (Scheme 2.4 b.). In their total 
synthesis of (+)-lithospermic acid, Ellman and coworkers99 reported an oxa–Michael 
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addition using NaOMe and pyridine to access their desired Z alkene 152 from isovanillin 
(151) and the phenyl substituted ynoate 150 (Scheme 2.4 c.). 
Scheme 2.4   Intermolecular oxa-Michael Addition of Phenols into Internal Ynoates 
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2.2.2  Efforts Toward a Cascade Reaction: Lactol Ynoate 
With these and other literature precedents in hand, we began our studies of 
developing a cascade oxa–Michael/aldol/Friedel–Crafts-like cyclization reaction to easily 
and efficiently access the tetrahydroxanthone core. 
To begin our investigations toward the desired cascade reaction as shown in Figure 
2.1, we first synthesized the desired lactol ynoate 100 racemically as follows. A DIBAL-
H reduction of 4,4-dimethoxybutanenitrile to 4,4-dimethoxybutanal (153) followed by an 
LDA-mediated methyl propiolate (135) addition gave alcohol 154 in 61% yield (Scheme 
2.5). Stirring at room temperature in CH2Cl2 with 0.5 equivalents of (±)-camphorsulfonic 
acid (CSA) gave methoxytetrahydrofuran 155 in 93% yield. To access the desired 
hemiacetal 100, compound 155 was stirred at room temperature in a mixture of acetic acid 
and water. The water and acetic acid were then azeotropically removed with toluene and 
heptane to give 100 in 71% yield and 1:1.2 dr.  
Scheme 2.5   Synthesis of Lactol Substrate 
 
With the lactol ynoate 100 in hand, we first began by screening solvents and bases 
with 1,3-dihydroxy-5-methoxybenzene (102) to induce an oxa–Michael addition. We 
found that polar protic solvents such as MeOH and polar aprotic solvents such as DMSO, 
DMA, and DMF decomposed the lactol ynoate (100). Nonpolar solvents such as toluene, 
CH2Cl2, and THF did not solubilize phenol 102 sufficiently for reactivity. We found that 
acetonitrile was an ideal solvent for both 100 and 102. Thus, we screened a panel of 
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Brønsted bases, Morita–Baylis–Hillman promoters100–102 and Lewis acids in acetonitrile. 
A summary of conditions is shown in Table 2.1 below. 
Table 2.1   Representative Conditions Screened for Cascade Process 
 
Entry Brønsted Base 
MBH 
Promoter 
Lewis Acid Solvent Result 
1 -- PBu3 -- CH3CN No conversion 
2 
K2CO3, Cs2CO3, 
KOtBu, KOH, 
K3PO4 
-- -- 
CH3CN, 
CH2Cl2, or 
toluene 
Full conversion 
of 100; 
decomposition 
3 Et3N, DIPEA -- 
MgCl2, MgBu2, 
ZnEt2 
CH2Cl2, THF, 
toluene, or 
CH3CN 
No conversion or 
decomposition 
4 -- DABCO -- CH3CN 
Full conversion 
of 100; 
byproduct (<5%) 
5  DABCO 
M(OTf)3 
M = Sc, Yb, Eu, 
La, Sm, Gd 
CH3CN 
Full conversion 
of 100; 
byproduct (<5%) 
In general, phosphine-based MBH promoters such as PBu3 showed no reactivity 
with lactol ynoate 100 (Table 2.1, Entry 1). Inorganic bases that did not solubilize in 
acetonitrile gave an intractable mixture of byproducts or decomposition of ynoate 100. 
Employing oxophilic Lewis acids such as Mg(II) and Zn(II) with and without mild amine 
bases either gave no conversion or immediate decomposition of the ynoate 100 (Table 2.1, 
Entry 3). The use of DABCO as outlined in Entries 4 and 5 (Table 2.1) resulted in full 
conversion of 100, however none of the desired oxa–Michael addition product was 
observed. Instead, these conditions led to small quantities of an isolable byproduct. Further 
spectroscopic characterization of this byproduct revealed it to be the pyranone 156 (Table 
2.2).  
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Table 2.2   Assignment of Pyranone Byproduct: δC, δH, and HMBC Correlations 
 
Atom No. δC (CDCl3) δH (CDCl3) HMBC  
1 174.4 -- -- 
2 70.9 4.93 -- 
3 24.5 2.74, 2.30 C1, C2, C4, C5 
4 100.4 5.13 C2, C5 
5 141.0 6.53 -- 
6 92.9 5.36 C1, C2 
7 171.8 -- -- 
We hypothesized that pyranone 156 arose from the following mechanism (Scheme 
2.6). Initial addition of DABCO into ynoate 100 would give allenoate intermediate 157. 
Following a protonation to afford methyl ester 158, a second equivalent of DABCO may 
open the lactol to the alkoxyaldehyde 159. This intermediate could then undergo 
transesterification with the methyl ester to give intermediate 160. Following a 
deprotonation to the thermodynamically unfavored Z enolate 161, an oxa–Michael addition 
to the furanone would afford adduct 162. Finally, the enolate could displace the first 
equivalent of DABCO to give pyranone 156. Unfortunately, we were unable to improve 
the yield of this interesting pyranone byproduct 156 to a useful level. However, these initial 
results suggested that DABCO was a good nucleophilic promoter that merited further 
studies. 
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Scheme 2.6   Proposed Mechanism to Pyranone Byproduct 
 Since we were unable to see any incorporation of phenol 102 in the reaction, we 
then tried reacting the more soluble 3,5-dimethoxyphenol (163)  with lactol ynoate 100. 
Reacting lactol 100 and phenol 163 with a stoichiometric amount of DABCO in acetonitrile 
gave the oxa-Michael alkene product 164 in ~10% yield (Scheme 2.7). We observed an 
nOe signal between the vinyl proton on C-3 and the methine proton on C-5 and concluded 
that the product was of the Z alkene configuration (Scheme 2.7). 
Although it was exciting to see evidence of a phenol addition into our ynoate, we 
were unable to induce the next aldol reaction in our desired cascade process. With these 
results in hand, we reasoned that a protected ynoate could provide better results in our 
efforts toward developing a cascade reaction.  
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Scheme 2.7   Key Result from Reacting Lactol Ynoate with 3,5-Dimethoxyphenol 
 
2.2.3  Efforts Toward a Cascade Reaction: Protected Ynoate 
A MOM-protected ynoate was synthesized racemically as follows. An LDA-
mediated methyl propiolate (135) addition to pent-4-enal (165) gave alcohol 166, which 
was then protected with chloromethyl methyl ether to give alkene 167 (Scheme 2.8). 
Lemieux–Johnson oxidative cleavage of the terminal alkene gave poor yields, and 
scalability with such an expensive reagent seemed impractical even with an OsO4 loading 
of only 2 mol%.  
We therefore pursued a more economical procedure based on ozonolysis. 
Unfortunately, most common reductive conditions found in the literature, such as 
dimethylsulfide, triphenylphosphine, and pyridine, either gave low yields or 
decomposition. We hypothesized that this could occur through conjugate addition of these 
soft nucleophiles into the ynoate moiety in intermediate 168. Fortunately, we found that 
quenching with zinc powder activated with acetic acid cleanly afforded the desired 
aldehyde 169 in good yield (>90% even on a 20 g scale). Additionally, the desired aldehyde 
could generally be used without further purification.  
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Scheme 2.8   Racemic Synthesis of MOM-Protected Ynoate 
 
We then screened a number of Brønsted bases, Morita-Baylis-Hillman promoters 
and Lewis acids to induce a cascade oxa–Michael/aldol/Friedel–Crafts-like cyclization 
sequence to the tetrahydroxanthone core with phenol 163 (Scheme 2.9). Gratifyingly, we 
found that treatment of ynoate 169 and phenol 163 with Cs2CO3 and DABCO in 
acetonitrile at ambient temperature for 24 hours gave the oxa–Michael/aldol intermediate 
170 with a 1:1.8 dr in 34% yield on a 74 mg scale (Scheme 2.9). We found that nonpolar 
solvents such as dichloromethane and toluene gave no reactivity. Acetone as solvent also 
afforded the desired product 170, however, dry acetonitrile consistently gave the best yield 
of the desired adduct. Control experiments showed that product 170 was stable under the 
reaction conditions, but ynoate 169 decomposed. Efforts to further optimize the yield, such 
as slow addition, varying equivalents of Cs2CO3 and DABCO, and lower temperatures, 
gave similar or lower yields. Other phenols such as 102, 171, and 172 gave no oxa–Michael 
reactivity with ynoate 169 under similar conditions (Scheme 2.9).   
With our optimized conditions in hand, we scaled up to 782 milligrams. At this 
increased scale, the overall yield was reduced to 11% (Scheme 2.9). However, the 1:1.8 dr 
was maintained. Unfortunately, numerous attempts to separate the two diastereomers of 
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170 were unsuccessful, so the mixture was carried forward toward the cyclization to the 
tetrahydroxanthone core.  
Scheme 2.9   oxa–Michael/Aldol Reaction Using Cs2CO3 and DABCO in CH3CN 
 
Lithium hydroxide in water and dioxane was used to saponify the methyl ester in 
compound 170 to carboxylic acid 176a in 90% yield. We then subjected 176a to pyridine 
and Mukaiyama’s reagent (175c)i to activate the carboxylic acid in order to cyclize to 
tetrahydroxanthone 177a (Scheme 2.10). Unfortunately, we only observed decomposition 
of 176a and trace amounts of the desired compound 177a under these mild conditions. 
Harsher conditions such as cyanuric chloride (175a) and oxalyl chloride led only to 
decomposition of 176a. We hypothesized that the unprotected secondary alcohol on C-1 
could also be activated by Mukaiyama’s reagent, thereby leading to decomposition. 
 
                                                        
i Condition developed by Dr. Martin Himmelbauer (Porco Group) during the synthesis of kibdelone A 
methyl ether (unpublished results) 
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Scheme 2.10  Cyclization to TBS-Protected Tetrahydroxanthone Core 
 
When alcohol 170 was protected as silyl ether 178, the crude yield of the 
saponification to acid 176b dropped to 62% yield (Scheme 2.10). However, we were able 
to successfully activate the carboxylic acid with Mukaiyama’s reagent to afford protected 
tetrahydroxanthone 177b based on 1H NMR spectroscopy in 44% yield (crude). To explore 
the proposed deprotection sequence to tetrahydroswertianolin aglycon 105, we would need 
to scale up the synthetic sequence to cyclohexanol 170. However at this stage, we 
hypothesized that developing a stepwise route to the tetrahydroxanthone core could 
increase the overall yield and scope of the synthesis. 
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2.3  Stepwise Route to Tetrahydroxanthone Core 
Our results from the cascade studies led us to reevaluate the design and 
implementation of a stepwise route to the tetrahydroxanthone core. Thus, we built on our 
group’s previous application of MgI2 to conduct an iodo–Morita–Baylis–Hillman (iodo-
MBH) reaction on the MOM-protected ynoate we synthesized. This led to the synthesis of 
a versatile iodo ketone intermediate and the discovery of a NaOMe-mediated 
intramolecular Friedel–Crafts-like cyclization on an unsaturated methyl ester.  
2.3.1  Literature Precedent: iodo–Morita–Baylis–Hillman Reactions 
The use of MgI2 as an iodinating reagent for conjugate addition into ynoate systems 
to give Z iodo-MBH adducts is well-documented. For example, in 2006 Li and 
coworkers103 reported that 3-iodoallenoates could be synthesized in situ  from methyl 
propiolate (135) and MgI2 which could then open oxirane 180 regioselectively to give 
alkene 181 as an E/Z mixture (1:4) in 74% yield (Scheme 2.11 a.). Connell and 
coworkers104 showed MgI2 could be used to add iodide into terminal and internal ynoates 
182a-j (Scheme 2.11 b.). Subsequent trapping of the allenoate intermediates with 
aldehydes 183a-j provided Z-selective iodo-MBH adducts 184a-j, where the iodine and 
ester have a cis relationship. 
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Scheme 2.11  Precedent for MgI2 Addition into Terminal and Internal Ynoates  
  
The Frontier group has reported on the use of a key β-iodoallenolate intermediate  
in their studies toward the synthesis of phomactin A.105–107 In the authors’ retrosynthetic 
analysis of phomactin A (185), the core is proposed to come from a β-iodoallenoalate 
intermediate 187 generated from a conjugate iodination of ynone 188 (Scheme 2.12 a.). In 
model studies, it was discovered that different Lewis acids favored the vinyl iodide product 
190 while others favored the further cyclized intermediate 191 (Scheme 2.12 b.). 
Frontier and coworkers then applied these conditions to ynone 188 toward their 
synthesis of phomactin A and found that a single diastereomer of vinyl iodide 192 was 
obtained in 60% yield (Scheme 2.12 c.). Unfortunately, the stereochemistry of the 
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secondary alcohol (192) was incorrect and required inversion prior to being carried forward 
in the authors’ synthetic studies toward phomactin A (185).  
Scheme 2.12  Frontier Group’s Synthesis of Phomactin Core via β-iodoallenoate 
 
 
2.3.2  Efforts Toward a Stepwise Route 
We began our studies by employing MgI2 as the conjugate iodinating reagent with 
lactol ynoate 100. Reacting MgI2 with lactol ynoate 100 led to 2 products: cyclized diol 
193 (in 18% yield and 1.5:1 dr) and vinyl iodide 194 as a yet undetermined single alkene 
stereoisomer in 74% yield (Scheme 2.13).  
 
Entry Conditions (equiv) Solvent T (°C) Ratio (190:191) % Conversion 
1 TiCl4 (1.2), NaI (1.1) CH2Cl2 -78 to 0 6:1 50 
2 TiCl4 (1.2), TBAI (1.1) CH2Cl2 -78 to 0 5:1 100 
3 TiCl4 (1.3), TBAI (1.3) CH2Cl2 -78 to 0 >20:1 100 
4 CeCl3 (1.2), NaI (1.1) CH3CN 23 >20:1 50 
5 BF3•OEt2 (1.3), TBAI (1.3) CH2Cl2 -40 to 0 <1:20 100 
      
  
46 
Scheme 2.13  Use of MgI2 on Lactone Ynoate 
 
We screened additives (NEt3, pyridine, DIPEA) with the MgI2 to open the lactol to 
the alkoxy-aldehyde form in order to favor production of diol 193 as the major product. 
Unfortunately, all attempts gave 194 as the major product or resulted in overall lower yield 
via decomposition of 100. We also screened other iodine sources (TBAI and NaI) to see if 
the selectivity would change, but all conditions led to no conversion or decomposition of 
100. With these results, we decided to turn our efforts toward developing a stepwise route 
with the protected ynoate 169.   
As expected, reacting 169 with MgI2 gave iodocyclohexanol 195 with a 1:1 dr and 
in 68% yield (Scheme 2.14). We then applied the K3PO4 in polar solvents (DMF, DMA, 
and DMSO) conditions that were employed in the synthesis of kibdelones C (22c) and A 
(22a) by Porco and coworkers65 (Scheme 1.3, 1.5) in order to couple 195 with phenol 163 
in order to access intermediate 170 (Scheme 2.14). However, all conditions in polar aprotic 
solvents with base led to decomposition of 195. We hypothesized that the unprotected 
secondary alcohol at C-8 led to decomposition pathways via SN2’ reaction at the iodo 
carbon C-4, much like the epimerization Ready and coworkers79 observed under their acid-
mediated cyclization of enedione to give diol 72 (Scheme 1.7). We hypothesize that we 
also observed this SN2’ reactivity in our attempts to cyclize the unprotected carboxylic acid 
176a to the tetrahydroxanthone core (Scheme 2.10).  
  
47 
Milder bases such as amines (Et3N, pyridine, DIPEA) gave no reactivity in our 
attempts to couple 195 with phenol 163, while Ullman coupling conditions employing 
Cu(I) led to decomposition (Scheme 2.14). Thus, we elected to oxidize the secondary 
alcohol in compound 195, which we reasoned would: 1) protect the secondary alcohol and 
2) further activate 195 as an oxa–Michael acceptor. Employing Dess-Martin periodinane 
(DMP) as the oxidant cleanly gave iodo ketone 196 in 90% yield (Scheme 2.15). We then 
screened bases that would promote displacement of the vinyl iodide with phenol 163. 
Scheme 2.14  Summary of Efforts to Couple Iodo Cyclohexanol with 3,5-Dimethoxyphenol 
   
We found that stirring ketone 196 with phenol 161 in nonpolar solvents with 
inorganic bases (K3PO4, Cs2CO3, K2CO3) and DABCO cleanly gave the desired ether 
compound 198 (Scheme 2.15). Our optimized conditions utilized stoichiometric K3PO4 
and catalytic DABCO while heating at 40 °C in CH2Cl2, which provided ether 198 in a 
90% yield. Although the coupling reaction proceeds with K3PO4 alone, it was accelerated 
by and proceeded at a lower temperature with a 20 mol% loading of DABCO. We 
hypothesized that DABCO may be creating a more reactive enamine intermediate such as 
197 by displacing the vinyl iodide.   
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Scheme 2.15  Oxidation to Iodo Ketone 
 Reduction of ketone 198 proved to be difficult as the ether bond formed in the 
previous step was found to be labile under basic and nucleophilic conditions. Reduction 
with DIBAL in CH2Cl2 at -78 °C gave the desired secondary alcohol 170 in 47% yield 
(60% brsm) as a 4.8:1 mixture of diastereomers (Table 2.3, Entry 1). Unfortunately, this 
condition gave lower and inconsistent yields when run on larger scale (>200 mg). When 
different solvents or longer reaction times were employed in attempts to induce complete 
conversion, an expected byproduct wherein the methyl ester was reduced to the aldehyde 
was observed (Table 2.3, Entry 2). Organic solvent soluble borohydride reagents such as 
tetramethylammonium triacetoxyborohydride and tetrabutylammonium borohydride gave 
no conversion. Sodium borohydride in methanol gave complete degradation of ketone 198, 
while nonpolar solvents such as dichloromethane gave no conversion likely due to the 
insolubility of sodium borohydride.  
Conditions employing sodium borohydride were optimized by screening additives 
such as Lewis acids, solvents, temperature, and reaction time. The optimized conditions of 
employing NaBH4, AcOH, and MeOH and stirring at ambient temperature afforded the 
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desired secondary alcohol 170 in 65% yield and a dr of 3:1, favoring the same diastereomer 
as in Entry 1 (Table 2.3, Entry 7). We then compared this to the diastereomeric ratio of 
the cascade reaction (Scheme 2.9) and found that the major diastereomer in this case was 
the opposite of that observed in the cascade reaction. 
Table 2.3   Summary of Optimization of Ketone Reduction 
 
Entry 
Reductant 
(equiv) 
Solvent 
Additive 
(equiv) 
Temp 
(°C) 
Time 
(h) 
Yield dr 
1 DIBAL (1.1) CH2Cl2 -- -78 6 
47% (60% brsm); 111 
mg scale 
37%; 1.1 g scale 
4.8:1 
2 DIBAL (1.1) THF -- -78 24 
Reduction of ester 
observed 
-- 
3 NaBH4 (1.1) MeOH -- -78 3 Decomposition  
4 NaBH4 (1.1) CH2Cl2 -- 23 24 No conversion -- 
5 NaBH4 (1.1) CH2Cl2 CeCl3•7H2O -78 3 Decomposition -- 
6 NaBH4 (1.1) CH2Cl2 MeOH (23) -78 3 52%; 101 mg scale 3.5:1 
7 NaBH4 (1.5) CH2Cl2 
AcOH (1.2) 
MeOH (1.5) 
23 3 65%; 541 mg scale 3:1 
 
With the desired compound 170 in hand, we reasoned that we could carry this 
material forward to optimize the sequence of TBS-protection, saponification, and 
Mukaiyama’s reagent-induced cyclization to get to TBS-protected tetrahydroxanthone 178 
(Scheme 2.10). However, a selective demethylation and TBS deprotection would still need 
to be explored to access tetrahydroswertianolin aglycon (105). Since we opted for a 
stepwise route that led us to iodo ketone 196, we decided that we did not need to limit 
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ourselves to the doubly alkylated phenol 163, and we explored if other nucleophiles could 
displace the vinyl iodide in 196. 
 Gratifyingly, we found that other phenols could participate in the oxa–Michael 
addition/iodide displacement on ketone 196 (Scheme 2.16). We found that the addition of 
bis-TIPS phloroglucinol (171) and of mono-TIPS phloroglucinol (172) into ketone 196 
afforded ether compounds 199 and 200 in 67% and 65% yield, respectively.    
We then conducted and optimized the sodium borohydride reduction for ether 
compounds 199 and 200 to afford alcohols 173 and 174, respectively (see Experimental 
Section, page 89 – 92). Compound 199 was more sluggish than compound 200 under the 
reduction conditions. For compound 174, we were able to determine the diastereomeric 
ratio by integration of the MOM group methylene protons in the 1H NMR spectrum to be 
3.3:1. For compound 173 the proton signals for both diastereomers overlapped. Integration 
of the 13C peaks for compound 173 allowed us to tentatively determine the dr to be ~2.9:1. 
Unfortunately, the diastereomers for both compound 173 and 174 could not be separated 
by column chromatography.   
Most excitingly we found that monomethoxy phloroglucinol (102) also reacted 
with iodo ketone 196 to afford adduct 201 in 67% yield (Scheme 2.16). Unlike for the 
other more soluble phenols 163, 171, and 172, isopropanol or acetone had to be used as a 
co-solvent due to the expected insolubility of phenol 102 in dichloromethane. When 
methanol was used as the co-solvent in this addition reaction, a methanol adduct with iodo 
ketone 196 was observed by MS and 1H NMR. Reduction of compound 201 with sodium 
borohydride afforded alcohol 104 as a 4:1 mixture of diastereomers in 42% yield.  
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Scheme 2.16  Phenol Additions to Iodo Ketone and NaBH4 Reduction 
 Gratifyingly, we were able to enrich most of the major product from the 4:1 
diastereomeric mixture of the monomethoxy alcohol 104 by recrystallization. This allowed 
us to cleanly isolate and assign the relative stereochemistry of the major diastereomer. We 
obtained an X-ray crystal structure which showed that the major diastereomer had a cis 
configuration of the hydroxyl and -OMOM groups (Figure 2.21). Conversely, for the 
dimethoxy compound 170 and both of the TIPS substrates 173 and 174, we were unable to 
separate the diastereomers to assign the relative stereochemistry of the major product. We 
plan to remove the TIPS groups in 173 and 174 to see if we can recrystallize the major 
diastereomer in order to assign the relative stereochemistry.  
 
Figure 2.2  X-Ray Crystal Structure of Major Diastereomer of Monomethoxy Cyclohexanol  
 We ran a geometry optimization on ketone 201 using DFT (B3LYP/6-31G**/gas 
phase) and found that the MOM group blocks the axial attack of the ketone on the top face 
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of the cyclohexene ring depicted in the minimized structure (Figure 2.3). Additionally, the 
re face hydrogen on the carbon α to the ketone is in the axial configuration which would 
block attack of the hydride from the re face. We postulate that axial addition of the hydride 
from the unhindered face is favored, leading to the observed cis diastereomer as the major 
product.   
 
Figure 2.3  Geometry Optimization of Monomethoxyketone 201 (DFT, B3LYP/6-31G**/gas phase) 
Additionally, compounds 174 and 104 were useful because we found a way to 
bypass the TBS protection and Mukaiyama’s reagent-induced cyclization to the 
tetrahydroxanthone core (Scheme 2.10). We hypothesized that we could use the free 
hydroxyl group to induce a Friedel–Crafts-type cyclization directly on the unsaturated 
methyl ester. We screened inorganic and organic bases, solvents, and temperatures; a 
representative table of conditions is shown below (Table 2.4). We found that reacting 174 
(4.6:1 dr) with NaOMe in 1,2-dichloroethane (DCE) using powdered 4 Å molecular sieves 
and heating in the microwave at 60 °C for 1 hour afforded the desired cyclized product as 
a single regioisomer (202) in 39% yield and 3.3:1 dr (Table 2.4, Entry 10). The 
regioisomer was determined to be tetrahydroxanthone 202 and not compound 203 by the 
downfield exchangeable proton at δ 12.29 and 12.24 ppm in the proton NMR, which we 
reasoned was due to hydrogen bonding with the ketone.  
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Table 2.4   Summary of Optimization of Friedel–Crafts-type Cyclization  
 
Entry 
Base  
(equiv) 
Solvent Additive 
Temp  
(°C) 
Time 
(h) 
Result 
1 Cs2CO3 (1.0) DCE 4 Å m.s. 80 12 decomposition 
2 KOtBu (1.0) DCE 4 Å m.s. 80 16 no conversion 
3 
Al(OiPr)3 
(1.0) 
DCE 4 Å m.s. 80 
48 
no conversion 
4 NaOH (1.0) DCE 4 Å m.s. 80 2 trace product 
5 NaOMe (1.0) DCE 4 Å m.s. 80 3 trace product 
6 NaOMe (1.0) DCE 4 Å m.s. μw 60 1 trace product 
7 
NaOMe 
(0.25) 
DCE 4 Å m.s. μw 60 
1 
no conversion 
8 NaOMe (5.0) DCE 4 Å m.s. μw 60 1 202, 20% 
9 NaOMe (5.0) DCE -- μw 60 1 no conversion 
10 NaOMe (5.0) DCE 
Powdered 
4 Å m.s. 
μw 60 
1 
202, 39%, 3.3:1 dr 
 
We then applied these conditions to compound 104. Pleasingly, we found that the 
NaOMe-induced cyclization in DCE of 104 afforded the desired tetrahydroxanthone 204 
in 53% yield (71% brsm) (Scheme 2.17). Additionally, the desired regioisomer was the 
only product observed. A possible mechanism we propose is shown below. Chelation of 
the sodium cation with the methyl ester (205) could favor the Friedel–Crafts-type 
cyclization at the ortho position over the para position relative to the phenolate (Scheme 
2.17).  
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Scheme 2.17  Cyclization to Tetrahydroxanthone Core with NaOMe and Possible Mechanism 
 
In an effort to obtain complete conversion, the reaction was conducted at higher 
temperatures. Temperatures higher than 70 °C led to a byproduct where the phenol reacts 
in an SN2 fashion with the solvent (DCE) to give alkylated alcohol 206 (Scheme 2.18 a.). 
Longer reaction times at temperatures lower than 70 °C led to complete conversion, 
however lower overall yield. More concentrated reaction conditions also gave lower yields. 
When these conditions were applied to a 2:1 (cis:trans) mixture of 104, the cyclized 
product ratio came out to be 1.5:1 (cis:trans) (Scheme 2.18 b.). From these results, we 
could hypothesize that the cis diastereomer undergoes decomposition faster than the trans 
diastereomer under the reaction conditions. Confirmation of this hypothesis would require 
isolation of the trans diastereomer and subjection to the same reaction conditions. 
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Scheme 2.18  Efforts Toward Optimization of Cyclization to the Tetrahydroxanthone Core 
 
The MOM group was then removed under acidic conditions in tert-butanol and 
dichloromethane (Scheme 2.19 a.). The core of tetrahydroswertianolin (105) was afforded 
in 36% yield (53% brsm). Subjecting a 1.3:1 dr mixture of 204 to the acidic tert-butanol 
deprotection conditions gave tetrahydroswertianoolinn aglycon (105) as a 1.4:1 dr mixture 
(Scheme 2.19 b.). When methanol was used as a co-solvent instead of tert-butanol, the 
methoxylated byproduct (208) was obtained in 54% yield (Scheme 2.19 c.). We propose 
that this byproduct results from an oxonium intermediate (207) generated via acid-
catalyzed dehydration of the tetrahydroxanthone (Scheme 2.19 c.). The diastereomeric 
ratio of this byproduct was about the same (2.6:1 based on 1H NMR integration) as the 
  
56 
starting material dr of 2.4:1. However, the relative stereochemistry of the major 
diastereomer as not yet been determined.  
Scheme 2.19  Synthesis of (±)-Tetrahydroswertianolin Aglycon 
 
 
2.4  Studies Toward Asymmetric Synthesis of Tetrahydroswertianolin Core 
With the synthetic studies on the racemic substrate in hand, we sought to synthesize 
the tetrahydroswertianolin core in an asymmetric fashion. We report our optimized 
asymmetric route to the iodo ketone intermediate toward the tetrahydroswertianolin core.  
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Pu and coworkers reported that octahydro-BINOL catalyst (S)-209 gave 95% ee in 
the methyl propiolate (135) addition to pent-4-enal (165) mediated by Et2Zn to give the S 
enantiomer of alcohol 166 (Scheme 2.20).108 Thus, to synthesize enantiopure MOM-
protected ynoate 169, we sought to synthesize the enantiomer of Pu and coworkers’ 
catalyst.  
Scheme 2.20  Pu Group’s Asymmetric Methyl Propiolate Addition to Pent-4-enal 
 
The synthesis of catalyst (R)-209 started with the hydrogenation of (R)-BINOL 
(210) to (R)-octahydro-BINOL (211) employing H2 and 5 mol% of Adam’s catalyst (PtO2) 
in acetic acid using a procedure reported by Schaus and coworkers.109 Bromination using 
Br2 gave 212 in good yield.
108 Pu and coworkers reported a boronic ester as a successful 
partner for the Suzuki coupling toward catalyst (S)-209. However, we found that boronic 
acid 215 was an adequate partner for the Suzuki coupling. Boronic acid 215 was 
synthesized in 55% yield via a methylation of 4-tert-butylphenol (213), monobromination 
with Br2,
108 and finally a lithium-halogen exchange with n-BuLi and quenching with 
triisopropylborate which was hydrolyzed under acidic workup conditions (Scheme 2.21). 
The Suzuki coupling between brominated (R)-octahydro-BINOL (212) and boronic acid 
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215 gave the desired catalyst (R)-209 under Pd0 conditions in 50% yield on a 420 milligram 
scale (27% yield on a 5.2 g scale).  
Scheme 2.21  Suzuki Coupling Between Bromo-H8-BINOL and Boronic Acid 
 
We iteratively repeated the asymmetric addition of methyl propiolate (135) to pent-
4-enal (163) using catalyst (R)-209. This enantiopure alcohol (R)-166 was then taken 
through the synthetic sequenced optimized with the racemic material to give iodo ketone 
(R)-196 (Scheme 2.22). 
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Scheme 2.22  Asymmetric Synthesis of Iodo Ketone 
 
The specific rotation of alcohol 166 we obtained employing catalyst (R)-209 was 
found to be [α]D = –9.64 (c = 1.06, CHCl3). The specific rotation of compound (S)-166 
synthesized by Pu and coworkers (Scheme 2.20) was reported to be [α]D = + 9.99 (c = 1.06, 
CHCl3).
108 We therefore concluded that we had synthesized our desired R enantiomer of 
alcohol 166. 
We also derivatized alcohol 166 with both enantiomers of 3,3,3-trifluoro-2-
methoxy-2-phenylpropanoic acid (MTPA or Mosher’s acid) to confirm that the absolute 
stereochemistry was of the R configuration (Scheme 2.23, Figure 2.4). Further 
confirmation of the absolute stereochemistry via derivatization of alcohol 166 with both 
enantiomers of α-methoxyphenylacetic acid (MPA or O-methyl-mandelic acid) are 
currently underway.110 
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Scheme 2.23  Absolute Stereochemistry Determination by Mosher’s Ester Analysis 
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Figure 2.4  1H NMR Spectra for MTPA Adducts with Alcohol (R)-166 
 
 
2.5  Future Work: Glycosylation and Reactivity Studies   
With an optimized route to the core of tetrahydroswertianolin, future work will 
focus on glycosylation and reactivity studies on the tetrahydroxanthone core and 
completion of the total synthesis using enantiopure iodo ketone (R)-196. Our aim is to 
apply dehydrative glycosidation in the synthesis and explore the nucleophilic and 
electrophilic reactivity of the tetrahydroxanthone core.  
In a dehydrative glycosidation, the glucose donor is normally activated with a 
dehydrating reagent and the reactive electrophilic intermediate is then captured by a 
glucose acceptor. Several examples of reagent controlled dehydrative glycosidations are 
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described below (Scheme 2.24). Gin and coworkers111–113 developed the use of a 
thiosulfonium dehydrating reagent that is generated in situ by mixing dimethyl sulfide with 
triflic anhydride. The authors propose that this diosulfonium (222) then activates the 
anomeric hydroxyl group in the glucose donor to generate intermediate 223 which is then 
attacked by the glucose acceptor. Panza and coworkers114 utilized Hendrickson’s reagent 
or triphenylphosphonium anhydride (POP) (227) to activate the anomeric hydroxyl group. 
The authors were able to synthesize trehalose like dimeric glucose structures (226a-d). 
More recently, Bennett and coworkers115,116 activated the anomeric hydroxyl group with 
an electron deficient, Ts-protected imidazole (229) and used the potassium salt of several 
sulfur nucleophiles (230) to synthesize compounds 231a-d. 
We propose utilizing dehydrative glycosylation to glycosylate tetrahydroxanthone 
235 (Figure 2.5). Alternatively, we would also like to explore the possibility of using 
tetrahydroxanthone 235 as the glucose acceptor and acetylated glucose 239c as the glucose 
donor under dehydrative conditions. To that end, we are planning to dehydrate 235 with 
Tf2O (237) and then quench with simpler nucleophiles, such as isopropanol (239a) or 
thiophenol (239b), to explore the chemical reactivity of the tetrahydroxanthone core. As a 
preliminary result, we had observed elimination of the allylic alcohol and addition of 
methanol under acidic methanolic conditions (Scheme 2.18).  
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Scheme 2.24  Examples of Dehydrative Glycosidations 
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Figure 2.5  Possible Strategies for Glycosylation of Tetrahydroxanthone Core  
Should our planned dehydrative glycosidations be unsuccessful, there are other 
glycosylation strategies that could be applied as well. As one example, Shipman and 
coworkers83 demonstrated the use of a trichloroacetimidate to glycosylate 
tetrahydroxanthone core 87 (Scheme 1.8) to access compound 244 in their studies toward 
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kigamicin A (21a) (Scheme 2.25 a.). In this case, the stereochemical control of the ametose 
sugar found in 21a is challenging as it lacks a hydroxyl group at the C-2 position. Lowary 
and coworkers117 used the trichloroacetimidate intermediate 245 to access the β isomer of 
the azido ether 246 (Scheme 2.25 b.). Anchimeric stabilization of the neighboring acetate 
group allows for this stereoselectivity. Liu and coworkers118 also used this effect to 
synthesize the α glycosylated ursanol 249 from trichloroacetimidate 247 (Scheme 2.25 c.).  
Scheme 2.25  Examples of Trichloroacetimidate Glycosylations 
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2.6  Conclusion 
In summary, we have presented our work on the development of a cascade reaction 
and a stepwise route to the tetrahydroxanthone core found in tetrahydroswertianolin and 
puniceaside B. Key reactions developed include a cascade oxa–Michael/aldol reaction 
between a MOM-protected ynoate and 3,5-dimethoxyphenol; synthesis of a versatile iodo 
ketone intermediate that was successfully reacted with four different phloroglucinol 
derivatives; and development of an intramolecular, anionic Friedel–Crafts-like cyclization 
of an aromatic ring onto an unsaturated methyl ester. Further tetrahydroxanthone reactivity 
studies and glycosylations are ongoing in order to finish the total synthesis of 
tetrahydroswertianolin.  
 
2.7  Experimental Section 
2.7.1  General Information 
The Scilligence ELN Reaction Planner (Scilligence Corp.) was used for 
experimental procedure planning. All reactions were performed in round-bottomed flasks 
under argon or nitrogen atmosphere, unless otherwise noted. Thermolyses were conducted 
in Teflon® capped, heavy wall sealed vials (Chemglass CG-1880) to minimize 
solvent/reagent evaporation. Stainless steel needles (Chemglass CG-3075) and Norm-
Ject™ syringes were used to transfer air-sensitive reagents. Analytical thin layer 
chromatography (TLC) was performed using 0.25 mm silica gel 60-F plates (Silicycle, 
Inc.). Ozonolysis was conducted with a Welsbach T-series ozonator (6 psi stream of 
oxygen; 60 volts). Flash chromatography was performed using 200-400 mesh silica gel 
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(Sorbent Technologies, Inc.). Preparative HPLC was performed on a Gilson PLC2020 
using a Waters SunFire™ Prep C18 OBD™ 5µm 19X50 mm column. Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.   
All 1H NMR spectra were recorded at 400 or 500 MHz at ambient temperature with 
CDCl3 (Cambridge Isotope Laboratories, Inc.) as the solvent, unless otherwise stated. All 
13C NMR spectra were recorded at 100 or 125 MHz at ambient temperature with CDCl3 as 
the solvent, unless otherwise stated. Chemical shifts are reported in parts per million 
relative to CDCl3 (
1H, δ 7.26; 13C, δ 77.1), CD3OD (1H, δ 3.31; 13C, δ 49.0), or (CD3)2SO 
(1H, δ 2.50; 13C, δ 39.5), unless otherwise stated.  
Data for 1H NMR are reported as follows: chemical shift, multiplicity (s = singlet; 
d = doublet; t = triplet; q = quartet; m = multiplet; br = broad; ovrlp = overlapping), 
coupling constants (J values), and integration. All 13C NMR spectra were recorded with 
complete proton decoupling.  
Infrared spectra were recorded on a Bruker ALPHA FT-IR spectrometer. High-
resolution mass spectra were obtained at the Boston University Chemical Instrumentation 
Center using a Waters Q-TOF mass spectrometer. Melting points were recorded on a Mel-
temp apparatus (Laboratory Devices). Analytical LCMS was performed on a Waters 
Acquity UPLC (Ultra Performance Liquid Chromatography (Waters MassLynx Version 
4.1) with a Binary solvent manager, SQ mass spectrometer, Water 2996 PDA (PhotoDiode 
Array) detector, and ELSD (Evaporative Light Scattering Detector). An Acquity UPLC 
BEH C18 1.7μm column was used for analytical UPLC-MS. Optical rotations were 
recorded on an AUTOPOL III digital polarimeter at 589 nm, and specific rotations are 
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given [α]D (concentration in grams/100 mL solvent). Chiral HPLC analysis of 
enantioenriched compounds was performed using a Waters 1525 Binary HPLC Pump with 
a Waters 2487 diode array detector.  
HPLC grade tetrahydrofuran, methylene chloride, diethyl ether, toluene, 
acetonitrile, and benzene were purchased from Fisher and VWR and were purified and 
dried by passing through a PURE SOLV® solvent purification system (Innovative 
Technology, Inc.). Anhydrous dimethoxyethane from Sigma Aldrich was degassed using 
freeze-pump-thaw. Reagents were purchased from Strem, Sigma Aldrich, Acros, TCI, Alfa 
Aesar, and Oakwood, and they were used as received unless otherwise noted.   
2.7.2 Experimental Section: Cascade Reaction 
4,4-Dimethoxybutanal (153): 
To 4-dimethoxybutanenitrile (992 mg, 7.68 mmol, 1.0 equiv) in CH2Cl2 (50 
mL) was added DIBAL-H (1M solution in hexanes, 8.4 mL, 8.45 mmol, 
1.10 equiv) at -78 °C. The reaction was monitored by 1H NMR until full conversion of 
starting material was observed. After stirring at -78 °C for 2 h, the reaction was quenched 
with saturated NH4Cl solution (6 mL) and extracted with CH2Cl2 (3x). The organic layer 
was washed with 1 M Rochelle’s salt solution and dried over Na2SO4. The solvent was 
evaporated in vacuo. Butanal 153 was isolated as a pale yellow oil (833 mg, 6.37 mmol, 
83%) after eluting through a silica pad with CH2Cl2.                  
1H NMR: (500 MHz, CDCl3) δ 9.76 (t, J = 1.4 Hz, 1H), 4.38 (t, J = 5.5 Hz, 1H), 3.33 (s, 
6H), 2.51 (td, J = 7.1, 1.5 Hz, 3H), 1.94 (td, J = 7.1, 5.5 Hz, 2H). 
(see literature for 13C and other spectral data)119 
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Dimethoxy Acetal (154): 
A 250 mL flame-dried flask was charged with freshly distilled N,N-
diisopropylamine (1.1 mL, 7.6 mmol, 1.20 equiv) and THF (45 mL). A 
solution of n-BuLi in hexanes (2.5 M, 2.9 mL, 6.9 mmol, 1.10 equiv) was 
added carefully at -78 °C. The flask was then warmed to 0 °C and stirred for 30 minutes. 
After cooling the reaction flask back to -78 °C, methyl propiolate (0.67 mL, 7.6 mmol, 1.20 
equiv) was added and stirred for 30 minutes. Then 4,4-dimethoxybutanal 153 (833 mg, 
6.37 mmol, 1.0 equiv) was added in one portion. After stirring at -78 °C for 4 h, the reaction 
was diluted with diethyl ether (12 mL), warmed to room temperature, quenched with 
saturated NH4Cl solution (6 mL), and extracted with diethyl ether (3x). The combined 
organic layers were washed with brine and dried over Na2SO4. The solvent was then 
concentrated in vacuo. The crude product was purified by column chromatography 
(hexanes:EtOAc, 4:1) to afford dimethoxy acetal 154 as a yellow oil (834 mg, 3.89 mmol, 
61%).                  
IR υmax (film): 3425, 2954, 2833, 2236, 1714, 1510, 1435, 1389, 1373, 1246, 1126, 1044, 
654, 734 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 4.42 – 4.37 (m, 1H), 4.33 – 4.26 (m, 1H), 3.92 (d, J = 4.7 
Hz, 1H), 3.64 (s, 3H), 3.21 (s, 6H), 1.73 – 1.64 (m, 4H). 
13C NMR: (125 MHz, CDCl3) δ 153.7, 103.9, 88.3, 75.7, 61.1, 52.8, 52.6, 31.5, 27.8. 
HR-MS (m/z): [C9H14O5+H]
+ calculated: 217.1076; found: 217.1080 (+ 1.8424 ppm).  
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Methoxy Tetrahydrofuran (155): 
A flame-dried flask was charged with acetal 154 (2.15 g, 9.90 mmol, 
1.0 equiv) and CH2Cl2 (66 mL). To this was added (±)-CSA (1.2 g, 
5.40 mmol, 0.55 equiv). The reaction was monitored for completion 
by TLC. After stirring at room temperature for 24 h, the reaction was diluted with CH2Cl2, 
quenched with saturated NaHCO3 solution (10 mL), and extracted with CH2Cl2 (3x). The 
combined organic layers were washed with brine and dried over Na2SO4. The solvent was 
then concentrated in vacuo. Methoxy tetrahydrofuran 155 was isolated as a brown oil (1.67 
g, 9.21 mmol, 93%) in a 1:1.2 dr and used without purification.  
IR υmax (film): 3423, 2957, 2240, 1720, 1693, 1436, 1258, 1099, 1029, 985, 749 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 5.11 – 5.06 (m, 1Ha), 5.04 (dt, J = 4.8, 0.7 Hz, 1Hb), 4.82 
– 4.74 (ovrlp, 1Ha, 1Hb), 3.75 (s, 3Ha), 3.75 (s, 3Hb), 3.37 (s, 3Hb), 3.32 (s, 3Ha), 2.39 – 
2.30 (m, 1Ha), 2.28 – 2.20 (ovrlp, 2Hb), 2.13 – 2.08 (m, 1Ha), 2.04 – 1.97 (ovrlp, 2Hb), 1.94 
– 1.86 (ovrlp, 2Ha). (Ha is major diastereomer). 
13C NMR: (125 MHz, CDCl3) δ 153.9, 153.7, 105.7, 105.6, 88.0, 86.5, 76.3, 75.6, 67.2, 
66.7, 55.1, 54.8, 52.8, 52.8, 32.8, 32.1, 30.7, 30.6. 
LR-MS (m/z): [C9H12O4+H]
+ calculated: 185.0814; found: 185.11 (Low Resolution). 
 
Lactol Ynoate (100): 
A flask was charged with methoxy tetrahydrofuran 155 (1.4 g, 7.6 
mmol, 1.0 equiv), acetic acid (30 mL) and water (30 mL). The reaction 
was monitored for completion by 1H NMR. After stirring at room 
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temperature for 24 h, the reaction was concentrated in vacuo with toluene and pentane to 
azeotropically remove the water and acetic acid. The crude product was purified by column 
chromatography (Hexanes:EtOAc, 3:1) to afford lactol ynoate 100 as a pale yellow oil in 
a 1:1.2 dr (917 mg, 5.4 mmol, 71%).                  
IR υmax (film):  3409, 2956, 2239, 1713, 1600, 1509, 1435, 1398, 1341, 1254, 1188, 1158, 
1126, 1093, 1026, 978, 927, 876, 842, 751 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 5.66 – 5.62 (m, 1Ha), 5.57 (ddd, J = 4.7, 3.2, 1.4 Hz, 1Hb), 
4.96 (dd, J = 8.0, 4.6 Hz, 1Ha), 4.78 (dddd, J = 7.5, 7.5, 0.6, 0.6 Hz, 1Hb), 3.78 (s, 3Ha), 
3.78 (s, 3Ha), 2.66 (dd, J = 3.3, 1.6 Hz, 1Hb), 2.56 (dd, J = 2.9, 1.3 Hz, 1Ha), 2.50 – 2.39 
(m, 1Ha), 2.37 – 2.25 (ovrlp, 2Hb), 2.22 – 2.11 (m, 1Ha), 2.11 – 2.03 (ovrlp, 2Hb), 2.03 – 
1.93 (ovrlp, 2Ha). (Ha is major diastereomer). 
13C NMR: (125 MHz, CDCl3) δ 153.9, 153.7, 105.7, 105.6, 88.0, 86.5, 76.3, 75.6, 67.2, 
66.7, 55.1, 54.8, 52.8, 52.8, 32.8, 32.1, 30.7, 30.6. 
HR-MS (m/z): [C8H10O4+Na]
+ calculated: 193.0477; found: 193.0484 (+3.6260 ppm).  
 
Pyranone (156): 
A flame-dried flask was charged with lactol ynoate 100 (25 mg, 150 µmol, 
1.0 equiv), 1,3-dihydroxy-5-methoxybenzene (102) (20 mg, 150 µmol, 1.0 
equiv), DABCO (16 mg, 150 µmol, 1.0 equiv), and CH3CN. The reaction was monitored 
for completion by TLC. After stirring at 40 °C for 48 h, the reaction was eluted through a 
silica pad with EtOAc. The crude product was purified by column chromatography 
(EtOAc:hexanes, 1:2) to afford pyranone 156 as a yellow resin (1 mg, 7.2 µmol, 4%).   
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IR υmax (film): 2959, 2930, 2890, 1717, 1653, 1596, 1260, 1242, 1205, 1193, 1152, 1121, 
1098, 1064, 1029 cm-1.   
1H NMR: (500 MHz, CDCl3) δ 6.53 (dd, J = 6.0, 3.2 Hz, 1H), 5.36 (d, J = 1.6 Hz, 1H), 
5.13 (ddd, J = 6.8, 6.0, 2.0 Hz, 1H), 4.93 (ddd, J = 12.2, 7.8, 1.6 Hz, 1H), 2.74 ( J = 16.1 
7.8 6.8 2H), 2.30 (dddd, J = 16.1, 12.2, 3.2, 2.0 Hz, 1H). 
13C NMR: (125 MHz, CDCl3) δ 174.6, 171.9, 141.1, 100.6, 93.0, 71.1, 24.6. 
HR-MS (m/z): [C7H6O3+H]
+ calculated: 139.0395; found: 139.0398 (+ 2.1577 ppm). 
 
Phenoxy Methyl Acrylate (164): 
 A flame-dried flask was charged with lactol ynoate 100 (15 mg, 88 
µmol, 1.0 equiv), 3,5-dimethoxyphenol (163) (14 mg, 88 µmol, 1.0 
equiv), DABCO (10 mg, 88 µmol, 1.0 equiv), and CH3CN (1 mL). After 
stirring at room temperature for 24 h, the reaction was quenched with 
saturated NH4Cl solution and extracted with EtOAc. The combined organic layers were 
washed with brine and dried over Na2SO4. The solvent was then concentrated in vacuo. 
The crude product was purified by column chromatography (EtOAc:CH2Cl2, 1:9) to afford 
phenoxy methyl acrylate 164 as a yellow resin (2 mg, 6.1 μmol, 7%). 
IR υmax (film): 3441, 3383, 2950, 2840, 1725, 1665, 1596, 1475, 1460, 1435, 1373, 1295, 
1206, 1153, 1126, 1059, 989, 831, 683 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.20 (d, J = 2.2 Hz, 1Ha), 6.18 – 6.15 (ovrlp, 1Hb, 2Ha, 
2Hb), 6.04 (d, J = 1.0 Hz, 1Hb), 5.83 (d, J = 1.1 Hz, 1Ha), 5.66 (d, J = 2.9 Hz, 1Ha), 5.55 
(d, J = 4.6 Hz, 1Hb), 4.76 (ddd, J = 8.6, 3.9, 1.0 Hz, 1Ha), 4.54 (t, J = 7.8 Hz, 1Hb), 3.75 
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(s, 6Ha), 3.75 (s, 6Hb), 3.60 (s, 3Ha), 3.60 (s, 3Hb), 2.74 (br s, 1Hb), 2.63 (br s, 1Ha), 2.36 – 
2.26 (m, 2Hb), 2.20 – 2.12 (m, 2Ha), 2.05 – 1.84 (ovrlp, 2Ha, 2Hb). (Ha is major 
diastereomer) 
 13C NMR: (125 MHz, CDCl3) δ 166.1, 165.4, 164.9, 164.9, 161.7, 161.7, 158.2, 158.1, 
104.8, 104.4, 99.5, 99.4, 95.5, 95.5, 95.4, 95.4, 78.6, 76.6, 55.6, 55.6, 51.5, 51.5, 33.8, 32.0, 
29.1, 28.3. 
1H NMR: (500 MHz, (CD3)2SO) δ 6.46 (dd, J = 4.8, 0.8 Hz, 1Hb), 6.25 (d, J = 5.0, 0.8 
Hz, 1Ha), 6.23 (ddd, J = 2.2, 2.2 Hz, 2Hb), 6.13 (t, J = 2.4 Hz, 2Ha), 6.08 (d, J = 0.9 Hz, 
1Hb), 5.78 (d, J = 0.8 Hz, 1Ha), 5.75 (s, 1Ha), 5.75 (s, 1Hb), 5.48 (td, J = 5.0, 1.7 Hz, 1Ha), 
5.40 (td, J = 4.7, 2.0 Hz, 1Hb), 4.58 (dd, J = 8.2, 4.9 Hz, 1Ha), 4.39 (t, J = 7.5 Hz, 1Hb), 
3.71 (s, 6Ha), 3.50 (s, 3Hb), 3.48 (s, 3Ha), 3.32 (s, 6Hb), 2.16 (dq, J = 12.1, 8.2 Hz, 1Ha), 
2.05 (ddt, J = 11.2, 7.3, 3.7 Hz, 1Hb), 1.96 – 1.78 (ovrlp, 2Ha, 2Hb), 1.75 (dt, J = 11.9, 4.3 
Hz, 1Hb), 1.66 (dddd, J = 11.0, 8.4, 4.2, 2.3 Hz, 1Ha). (Ha is major diastereomer) 
13C NMR: (100 MHz, (CD3)2SO) δ 167.4, 165.5, 164.0, 163.8, 161.1, 161.1, 157.7, 157.5, 
103.4, 103.2, 98.5, 98.4, 95.4, 95.3, 95.0, 94.9, 76.5, 75.2, 55.4, 54.9, 50.9, 50.9, 33.1, 32.1, 
29.3, 28.2. 
HR-MS (m/z): [C16H20O7+Na]
+ calculated: 347.1107; found: 347.1103 (– 1.1524 ppm).  
 
Pent-4-enal (165): 
To allyl vinyl ether stabilized with 0.1% KOH, 5 mL of DI, water was added 
and the mixture was stirred for 5 minutes. The organic layer was then dried over Na2SO4. 
The dried allyl vinyl ether (7.4 g, 87.97 mmol) was then placed in a Teflon® capped, heavy 
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wall sealed vial (Chemglass CG-1880) and heated in an oil bath at 150 °C for 18 h. The 
reaction was monitored for completion by 1H NMR. The reaction was then cooled to room 
temperature, and pent-4-enal 165 was isolated as a viscous, colorless oil (7.2 g, 85.6 mmol, 
98%) and used without purification in the next step.     
IR υmax (film): 3403, 3077, 2925, 1710, 1640, 1443, 1415, 1354, 994, 911 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 9.78 (t, J = 1.6 Hz, 1H), 5.83 (dddd, J = 17.0, 10.2, 6.5, 
6.5 Hz, 1H), 5.06 (ddd, J = 17.0, 3.2, 1.5 Hz, 1H), 5.02 (ddd, J = 10.2, 2.9, 1.5 Hz, 1H), 
2.54 (ddd, J = 7.1, 7.1, 1.6 Hz, 2H), 2.45 – 2.26 (m, 2H). 
13C NMR: (125 MHz, CDCl3) δ 201.7, 136.4, 115.5, 42.6, 26.0. 
 
Hydroxy Ynoate (166): 
A 1 L flame-dried flask was charged with freshly distilled N,N-
diisopropylamine (14.5 mL, 102.72 mmol, 1.20 equiv) and THF (300 
mL). To this was added a solution of n-BuLi in hexanes (2.5 M, 37.7 mL, 94.16 mmol, 
1.10 equiv) at -78 °C. The reaction was then warmed to 0 °C and stirred for 30 minutes. 
To this, methyl propiolate (8.4 mL, 85.60 mmol, 1.10 equiv) was added at -78 °C, and the 
reaction was stirred for 30 minutes. Finally, pent-4-enal 165 (7.2 g, 85.60 mmol, 1.0 equiv) 
was added to the reaction. After 1 h, the reaction was quenched with 3N HCl solution (200 
mL) and extracted with EtOAc (200 mL, 3x). The combined organic layers were washed 
with brine and dried over Na2SO4. The solvent was concentrated in vacuo. Hydroxy ynoate 
166 was isolated as a light brown oil (13.0 g, 77.29 mmol, 90%) and used without 
purification.                 
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IR υmax (film): see (R)-166 (page 102) 
1H NMR: (500 MHz, CDCl3) δ 5.78 (dddd, J = 17.0, 10.2, 6.7, 6.7 Hz, 1H), 5.06 (ddd, J 
= 17.0, 3.3, 1.5 Hz, 1H), 4.99 (ddd, J = 10.2, 3.0, 1.5 Hz, 1H), 4.49 (dd, J = 6.7, 6.7 Hz, 
1H), 3.76 (s, 3H), 2.81 (br s, 1OH), 2.22 – 2.17 (m, 2H), 1.92 – 1.77 (m, 2H). 
13C NMR: (125 MHz, CDCl3) δ 154.0, 137.1, 115.9, 88.3, 76.4, 61.5, 52.9, 35.9, 29.2. 
LR-MS (m/z): [C9H12O3+H]
+ calculated: 169.0865; found: 169.08 (Low Resolution). 
 
Methoxymethyl Ynoate (167): 
A 2 L flame-dried flask was charged with hydroxy ynoate 166 (13.0 g, 
77.29 mmol, 1.0 equiv), CH2Cl2 (750 mL), and freshly distilled N,N-
diisopropylethylamine (29.6 mL, 170.05 mmol, 2.20 equiv). To this, 
chloromethyl methyl ether (6.5 mL, 85.02 mmol, 1.10 equiv) was carefully added at 0 °C. 
The reaction was slowly warmed to ambient temperature and monitored for completion by 
TLC analysis. After stirring for 24 h, the reaction was quenched with DI water (400 mL) 
and extracted with CH2Cl2 (200 mL, 3x). The combined organic layers were washed with 
brine and dried over Na2SO4. The solvent was then concentrated in vacuo. Methoxymethyl 
ynoate 167 was isolated as a light brown oil (15.8 g, 74.44 mmol, 96%) and used without 
purification in the next step.                 
IR υmax (film): 3079, 2952, 2892, 2846, 2235, 1716, 1671, 1641, 1604, 1435, 1247, 1150, 
1097, 1021, 916, 804, 750, 638 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 5.81 (dddd, J = 17.0, 10.2, 6.7 Hz, 1H), 5.07 (ddd, J = 
17.0, 3.4, 1.6 Hz, 1H), 5.02 (ddd, J = 10.2, 2.9, 1.6 Hz, 1H), 4.88 (d, J = 7.0 Hz, 1H), 4.61 
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(d, J = 7.0 Hz, 1H), 4.44 (dd, J = 6.6, 6.6 Hz, 1H), 3.78 (s, 3H), 3.39 (s, 3H), 2.27 – 2.22 
(m, 2H), 1.99 – 1.77 (m, 2H). 
13C NMR: (125 MHz, CDCl3) δ 153.7, 137.1, 115.8, 94.8, 86.3, 77.1, 64.8, 56.0, 52.9, 
34.2, 29.3. 
LR-MS (m/z): [C11H16O4+Na]
+ calculated: 235.0946; found: 235.09 (Low Resolution). 
 
Protected oxo-Ynoate (169): 
A 1 L flame-dried flask was charged with methoxymethyl ynoate 167 
(23.0 g, 108.37 mmol, 1.0 equiv) and CH2Cl2 (500 mL). After cooling 
the reaction to -78 °C, ozone was carefully bubbled through the reaction 
solution. The brown solution turned yellow and eventually became almost clear. Ozone 
bubbling continued for 1.75 h or until the starting material was fully consumed as indicated 
by TLC analysis. N2 was then bubbled through the reaction mixture for 10 minutes at -78 
°C. Zinc powder (35.4 g, 541.85 mmol, 5.0 equiv) was then added. While stirring 
vigorously, acetic acid (6.2 mL, 108.37 mmol, 1.0 equiv) was carefully added, dropwise. 
The reaction flask was then warmed to room temperature and monitored carefully by TLC 
until the intermediate was fully quenched (the Rf values of the intermediate and product in 
EtOAc:hexanes (1:4) are 0.5 and 0.25, respectively). The quenched reaction was then 
filtered through a fritted funnel, and the acetic acid was neutralized with saturated NaHCO3 
solution. Following extraction with CH2Cl2 (500 mL, 3x) and drying over sodium sulfate, 
the solvent was evaporated in vacuo. Protected oxo-ynoate 169 was isolated as a pale 
yellow oil (23.0 g, 107.37 mmol, >98%) and used without purification in the next step. 
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Rf  = 0.25; EtOAc:hexanes (1:4); CAM, KMnO4              
IR υmax (film): 3434, 2957, 2239, 1709, 1435, 1252, 1175, 1148, 1093, 1020, 750 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 9.79 (dd, J = 1.1, 1.1 Hz, 1H), 4.86 (d, J = 7.0 Hz, 1H), 
4.59 (d, J = 7.0 Hz, 1H), 4.52 (dd, J = 6.2, 6.2 Hz, 1H), 3.78 (s, 3H), 3.37 (s, 3H), 2.76 – 
2.55 (m, 2H), 2.16 – 2.08 (m, 2H). 
13C NMR: (125 MHz, CDCl3) δ 200.8, 153.4, 94.6, 85.1, 77.3, 64.1, 55.9, 52.8, 39.3, 27.4. 
HR-MS (m/z): [C10H14O5+Na]
+ calculated: 237.0739; found: 237.0744 (+ 2.1090 ppm). 
 
Dimethoxy Cyclohexanol (168): 
A 10 mL flame-dried flask was charged with 3,5-dimethoxyphenol (163) 
(53 mg, 345 μmol, 1.0 equiv), Cs2CO3 (28 mg, 86 μmol, 0.25 equiv), and 
DABCO (10 mg, 96 μmol, 0.25 equiv), and CH3CN (5 mL). The mixture 
was degassed with an argon balloon. To this, protected oxo-ynoate 169 
(74 mg, 345 μmol, 1.0 equiv) dissolved in CH3CN (2 mL) was added. The reaction was 
monitored for completion by TLC. After stirring at room temperature for 24 h, the reaction 
was quenched with saturated NH4Cl solution and extracted with EtOAc. The combined 
organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
(EtOAc:CH2Cl2, 1:9 to EtOAc:CH2Cl2, 1:3) to afford dimethoxy cyclohexanol 170 as an 
orange resin (43 mg, 116 μmol, 34%, 1:1.8 dr).  
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Under the same reaction conditions and on a 3.65 mmol scale of protected oxo-ynoate 169, 
dimethoxy cyclohexanol 170 was isolated as an orange resin (150 mg, 407 μmol, 11%, 
1:1.8 dr).                                    
IR υmax (film): 3467, 2949, 2842, 2232, 1716, 1595, 1435, 1257, 1205, 1151, 1027, 920, 
827, 751, 723, 681 cm-1.   
1H NMR: (500 MHz, CDCl3) δ 6.15 (t, J = 2.2 Hz, 1Hb), 6.14 (ovrlp, 1Ha), 6.12 (d, J = 
2.2 Hz, 2Hb), 6.11 (d, J = 2.2 Hz, 2Ha), 4.72 (m, 1Hb), 4.62 (m, 1Ha), 4.58 (d, J = 6.9 Hz, 
1Hb), 4.56 (d, J = 6.9 Hz, 1Ha), 4.53 (d, J = 6.9 Hz, 1Hb), 4.49 (d, J = 6.9 Hz, 1Ha), 4.26 (t, 
J = 5.3 Hz, 1Ha), 4.23 (t, J = 3.4 Hz, 1Hb), 3.74 (s, 6Ha), 3.74 (s, 6Hb), 3.62 (s, 3Hb), 3.61 
(s, 3Ha), 3.29 (s, 3Hb), 3.28 (s, 3Ha), 2.37 (s, 1Ha), 2.37 (s, 1Hb), 2.13 – 2.04 (ovrlp, 1Ha, 
1Hb), 1.92 – 1.85 (ovrlp, 2Ha, 2Hb), 1.85 – 1.79 (ovrlp, 1Ha, 1Hb). (Hb is major 
diastereomer) 
13C NMR: (125 MHz, CDCl3) δ 167.7, 167.5, 161.6, 161.6, 158.5, 158.4, 158.3, 158.2, 
158.0, 156.9, 121.2, 120.6, 96.4, 96.2, 96.0, 95.8, 95.1, 94.9, 70.4, 69.5, 66.5, 65.3, 55.7, 
55.5, 52.1, 52.1, 26.4, 25.6, 25.3, 24.4. 
HR-MS (m/z): [C18H24O8+Na]
+ calculated: 391.1369; found: 391.1360 (– 2.3010 ppm). 
 
Dimethoxy TBS Cyclohexene (178): 
 A 10 mL flame-dried flask was charged with dimethoxy cyclohexanol 
170 (115 mg, 312 μmol, 1.0 equiv, 1:1.3 dr), CH2Cl2 (5 mL), and N,N-
diisopropylethylamine (108 μL, 624 μmol, 2.0 equiv). To this, tert-
butyldimethylsilyl trifluoromethane-sulfonate (79 μL, 343 μmol, 1.1 
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equiv) was added at 0 °C. The reaction was monitored by TLC. After stirring at 0 °C for 3 
h, the reaction was quenched with saturated NH4Cl solution and extracted with CH2Cl2. 
The combined organic phases were washed with brine and dried over Na2SO4. The solvent 
was concentrated in vacuo. The crude product was purified by column chromatography 
(EtOAc:hexanes, 0:1 to EtOAc:hexanes, 1:9) to afford dimethoxy TBS cyclohexene 178 
as a brown oil (72 mg, 149 μmol, 48%, 1:1.3 dr).   
IR υmax (film): 2952, 2898, 2856, 1722, 1596, 1473, 1434, 1258, 1206, 1153, 1063, 1030, 
920, 777 cm-1.   
1H NMR: (500 MHz, CDCl3) δ 6.15 (ovrlp, 1Ha, 1Hb), 6.13 (ovrlp, 1Ha, 1Hb), 6.10 (ovrlp, 
1Ha, 1Hb), 4.82 (t, J = 3.4 Hz, 1Hb), 4.77 – 4.72 (m, 1Ha), 4.60 (d, J = 6.8 Hz, 1Hb), 4.56 
(ovrlp, 1Ha, 1Hb), 4.52 (d, J = 6.9 Hz, 1Ha), 4.22 (t, J = 3.5 Hz, 1Hb), 4.19 (t, J = 5.2 Hz, 
1Ha), 3.74 (ovrlp, 6Ha, 6Hb), 3.61 (s, 3Ha), 3.53 (s, 3Hb), 3.29 (s, 3Ha), 3.29 (s, 3Hb), 2.17 
– 2.05 (ovrlp, 1Ha, 1Hb), 2.03 – 1.96 (ovrlp, 1Ha, 1Hbj), 1.81 – 1.75 (ovrlp, 1Ha, 1Hb), 1.70 
– 1.58 (ovrlp, 1Ha, 1Hb), 0.85 (s, 9Ha), 0.84 (s, 9Hb), 0.09 (s, 3Ha), 0.08 (s, 3Hb), 0.04 (s, 
3Ha), 0.01 (s, 3Hb). (Hb is major diastereomer) 
13C NMR: (125 MHz, CDCl3) δ 166.9, 166.7, 161.5, 161.5, 158.5, 158.1, 155.6, 153.4, 
125.2, 122.2, 96.4, 96.0, 95.9, 95.9, 95.1, 95.0, 69.7, 69.5, 67.3, 65.8, 55.6, 55.6, 55.5, 55.5, 
51.8, 51.7, 28.3, 26.9, 25.9, 24.1, 18.0, 18.0, -4.3, -4.6. 
HR-MS (m/z): [C24H38O8Si+Na]
+ calculated: 505.2234; found: 505.2229 (– 0.9897 ppm).  
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2.7.3 Experimental Section: Stepwise Route 
Iodocyclohexene (193) and Iodoacrylate (194): 
A flame-dried flask was charged with magnesium diiodide 
(110 mg, 0.39 mmol, 2.2 equiv) and CH2Cl2 (2.2 mL). The 
mixture was sonicated for 10 minutes at room temperature. 
To this, lactol ynoate 100 (30 mg, 0.18 mmol, 1.0 equiv) dissolved in CH2Cl2 (0.3 mL) was 
carefully added at -78 °C. The reaction was then warmed to 0 °C and monitored for 
completion by TLC.  After stirring at 0 °C for 6 h, the reaction was quenched with water 
(1.0 mL) and extracted with EtOAc (3x). The combined organic phases were washed with 
brine and dried over Na2SO4. The solvent was concentrated in vacuo. The crude product 
was purified by column chromatography (EtOAc:hexanes, 1:3) to afford iodocyclohexene 
193 as a pale  yellow oil (8 mg, 0.03 mmol, 15%, 1.5:1 dr) and iodoacrylate 194 as a yellow 
oil (40 mg, 0.13 mmol, 74%, 1.4:1 dr).  
Iodocyclohexene (193):           
IR υmax (film): 3440, 3326, 2952, 2841, 1718, 1665, 1596, 1474, 1459, 1435, 1374, 1298, 
1260, 1206, 1153, 1125, 1059, 989, 933, 825, 680, 538 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 4.50 (t, J = 4.4 Hz, 1Ha), 4.45 (t, J = 5.2 Hz, 1.5Hb), 4.36 
(t, J = 4.4 Hz, 1Ha), 4.25 (t, J = 5.6 Hz, 1.5Hb), 3.86 (s, 3Ha), 3.86 (s, 4.5Hb), 2.57 (br s, 
1Ha, 1Hb), 2.48  (br s, 1Hb), 2.36 (br s, 1Ha), 2.31 – 2.21 (m, 1H), 2.15 – 2.06 (m, 1H), 2.05 
– 1.98 (m, 3H), 1.96 – 1.90 (m, 3H), 1.86 – 1.73 (m, 2H).  
13C NMR: (125 MHz, CDCl3) δ 167.9, 167.9, 142.4, 141.1, 113.6, 113.6, 73.7, 73.5, 67.9, 
67.3, 52.5, 52.5, 27.6, 27.3, 27.2, 26.6. 
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HR-MS (m/z): [C8H11IO4+Na]
+ calculated: 320.9600; found: 320.9609 (+ 2.8041 ppm). 
Iodoacrylate (194): 
IR υmax (film): 3446, 2991, 2949, 1725, 1677, 1293, 1195, 1170, 1048, 942, 869 cm-1.  
1H NMR: (500 MHz, CDCl3) δ 6.94 (d, J = 1.5 Hz, 1Ha), 6.71 (d, J = 1.4 Hz, 1Hb), 5.76 
(d, J = 4.8 Hz, 1Hb), 5.71 (d, J = 2.8 Hz, 1Ha), 4.84 (ddd, J = 8.1, 4.7, 1.4 Hz, 1Hb), 4.69 
(ddt, J = 8.1, 6.7, 1.5 Hz, 1Ha), 3.76 (s, 6H), 2.50–2.35 (m, 2H), 2.08–1.85 (ovrlp m, 6H). 
13C NMR: (125 MHz, CDCl3) δ 165.3, 165.1, 123.1, 122.8, 122.7, 122.6, 100.3, 100.2, 
87.9, 85.7, 51.9, 51.9, 33.1, 31.7, 31.0, 30.3. 
HR-MS (m/z): [C8H11IO4+H–H2O]+ calculated: 280.9675; found: 280.9688 (+ 4.6269 
ppm). 
 
Iodocyclohexanol (195): 
A 2 L flame-dried flask was charged with MgI2 (9.74 g, 35.01 mmol, 1.0 
equiv) and CH2Cl2 (600 mL). The mixture was sonicated for 1 h while 
degassing with an argon balloon. To this, protected ynoate 169 (7.5 g, 35.01 
mmol, 1.0 equiv) in CH2Cl2 (50 mL) was added at -78 °C. The reaction was then warmed 
to -15 °C and monitored for completion by TLC.  After stirring at -15 °C for 24 h, the 
reaction was quenched with saturated NH4Cl (250 mL) and extracted with EtOAc (200 mL, 
3x). The combined organic phases were washed with brine nad dried over Na2SO4. The 
solvent was concentrated in vacuo. The crude product was purified by column 
chromatography (EtOAc: CH2Cl2, 1:2) to afford iodocyclohexanol 195 as an orange oil 
(8.3 g, 24.26 mmol, 68%, 1.5:1 dr).                  
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IR υmax (film): 3440, 2949, 2890, 1719, 1631, 1434, 1252, 1147, 1018, 916, 750 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 4.78 (d, J = 3.4 Hz, 2Ha, 2Hb), 4.48 (m, 1Ha), 4.44 (s, 
1Hb), 4.29 (t, J = 4.1 Hz, 1Ha), 4.19 (t, J = 4.2 Hz, 1Hb), 3.85 (s, 3Ha, 3Hb), 3.48 (s, 3Ha, 
3Hb), 2.53 (d, J = 4.6 Hz, 1Ha), 2.29 (d, J = 6.6 Hz, 1Hb), 2.24 – 2.15 (m, 1H), 2.11 – 1.96 
(ovrlp, 3H), 1.93 – 1.75 (ovrlp, 4H). 
13C NMR: (125 MHz, CDCl3) δ 168.3, 168.2, 144.9, 142.8, 108.1, 105.9, 96.5, 96.5, 78.7, 
78.4, 68.4, 66.9, 56.4, 56.3, 52.4, 52.4, 26.8, 26.7, 26.3, 25.8. 
HR-MS (m/z): [C10H15IO5+Na]
+ calculated: 364.9862; found: 364.9863 (+ 0.2740 ppm). 
 
Iodo Ketone (196): 
A 500 mL flame-dried flask was charged with iodocyclohexanol 195 (2.31 
g, 6.75 mmol, 1.0 equiv), CH2Cl2 (200 mL), and Dess-Martin periodinane
120 
(3.0 g, 7.09 mmol, 1.05 equiv). The reaction was monitored for completion by TLC. After 
stirring at room temperature for 2 h, the reaction was quenched with saturated NaHCO3 
(100 mL) and saturated sodium thiosulfate (100 mL) and stirred until both aqueous and 
organic layers were transparent. After extracting with CH2Cl2 (100 mL, 3x), the combined 
organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
(EtOAc:CH2Cl2, 1:0) to afford iodo ketone 196 as a pale yellow solid (2.2 g, 6.59 mmol, 
98%).  
m.p.: decomposed (EtOAc)               
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IR υmax (film): 2957, 2896, 1739, 1682, 1606, 1435, 1332, 1285, 1260, 1236, 1149, 1091, 
1052, 1025, 798 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 4.83 (d, J = 7.1 Hz, 1H), 4.81 (d, J = 7.1 Hz, 1H), 4.51 
(dd, J = 6.4, 4.0 Hz, 1H), 3.88 (s, 3H), 3.49 (s, 3H), 2.74 (ddd, J = 17.1, 8.9, 4.6 Hz, 1H), 
2.50 (ddd, J = 17.1, 8.2, 4.5 Hz, 1H), 2.35 (dddd, J = 14.2, 8.8, 4.5, 4.0 Hz, 1H), 2.17 (dddd, 
J = 14.2, 8.2, 6.4, 4.6 Hz, 1H). 
13C NMR: (125 MHz, CDCl3) δ 190.3, 166.0, 145.0, 127.4, 96.5, 77.0, 56.5, 52.9, 33.4, 
28.4. 
HR-MS (m/z): [C10H13IO5+Na]
+ calculated: 362.9705; found: 362.9694 (– 3.0305 ppm). 
 
Dimethoxy Ketone (198): 
A 250 mL flame-dried flask was charged with 3,5-dimethoxyphenol 
(163) (1.7 g, 11.12 mmol, 2.0 equiv), K3PO4 (1.8 g, 8.34 mmol, 1.50 
equiv), DABCO (124 mg, 1.11 mmol, 0.2 equiv), and CH2Cl2 (100 mL). 
The heterogeneous mixture was then degassed with an argon balloon.  To 
this, iodo ketone 196 (1.9 g, 5.56 mmol, 1.0 equiv) dissolved in CH2Cl2 (10 mL) was added. 
A reflux condenser was attached, and the reaction was heated at 40 °C and monitored for 
completion by TLC. After stirring at 40 °C for 24 h, the reaction was cooled to room 
temperature, diluted with EtOAc (100 mL), and quenched with water (20 mL) and a few 
drops of 0.5 M KHSO4 solution. After extracting with EtOAc (100 mL, 2x), the combined 
organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
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(gradient: EtOAc:CH2Cl2, 0:1, to EtOAc:CH2Cl2, 2:3) to afford dimethoxy ketone 198 as 
a yellow resin (1.8 g, 4.91 mmol, 88%).                  
IR υmax (film): 2949, 2841, 1736, 1671, 1610, 1588, 1432, 1354, 1295, 1245, 1204, 1151, 
1126, 1023, 919, 833, 681 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.29 (t, J = 2.2 Hz, 1H), 6.24 (d, J = 2.2 Hz, 2H), 4.63 (d, 
J = 7.0 Hz, 1H), 4.54 (d, J = 7.0 Hz, 1H), 4.47 (t, J = 3.8 Hz, 1H), 3.77 (s, 6H), 3.60 (s, 
3H), 3.35 (s, 3H), 2.78 (ddd, J = 17.0, 12.1, 5.0 Hz, 1H), 2.46 (dt, J = 17.0, 4.4 Hz, 1H), 
2.24 (dq, J = 13.4, 4.4 Hz, 1H), 2.18 – 2.08 (m, 1H). 
13C NMR: (125 MHz, CDCl3) δ 194.9, 168.4, 164.4, 161.5, 155.3, 120.0, 98.7, 97.8, 96.6, 
69.3, 56.0, 55.7, 52.3, 32.3, 27.0. 
HR-MS (m/z): [C18H22O8+Na]
+ calculated: 389.1212; found: 389.1212 (+ 0.0000 ppm).  
 
Bis-TIPS Ketone (199): 
A 250 mL flame-dried flask was charged with 3,5-bis-
(triisopropylsilyloxy)phenol (171) (2.3 g, 5.26 mmol, 1.2 equiv), K3PO4 
(930 mg, 4.38 mmol, 1.0 equiv), DABCO (49 mg, 438 μmol, 0.1 equiv), 
and CH2Cl2 (60 mL). The heterogeneous mixture was then degassed 
with an argon balloon. To this, iodo ketone 196 (1.5 g, 4.38 mmol, 1.0 equiv) dissolved in 
CH2Cl2 (20 mL) was added. A reflux condenser was attached, and the reaction was heated 
at 40 °C and monitored for completion by TLC. After stirring at 40 °C for 24 h, the reaction 
was cooled to room temperature, diluted with CH2Cl2 (100 mL), quenched with water (20 
mL), and extracted with CH2Cl2. The combined organic phases were washed with brine 
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and dried over Na2SO4. The solvent was concentrated in vacuo. The crude product was 
purified by column chromatography (gradient: EtOAc:hexanes, 0:1, to EtOAc:hexanes, 1:4) 
to afford bis-TIPS ketone 199 as a pale yellow amorphous solid (1.9 g, 2.93 mmol, 67%).                  
IR υmax (film): 2946, 2893, 2867, 1744, 1680, 1600, 1582, 1460, 1355, 1260, 1173, 1124, 
1030, 1015, 882, 755, 685 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.24 (t, J = 2.1 Hz, 1H), 6.19 (d, J = 2.1 Hz, 2H), 4.58 (d, 
J = 7.0 Hz, 1H), 4.48 (d, J = 7.0 Hz, 1H), 4.42 (t, J = 3.7 Hz, 1H), 3.67 (s, 3H), 3.31 (s, 
3H), 2.76 (ddd, J = 17.0, 12.3, 4.9 Hz, 1H), 2.44 (dt, J = 17.0, 4.3 Hz, 1H), 2.23 (dq, J = 
14.1, 4.3 Hz, 1H), 2.07 (ddt, J = 16.1, 14.2, 4.2 Hz, 1H), 1.28 – 1.16 (m, 6H), 1.08 (s, 18H), 
1.07 (s, 18H). 
13C NMR: (125 MHz, CDCl3) δ 195.0, 168.4, 164.4, 157.8, 155.0, 121.0, 108.9, 105.2, 
96.8, 69.0, 56.0, 52.4, 32.3, 27.1, 18.0, 12.7. 
HR-MS (m/z): [C34H58O8Si2+Na]
+ calculated: 673.3568; found: 673.3565 (– 0.4455 ppm). 
 
Mono-TIPS Ketone (200): 
A 250 mL flame-dried flask was charged with 5-
triisopropylsilyloxybenzene-1,3-diol (172) (1.46 g, 5.16 mmol, 1.5 equiv), 
K3PO4 (1.10 g, 5.16 mmol, 1.50 equiv), DABCO (77 mg, 688 μmol, 0.2 
equiv), and CH2Cl2 (90 mL). The heterogeneous mixture was then 
degassed with an argon balloon. To this, iodo ketone 196 (1.17 g, 3.44 mmol, 1.0 equiv) 
dissolved in CH2Cl2 (21 mL) was added. A reflux condenser was attached, and the reaction 
was heated at 40 °C and monitored for completion by TLC. After stirring at 40 °C for 48 
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h, the reaction was cooled to room temperature, diluted with CH2Cl2 (100 mL), quenched 
with saturated NH4Cl solution (100 mL), and extracted with CH2Cl2 (100 mL, 3x). The 
combined organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
(gradient: EtOAc:hexanes, 0:1, to EtOAc:hexanes, 2:5) to afford mono-TIPS ketone 200 
as a pale yellow amorphous solid (1.1 g, 2.22 mmol, 65%).   
IR υmax (film): 3383, 2950, 2868, 2233, 1717, 1605, 1258, 1197, 1150, 1031, 826 cm-1.  
1H NMR: (500 MHz, CDCl3) δ 6.21 (t, J = 2.1 Hz, 1H), 6.19 (t, J = 2.1 Hz, 1H), 6.16 (t, 
J = 2.1 Hz, 1H), 4.62 (d, J = 7.0 Hz, 1H), 4.54 (d, J = 7.0 Hz, 1H), 4.45 (t, J = 3.8 Hz, 1H), 
3.64 (s, 3H), 3.34 (s, 3H), 2.78 (ddd, J = 17.0, 12.2, 4.9 Hz, 1H), 2.46 (dt, J = 17.0, 4.3 Hz, 
1H), 2.28 – 2.19 (m, 1H), 2.16 – 2.06 (m, 1H), 1.29 – 1.19 (m, 3H), 1.09 (ovrlp, 18H). 
13C NMR: (125 MHz, CDCl3) δ 195.8, 169.1, 164.8, 158.2, 157.8, 155.0, 120.2, 104.8, 
104.3, 100.5, 96.7, 69.2, 56.0, 52.6, 32.3, 27.0, 18.0, 18.0, 12.7. 
LR-MS (m/z): [C25H38O8Si+H]
+ calculated: 495.2414; found: 495.26 (Low Resolution). 
 
Monomethoxy Ketone (201): 
A 500 mL flame-dried flask was charged with 1,3-dihydroxy-5-
methoxybenzene (102) (5.56 g, 39.69 mmol, 3.0 equiv) and acetone (50 
mL). The solution was degassed with an argon balloon. To this, K3PO4 
(4.21 g, 19.85 mmol, 1.50 equiv) and DABCO (297 mg, 2.65 mmol, 0.2 
equiv) were added, and the reaction was stirred at room temperature for 0.5 h. Then iodo 
ketone 196 (4.50 g, 13.23 mmol, 1.0 equiv) dissolved in CH2Cl2 (225 mL) was added to 
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the heterogeneous reaction mixture, and a reflux condenser was attached. The reaction was 
heated at 60 °C and monitored for completion by TLC. After stirring at 60 °C for 72 h,  the 
reaction was cooled to room temperature, diluted with CH2Cl2 (100 mL), quenched with 
saturated NH4Cl solution (100 mL), and extracted with EtOAc (3x). The combined organic 
phases were washed with brine and dried over Na2SO4. The solvent was concentrated in 
vacuo. The crude product was purified by column chromatography (gradient: 
EtOAc:hexanes, 0:1, to EtOAc:hexanes, 2:5) to afford monomethoxy ketone 201 as an 
orange amorphous solid (3.1 g, 8.80 mmol, 67%).                  
IR υmax (film): 3377, 2954, 2844, 1729, 1606, 1500, 1439, 1358, 1303, 1260, 1211, 1197, 
1148, 1027, 823, 800 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 7.53 (br s, 1H), 6.24 (t, J = 2.2 Hz, 1H), 6.14 (d, J = 2.2 
Hz, 2H), 4.59 (d, J = 7.0 Hz, 1H), 4.49 (d, J = 7.0 Hz, 1H), 4.45 (t, J = 3.8 Hz, 1H), 3.70 
(s, 3H), 3.58 (s, 3H), 3.30 (s, 3H), 2.74 (ddd, J = 17.0, 12.0, 5.0 Hz, 1H), 2.43 (dt, J = 17.0, 
4.3 Hz, 1H), 2.23 – 2.17 (m, 1H), 2.14 – 2.06 (m, 1H).  
13C NMR: (125 MHz, CDCl3) δ 196.1, 169.5, 164.9, 161.5, 158.4, 154.9, 119.3, 100.3, 
99.0, 98.3, 96.6, 69.2, 56.0, 55.6, 52.5, 32.2, 26.8.  
HR-MS (m/z): [C17H20O8+Na]
+ calculated: 375.1056; found: 375.1042 (– 3.7323 ppm). 
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Dimethoxy Cyclohexanol (170): 
Method A: A 50 mL flame-dried flask was charged with dimethoxy 
ketone 198 (321 mg, 876 μmol, 1.0 equiv) and CH2Cl2 (25 mL). The 
solution was degassed with an argon balloon. To this, sodium 
borohydride (165 mg, 4.38 mmol, 5.0 equiv), methanol (0.25 mL, 6.18 
mmol, 7.0 equiv), and acetic acid (0.35 mL, 6.18 mmol, 7.0 equiv) were added at 0 °C. The 
reaction was then warmed to room temperature and monitored for completion by TLC. 
After stirring at room temperature for 24 h, the reaction was quenched with saturated 
NH4Cl solution and extracted with CH2Cl2. The combined organic phases were washed 
with brine and dried over Na2SO4. The solvent was concentrated in vacuo. The crude 
product was purified by column chromatography (gradient: EtOAc:CH2Cl, 0:1, to 
EtOAc:CH2Cl, 1:2) to afford dimethoxy cyclohexanol 170 as a yellow resin (119 mg, 325 
μmol, 37%, 89% brsm, 3:1 dr).  
Method B: A 25 mL flame-dried flask was charged with dimethoxy ketone 198 (195 mg, 
532 μmol, 1.0 equiv) and CH2Cl2 (10 mL). The solution was degassed with an argon 
balloon. To this, sodium borohydride (20 mg, 532 μmol, 1.0 equiv) and methanol (0.5 mL, 
12.3 mmol, 23.0 equiv) were added at -78 °C. The reaction was then warmed to room 
temperature and monitored for completion by TLC. After stirring at room temperature for 
48 h, the reaction was quenched with saturated NH4Cl solution and extracted with CH2Cl2. 
The combined organic phases were washed with brine and dried over Na2SO4. The solvent 
concentrated in vacuo. The crude product was purified by column chromatography 
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(gradient: EtOAc:CH2Cl, 0:1, to EtOAc:CH2Cl, 1:2) to afford dimethoxy cyclohexanol 170 
as a yellow resin (101 mg, 274 μmol, 52%, 3.5:1 dr). 
IR υmax (film): 3467, 2949, 2840, 1719, 1592, 1434, 1203, 1191, 1147, 1023, 960, 917, 
882, 825, 538 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.15 (d, J = 2.2 Hz, 1Hb), 6.14 (t, J = 2.2 Hz, 1Ha), 6.12 
(d, J = 2.2 Hz, 2Hb), 6.11 (d, J = 2.2 Hz, 2Ha), 4.74 – 4.72 (m, 1Hb), 4.64 – 4.61 (m, 1Ha), 
4.59 (d, J = 6.9 Hz, 1Hb), 4.56 (d, J = 6.9 Hz, 1Ha), 4.53 (d, J = 6.9 Hz, 1Hb), 4.49 (d, J = 
6.9 Hz, 1Ha), 4.27 (t, J = 5.4 Hz, 1Ha), 4.24 (t, J = 3.4 Hz, 1Hb), 3.74 (s, 6Ha), 3.74 (s, 6Hb), 
3.63 (s, 3Hb), 3.62 (s, 3Ha), 3.29 (s, 3Hb), 3.28 (s, 3Ha), 2.13 – 2.02 (ovrlp, 1Ha, 1Hb), 1.98 
– 1.91 (ovrlp, 2Ha, 2Hb), 1.86 – 1.80 (ovrlp, 1Ha, 1Hb). (Ha is major diastereomer) 
13C NMR: (125 MHz, CDCl3) δ 167.5, 167.4, 161.8, 161.5, 161.5, 161.4, 158.1, 158.1, 
158.0, 158.0, 121.4, 120.7, 96.3, 96.1, 95.9, 95.7, 95.0, 94.9, 70.3, 69.4, 66.4, 65.1, 55.6, 
55.4, 52.0, 52.0, 26.4, 25.6, 25.3, 24.3. 
HR-MS (m/z): [C18H24O8+Na]
+ calculated: 391.1369; found: 391.1377 (+ 2.0453 ppm).  
 
Bis-TIPS Cyclohexanol (171): 
Method A: A 10 mL flame-dried flask was charged with sodium 
borohydride (29 mg, 768 μmol, 5.0 equiv), methanol (11 μL, 278 μmol, 
1.81 equiv), and CH2Cl2 (2 mL). To this, bis-TIPS ketone 199 (100 mg, 
153 μmol, 1.0 equiv) dissolved in CH2Cl2 (1 mL) was added at 0 °C. 
The reaction was monitored for completion by TLC. After stirring at 0 °C for 3 h, the 
reaction was quenched with acetone (1 mL) then a saturated NH4Cl solution and extracted 
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with CH2Cl2 (2x). The combined organic phases were washed with brine and dried over 
Na2SO4. The solvent concentrated in vacuo. The crude product was purified by column 
chromatography (gradient: EtOAc:hexanes, 0:1 to EtOAc:hexanes, 1:4) to afford bis-TIPS 
cyclohexanol 173 as a yellow resin (49 mg, 75 μmol, 49%).                   
Method B: A 50 mL flame-dried flask was charged with sodium borohydride (154 mg, 
4.07 mmol, 5.0 equiv), zirconium isopropoxide (53 mg, 162 μmol, 0.20 equiv), and CH2Cl2 
(12 mL). To this, bis-TIPS ketone 199 (530 mg, 814 μmol, 1.0 equiv) dissolved in CH2Cl2 
(3 mL) was added at 0 °C. The reaction was warmed to room temperature and monitored 
for completion by TLC. After stirring at room temperature for 48 h, methanol (1 mL) was 
added to the reaction. The reaction was stirred at room temperature for 0.5 h and then 
quenched with acetone (1 mL) and a saturated NH4Cl solution and extracted with CH2Cl2 
(2x). The combined organic phases were washed with brine and dried over Na2SO4. The 
solvent was concentrated in vacuo. The crude product was purified by column 
chromatography (gradient: EtOAc:hexanes, 0:1 to EtOAc:hexanes, 1:4) to afford bis-TIPS 
cyclohexanol 173 as a yellow resin (206 mg, 315 μmol, 39%).                  
IR υmax (film): 2945, 2894, 2867, 1693, 1587, 1453, 1292, 1260, 1169, 1100, 1032, 1013, 
882, 758, 652 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.11 (ovrlp, 1Ha, 1Hb), 6.10 (ovrlp, 2Ha, 2Hb), 4.71 (m, 
1Hb), 4.60 (m, 1Ha), 4.56 – 4.51 (ovrlp, 1Ha, 1Hb, 1Ha, 1Hb), 4.23 (t, J = 5.3 Hz, 1Ha), 4.20 
(t, J = 3.3 Hz, 1Hb), 3.60 (s, 3Hb), 3.59 (s, 3Ha), 3.44 (d, J = 2.9 Hz, 1Ha), 3.27 (s, 3Hb), 
3.26 (s, 3Ha), 2.84 (d, J = 3.2 Hz, 1Hb), 2.10 – 2.05 (ovrlp, 1Ha, 1Hb), 1.96 – 1.90 (ovrlp, 
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2Ha, 2Hb), 1.82 – 1.76 (ovrlp, 1Ha, 1Hb), 1.22 (ovrlp, 6Ha, 6Hb), 1.08 (s, 9Ha), 1.08 (s, 9Ha), 
1.06 (s, 9Hb), 1.06 (s, 9Hb). (Ha is the major diastereomer). 
13C NMR: (125 MHz, CDCl3) δ 167.7, 167.5, 158.9, 158.6, 158.2, 157.9, 157.7, 157.7, 
121.7, 121.3, 106.8, 106.7, 102.0, 101.8, 96.3, 96.0, 70.8, 69.7, 66.5, 65.3, 55.6, 52.1, 31.7, 
31.0, 26.3, 25.4, 18.0, 18.0, 12.7, 12.7. 
HR-MS (m/z): [C34H60O8Si2+Na]
+ calculated: 675.3724; found: 675.3722 (– 0.2961  ppm).  
 
Mono-TIPS Cyclohexanol (174): 
A 100 mL flame-dried flask was charged with mono-TIPS ketone 200 
(1.0 g, 2.04 mmol, 1.0 equiv), CH2Cl2 (50 mL), and NaBH4 (77 mg, 2.04 
mmol, 1.0 equiv). To this, methanol (1 mL) was added at -50 °C. The 
reaction was then warmed to -10 °C and monitored for completion by 
TLC. After stirring at -10 °C for 24 h, the reaction was quenched with a saturated NH4Cl 
solution and extracted with CH2Cl2. The combined organic phases were washed with brine 
and dried over Na2SO4. The solvent was concentrated in vacuo. The crude product was 
purified by column chromatography (gradient: EtOAc:hexanes, 0:1, to EtOAc:hexanes, 2:3) 
to afford mono-TIPS cyclohexanol 174 a pale yellow resin (735 mg, 1.48 mmol, 73%, 
4.6:1 dr). 
IR υmax (film): 3398, 3381, 2946, 2893, 2867, 1713, 1596, 1495, 1458, 1439, 1355, 1286, 
1161, 1027, 1000, 882, 683 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.08 – 6.05 (ovrlp, 3Ha, 3Hb), 5.27 (br s, 1Hb), 5.22 (br s, 
1Ha), 4.73 (m, 1Hb), 4.62 (tt, J = 6.4, 2.9 Hz, 1Ha), 4.57 (ovrlp, 1Ha, 1Hb), 4.54 (ovrlp1Ha, 
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1Hb), 4.25 (t, J = 5.4 Hz, 1Ha), 4.23 – 4.21 (m, 1Hb), 3.73 (s, 3Ha), 3.72 (s, 3Hb), 3.62 (s, 
3Hb), 3.60 (s, 3Ha), 3.30 (s, 3Hb), 3.28 (s, 3Ha), 2.11 – 2.08 (ovrlp, 1Ha, 1Hb), 1.97 – 1.93 
(ovrlp, 2Ha, 2Hb), 1.84 – 1.79 (ovrlp, 1Ha, 1Hb), 1.29 – 1.17 (ovrlp, 3Ha, 3Hb), 1.09 (s, 
9Ha), 1.09 (s, 9Hb), 1.08 (s, 9Ha), 1.07 (s, 9Hb). (Ha is the major diastereomer)  
13C NMR: (125 MHz, CDCl3) δ 167.8, 167.7, 158.8, 158.5, 158.3, 158.2, 158.0, 157.9, 
157.8, 157.7, 121.1, 120.8, 102.4, 102.3, 101.4, 101.1, 97.4, 97.1, 96.3, 96.1, 70.7, 69.5, 
66.7, 65.4, 55.7, 55.5, 52.2, 52.2, 49.0, 45.8, 28.6, 28.0, 26.3, 25.5, 18.0, 18.0, 12.7, 12.7. 
HR-MS (m/z): [C25H40O8Si+H]
+ calculated: 497.2571; found: 497.2568 (– 0.6033 ppm). 
 
Monomethoxy Cyclohexanol (104): 
A 250 mL flame-dried flask was charged with monomethoxy ketone 201 
(2.27 g, 6.44 mmol, 1.0 equiv), NaBH4 (244 mg, 6.44 mmol, 1.0 equiv), 
and CH2Cl2 (100 mL). To this, methanol (2.6 mL, 64.4 mmol, 10.0 equiv) 
was added at -78 °C. The reaction was warmed to room temperature and 
monitored for completion by TLC. After stirring at room temperature for 24 h, the reaction 
was quenched with a saturated NH4Cl solution and extracted with EtOAc. The combined 
organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
(gradient: EtOAc:hexanes, 1:4 to EtOAc:hexanes, 1:1) to afford monomethoxy 
cyclohexanol 104 as a yellow resin. The major cis diastereomer was then triturated from 
the mixture with CH2Cl2 to give cis-104 as a white solid (503 mg, 1.42 mmol g, 4.91 mmol, 
22%) and a 2:1 mixture of cis/trans-104 as a pale yellow solid (612 mg, 1.74 mmol, 27%). 
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cis-monomethoxy cyclohexanol (104):      
m.p.: 122 – 124 °C (CH2Cl2) 
IR υmax (film): 3365, 2951, 1707, 1601, 1500, 1437, 1362, 1277, 1194, 1153, 1100, 1057, 
1028, 952, 920, 827, 682 cm-1.        
1H NMR: (500 MHz, (CD3)2CO) δ 8.42 (s, 1H), 6.11 (t, J = 2.2 Hz, 1H), 6.03 (p, J = 2.2 
Hz, 2H), 4.65 (ddd, J = 7.4, 5.8, 5.6 Hz, 1H), 4.57 (d, J = 6.8 Hz, 1H), 4.50 (d, J = 6.8 Hz, 
1H), 4.20 (t, J = 4.6 Hz, 1H), 4.17 (d, J = 5.8 Hz, 1H), 3.72 (s, 3H), 3.57 (s, 3H), 3.25 (s, 
4H), 2.02 (td, J = 5.3, 3.0 Hz, 1H), 1.98 – 1.91 (m, 1H), 1.90 – 1.77 (m, 2H). 
13C NMR: (125 MHz, (CD3)2CO) δ 167.2, 162.6, 160.1, 159.2, 154.7, 125.9, 97.6, 96.6, 
96.6, 95.5, 70.1, 67.0, 55.6, 55.5, 51.7, 27.9, 26.5. 
HR-MS (m/z): [C17H22O8+Na]
+ calculated: 377.1212; found: 377.1207 (–  1.3258 ppm). 
1H NMR: (500 MHz, CDCl3) δ 6.12 (t, J = 2.2 Hz, 1H), 6.09 (t, J = 2.2 Hz, 1H), 6.05 (t, 
J = 2.2 Hz, 1H), 4.85 (br s, 1H), 4.63 (t, J = 5.9 Hz, 1H), 4.58 (d, J = 6.9 Hz, 1H), 4.53 (d, 
J = 6.9 Hz, 1H), 4.27 (t, J = 5.4 Hz, 1H), 3.74 (s, 3H), 3.62 (s, 3H), 3.29 (s, 3H), 2.14 – 
2.05 (m, 1H), 1.99 – 1.93 (ovrlp, 2H), 1.86 – 1.79 (m, 1H). 
cis/trans-monomethoxy cyclohexanol (104):                       
1H NMR: (500 MHz, CDCl3) δ 6.13 – 6.10 (ovrlp, 1Ha, 1Hb), 6.10 – 6.08 (ovrlp, 1Ha, 
1Hb), 6.05 – 6.03 (ovrlp, 1Ha, 1Hb), 4.74 (br s, 1Ha), 4.67 (s, 1Hb), 4.60 (d, J = 6.9 Hz, 
1Hb), 4.58 (d, J = 6.9 Hz, 1Ha), 4.56 (d, J = 6.9 Hz, 1Hb), 4.53 (d, J = 6.9 Hz, 1Ha), 4.27 (t, 
J = 5.4 Hz, 1Ha), 4.24 (t, J = 3.6 Hz, 1Hb),  3.74 (ovrlp, 3Ha, 3Hb), 3.64 (s, 3Hb), 3.62 (s, 
3Ha), 3.30 (s, 3Hb), 3.29 (s, 3Ha), 2.13 – 2.05 (ovrlp, 1Ha, 1Hb), 1.98 – 1.93 (ovrlp, 2Ha, 
2Hb), 1.86 – 1.79 (ovrlp, 1Ha, 1Hb). (Ha is the major cis diastereomer). 
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HR-MS (m/z): [C17H22O8+Na]
+ calculated: 377.1212; found: 377.1203 (–  2.3865 ppm). 
 
Mono-TIPS Tetrahydroxanthone (202): 
A 35 mL flame-dried microwave flask was charged with mono-
TIPS cyclohexanol 174 (4.6:1 dr, 300 mg, 604 μmol, 1.0 equiv), 
activated powdered 4 Å molecular sieves (300 mg), and DCE (10 
mL). To this, NaOMe (163 mg, 3.02 mmol, 5.0 equiv) was added. The reaction vessel was 
capped with a silicon cap and placed in the microwave at 60 °C and stirred for 1 h. The 
reaction was then diluted with EtOAc and quenched with 1N HCl solution. Both phases 
were then filtered through a fritted funnel, and the aqueous layer was extracted with CH2Cl2. 
The combined organic phases were washed with brine and dried over Na2SO4. The solvent 
was concentrated in vacuo. The crude product was purified by column chromatography 
(EtOAc:hexanes, 1:3) to afford mono-TIPS tetrahydroxanthone 202 as a pale yellow 
amorphous solid (109 mg, 234 μmol, 3.3:1 dr, 39%).                  
IR υmax (film): 3484, 2946, 2892, 2867, 1655, 1621, 1586, 1447, 1182, 1152, 1096, 1062, 
1031, 1010, 800 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 12.29 (s, 1Ha), 12.24 (s, 1Hb), 6.34 (dd, J = 2.2 Hz, 1Ha), 
6.33 (d, J = 2.1 Hz, 1Hb), 6.30 (d, J = 2.1 Hz, 1Hb), 6.30 (d, J = 2.2 Hz, 1Ha), 4.99 (t, J = 
4.3 Hz, 1Ha), 4.93 (dd, J = 7.4, 6.3 Hz, 1Hb), 4.88 (d, J = 6.9 Hz, 1Hb), 4.86 (d, J = 7.0 Hz, 
1Ha), 4.80 (d, J = 6.9 Hz, 1Hb), 4.80 (d, J = 7.0 Hz, 1Ha), 4.53 (t, J = 4.2 Hz, 1Ha), 4.49 (t, 
J = 4.4 Hz, 1Hb), 4.32 (br s, 1OHa, 1OHb), 3.47 (s, 3Hb), 3.46 (s, 3Ha), 2.19 – 2.11 (ovrlp, 
  
95 
1Ha, 1Hb), 2.04 – 2.00 (ovrlp, 2Ha, 2Hb), 1.88 – 1.81 (ovrlp, 1Ha, 1Hb), 1.31 – 1.23 (ovrlp, 
3Ha, 3Hb), 1.10 – 1.09 (ovrlp, 18Ha, 18Hb). 
13C NMR: (125 MHz, CDCl3) δ 183.1, 182.6, 163.3, 163.2, 162.8, 162.8, 162.1, 157.6, 
119.9, 119.4, 106.0, 105.9, 103.9, 98.7, 96.1, 96.1, 69.9, 69.6, 64.5, 62.0, 55.8, 55.8, 25.6, 
25.5, 25.3, 24.7, 17.9, 17.9, 12.8, 12.7. 
HR-MS (m/z): [C24H36O7Si+H]
+ calculated: 465.2309; found: 468.2331 (+ 4.7288 ppm). 
 
cis-Monomethoxy Tetrahydroxanthone (204): 
A 35 mL flame-dried microwave flask was charged with cis-
monomethoxy cyclohexanol cis-104 (64 mg, 180 μmol, 1.0 equiv), 
activated powdered 4 Å molecular sieves (60 mg), and DCE (5 mL). 
The solution was degassed with an argon balloon. To this was added NaOMe (24 mg, 451 
μmol, 2.5 equiv). The reaction vessel was capped with a silicon cap and placed in the 
microwave at 60 °C and stirred for 7 h. The reaction was then diluted with EtOAc, 
quenched with a saturated NH4Cl solution, and extracted with EtOAc. The combined 
organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
(EtOAc:hexanes, 1:2) to afford cis-monomethoxy tetrahydroxanthone cis-204 as a white 
solid (31 mg, 96 μmol, 53%, 71% brsm). 
m.p.: 107 – 110 °C (EtOAc) 
IR υmax (film):  2979, 2970, 2953, 2884, 2228, 2164, 2151, 2001, 1656, 1449, 1385, 1209, 
1197, 1159, 1080, 1063, 1032, 482, 443, 436, 418 cm-1. 
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1H NMR: (500 MHz, CDCl3) δ 12.31 (s, 1H), 6.36 (d, J = 2.3 Hz, 1H), 6.35 (d, J = 2.3 
Hz, 1H), 4.95 (t, J = 6.9 Hz, 1H), 4.89 (d, J = 6.9 Hz, 1H), 4.82 (d, J = 6.9 Hz, 1H), 4.51 
(t, J = 4.3 Hz, 1H), 4.27 (brs, 1H), 3.86 (s, 3H), 3.48 (s, 3H), 2.20 – 2.12 (m, 1H), 2.08 – 
1.99 (m, 2H), 1.90 – 1.81 (m, 1H). 
13C NMR: (125 MHz, CDCl3) δ 183.1, 166.1, 162.8, 162.2, 157.8, 120.0, 105.6, 98.4, 
96.1, 92.7, 69.7, 64.6, 56.0, 55.9, 25.6, 25.4. 
HR-MS (m/z): [C16H18O7+Na]
+ calculated: 345.0950; found: 345.0935 (– 4.3466 ppm).  
 
cis/trans-Monomethoxy Tetrahydroxanthone (204): 
A 35 mL flame-dried microwave flask was charged with cis/trans-
monomethoxy cyclohexanol cis/trans-104 (292 mg, 824 μmol, 1.0 
equiv, 2:1 cis/trans), activated powdered 4 Å molecular sieves (292 
mg), and DCE (9 mL). The solution was degassed with an argon balloon. To this was added 
NaOMe (111 mg, 2.06 mmol, 2.5 equiv). The reaction vessel was capped with a silicon 
cap and placed in the microwave at 65 °C and stirred for 12 h. The reaction was then diluted 
with EtOAc, quenched with a saturated NH4Cl solution, and extracted with EtOAc. The 
combined organic phases were washed with brine and dried over Na2SO4. The solvent was 
concentrated in vacuo. The crude product was purified by column chromatography 
(EtOAc:hexanes, 1:2) to afford cis/trans-monomethoxy tetrahydroxanthone cis/trans-204 
as a white solid (66 mg, 205 μmol, 25%, 45% brsm, 1.5:1 cis/trans). 
1H NMR: (500 MHz, CDCl3) δ 12.33 (s, 1Hb), 12.28 (s, 1Ha), 6.34 (ovrlp, 1Ha, 1Hb), 6.32 
(ovrlp, 1Ha, 1Hb), 4.99 (t, J = 4.4 Hz, 1Hb), 4.93 (dd, J = 7.4, 6.3 Hz, 1Ha), 4.88 (d, J = 6.9 
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Hz, 1Ha), 4.86 (d, J = 6.8 Hz, 1Hb), 4.82 – 4.77 (ovrlp, 1Ha, 1Hb), 4.65 (s, 1Hb), 4.54 (d, J 
= 4.1 Hz, 1Hb), 4.49 (t, J = 4.5 Hz, 1Ha), 4.28 (br s, 1Ha), 3.84 (ovrlp, 3Ha, 3Hb), 3.47 (s, 
3Ha), 3.47 (s, 3Hb), 2.24 – 2.14 (m, 1Ha, 1Hb), 2.04 – 2.0 (ovrlp, 2Ha, 2Hb), 1.98 – 1.91 (m, 
1Hb), 1.89 – 1.81 (m, 1Ha). (Ha is major cis diastereomer, 1.5:1). (Ha is the major cis 
diastereomer). 
13C NMR: (125 MHz, CDCl3) δ 183.0, 182.5, 166.0, 166.0, 162.9, 162.8, 162.1, 162.1, 
157.7, 157.7, 119.9, 119.5, 105.6, 105.5, 98.3, 98.3, 96.0, 96.0, 92.6, 92.5, 69.7, 69.4, 64.4, 
61.9, 56.0, 55.9, 55.9, 55.8, 25.5, 25.5, 25.3, 24.6. 
 
cis-Tetrahydroswertianolin Aglycon (105): 
A 10 mL flame-dried flask was charged with cis-monomethoxy 
tetrahydroxanthone cis-204 (39 mg, 121 μmol, 1.0 equiv), CH2Cl2 (2.0 
mL), and t-BuOH (1.0 mL). Then conc. HCl (9 μL, 363 μmol, 3.0 
equiv) was added, and the reaction was stirred at room temperature for 48 h. The reaction 
was then quenched with saturated NaHCO3 and extracted with CH2Cl2. The combined 
organic phases were washed with brine, dried over Na2SO4, and concentrated in vacuo. 
The crude product was purified by column chromatography (gradient: EtOAc:CH2Cl2, 0:1 
to EtOAc:CH2Cl2, 2:3) to afford cis-tetrahydroswertianolin aglycon cis-105 as a white 
solid (12 mg, 43 μmol, 36%, 53% brsm).            
m.p.: 165 – 167 °C (EtOAc)       
IR υmax (film): 3337, 3111, 2953, 1693, 1643, 1545, 1453, 1428, 1235, 1023, 741, 608, 
442, 421 cm-1. 
  
98 
1H NMR: (500 MHz, CD3OD) δ 6.53 (d, J = 2.3 Hz, 1H), 6.33 (d, J = 2.3 Hz, 1H), 4.93 
(t, J = 3.9 Hz, 1H), 4.59 (dd, J = 9.1, 6.0 Hz, 1H), 3.87 (s, 3H), 2.12 (ddd, J = 12.3, 9.2, 
3.2 Hz, 1H), 2.09 – 2.02 (m, 1H), 1.97 (ddt, J = 14.1, 5.8, 3.4 Hz, 1H), 1.90 – 1.78 (m, 1H). 
13C NMR: (125 MHz, CD3OD) δ 183.2, 167.6, 167.4, 163.2, 159.1, 119.6, 106.3, 99.0, 
93.4, 67.4, 62.1, 56.5, 28.8, 27.4. 
HR-MS (m/z): [C14H14O6+H]
+ calculated: 279.0869; found: 279.0879 (+ 3.5831 ppm). 
 
cis/trans-Tetrahydroswertianolin Aglycon (105): 
A 10 mL flame-dried flask was charged with cis/trans-monomethoxy 
tetrahydroxanthone cis/trans-204 (75 mg, 233 μmol, 1.0 equiv, 1.3:1 
cis/trans), CH2Cl2 (3.0 mL), and t-BuOH (2.0 mL). To this, conc. HCl 
(17 μL, 698 μmol, 3.0 equiv) was added, and the reaction was stirred at room temperature 
for 48 h. The reaction was quenched with saturated NaHCO3 and extracted with CH2Cl2. 
The combined organic phases were washed with brine and dried over Na2SO4. The solvent 
was concentrated in vacuo. The crude product was purified by column chromatography 
(gradient: EtOAc:CH2Cl2, 0:1 to EtOAc:CH2Cl2, 2:3) to afford cis/trans-
tetrahydroswertianolin aglycon cis/trans-105 as a white solid (25 mg, 90 μmol, 39%, 45% 
brsm, 1.4:1 cis/trans). 
1H NMR: (500 MHz, CD3OD) δ 7.89 (s, 1Hb), 6.51 (ovrlp, 1Ha, 1Hb), 6.31 (ovrlp, 1Ha, 
1Hb), 4.94 (t, J = 3.6 Hz, 1Hb), 4.92 (t, J = 3.9 Hz, 1Ha), 4.58 (dd, J = 9.1, 6.1 Hz, 1Ha), 
4.52 (dd, J = 4.5, 3.0 Hz, 1Hb), 3.87 (s, 3Ha), 3.86 (s, 3Hb), 2.34 – 2.25 (m, 1Hb), 2.16 – 
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2.09 (m, 1Ha), 2.09 – 2.02 (ovrlp, 1Ha, 1Hb, 1Hb), 1.96 (m, 1Ha), 1.91 – 1.77 (ovrlp, 1Ha, 
1Hb). (Ha is the major cis diastereomer). 
13C NMR: (125 MHz, CD3OD) δ 183.2, 183.1, 167.5, 167.4, 167.4, 166.3, 163.2, 163.2, 
159.2, 159.1, 119.6, 119.4, 106.5, 106.2, 99.0, 99.0, 93.4, 93.4, 67.4, 65.5, 62.1, 61.4, 56.5, 
56.5, 28.8, 27.4, 27.0, 26.5. 
 
Monomethoxy Methoxy Tetrahydroxanthone (208): 
A flask was charged with cis/trans-monomethoxy tetrahydroxanthone 
204 (12 mg, 37 μmol, 1.0 equiv, 2.4:1 cis/trans), CH2Cl2 (2 mL), and 
MeOH (1 mL, 24.7 mmol). To this, conc. HCl (10 μL, 326 μmol, 8.8 
equiv) was added. The reaction was then heated at 40 ºC for 48 h and then quenched with 
brine. After extracting with CH2Cl2, the combined organic phases were dried over Na2SO4. 
The solvent was concentrated in vacuo. The crude product was purified by column 
chromatography (gradient: EtOAc:hexanes, 0:1 to EtOAc:hexanes, 1:1) to afford 
monomethoxy methoxy tetrahydroxanthone 208 as a white solid (4 mg, 13.7 μmol, 37%, 
2.6:1 dr).               
m.p.: 166 – 172 °C (EtOAc)       
IR υmax (film): 3408, 2926, 2851, 1656, 1621, 1589, 1504, 1448, 1370, 1288, 1196, 1127, 
1097, 1066, 1031, 957, 906, 794 cm-1.  
1H NMR: (500 MHz, CDCl3) δ 12.61 (s, 1Hb), 12.60 (s, 1Ha), 6.38 – 6.30 (ovrlp, 1Ha, 
1Ha, 1Hb, 1Hb), 4.60 (ovrlp, 1Ha, 1Hb), 4.55 (dd, J = 4.7, 1.8 Hz, 1Hb), 4.52 (m, 1Ha), 3.84 
(s, 3Hb), 3.83 (s, 3Ha), 3.49 (s, 3Ha), 3.48 (s, 3Hbf), 2.29 (tt, J = 14.3, 3.8 Hz, 1Hb), 2.22 – 
  
100 
2.04 (ovrlp, 1Ha, 1Ha, 1Hb), 1.97 – 1.90 (m, 1Hb), 1.84 (tt, J = 14.2, 3.2 Hz, 1Ha), 1.61 – 
1.55 (ovrlp, 1Ha, 1Hb). (Ha is major diastereomer, 2.6:1). 
13C NMR: (125 MHz, CDCl3) δ 181.6, 181.3, 165.8, 165.8, 165.6, 164.2, 162.4, 162.3, 
157.6, 157.4, 117.5, 117.0, 105.8, 105.5, 98.3, 98.2, 92.7, 92.6, 68.9, 68.7, 67.3, 64.9, 57.7, 
57.7, 55.9, 55.9, 26.2, 25.4, 24.5, 21.0. 
HR-MS (m/z): [C15H16O6+Na]
+ calculated: 315.0845, found: 315.0860 (+ 4.7606 ppm). 
 
2.7.4 Experimental Section: Asymmetric Synthesis of Tetrahydroxanthone Core 
(R)-Octahydro-BINOL (208) 109 and brominated (R)-octahydro-BINOL (209) 108 
were prepared from (R)-BINOL following literature procedures. Boronic acid 212 was 
prepared from tert-butyl phenol with modifications from literature procedure.108 
  
(R)-tert-Butyloctahydro-BINOL ((R)-206):108 
A Schlenk flask was charged with brominated (R)-octahydro-BINOL 
(212) (619 mg, 1.37 mmol, 1.0 equiv), boronic acid 215 (855 mg, 4.11 
mmol, 3.0 equiv), sodium carbonate (726 mg, 6.85 mmol, 5.0 equiv), 
and palladium triphenylphosphine tetrakis (158 mg, 137 μmol, 10 
mol%) under inert atmosphere. To this, DME (10 mL) and water (8 mL) that had been 
freeze/pump/thawed were added. After stirring at 95 °C for 24 h, the reaction was quenched 
with 2N HCl solution (100 mL) and extracted with CH2Cl2. The combined organic phases 
were washed with brine and dried over Na2SO4. The solvent was concentrated in vacuo. 
The crude product was purified by column chromatography (gradient: CH2Cl2:hexanes, 0:1 
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to CH2Cl2:hexanes, 1:2) to afford (R)-tert-butyloctahydro-BINOL (R)-209 as a white solid 
(420 mg, 679 μmol, 50%).  
With the same batch of 212 and 215 but a different source of Pd(PPh3)4, (R)-tert-
butyloctahydro-BINOL (R)-209 was isolated as a white solid (5.2 g, 8.40 mmol, 27%).                   
IR υmax (film): 3527, 3383, 2961, 2932, 2860, 2837, 1499, 1459, 1258, 1237, 1020, 733, 
702, 661 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 7.42 (d, J = 2.5 Hz, 2H), 7.34 (dd, J = 8.6, 2.5 Hz, 2H), 
7.05 (s, 2H), 6.91 (d, J = 8.6 Hz, 2H), 5.82 (s, 2H), 3.81 (s, 6H), 2.83 (t, J = 6.1 Hz, 4H), 
2.53 (dt, J = 17.1, 6.1 Hz, 2H), 2.30 (dt, J = 17.1, 6.1 Hz, 2H), 1.83 – 1.69 (m, 8H). 
13C NMR: (125 MHz, CDCl3) δ 153.7, 148.7, 144.3, 136.6, 131.4, 129.6, 129.4, 127.1, 
125.4, 124.2, 124.1, 110.8, 56.1, 34.3, 31.6, 29.5, 27.3, 23.3, 23.2. 
HR-MS (m/z): [C42H50O4+Na]
+ calculated: 641.3607; found: 641.3616 (+ 1.4033 ppm). 
 
(R)-Hydroxy Ynoate ((R)-166): 
A 250 mL flame-dried flask was charged with (R)-tert-butyloctahydro-
BINOL (R)-209 (2.6 g, 4.20 mmol, 0.2 equiv), THF (75 mL), NMI (83 μL, 
1.05 mmol, 0.05 equiv), and methyl propiolate (3.74 mL, 42.0 mmol, 2.0 
equiv). To this, neat Et2Zn (4.32 mL, 42.0 mmol, 2.0 equiv) was carefully added at room 
temperature. After stirring the reaction for 1 h, Ti(OiPr)4 (3.11 mL, 10.5 mmol, 0.5 equiv) 
was added to the reaction.  The reaction was then stirred for 0.5 h. To this was added pent-
4-enal (2.06 mL, 21.0 mmol, 1.0 equiv). After stirring at room temperature for 72 h, the 
reaction was carefully quenched with 2N HCl solution (100 mL) and extracted with EtOAc 
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(100 mL, 3x). The combined organic layers were washed with 1N Rochelle’s salt solution 
(100 mL) and brine and dried over Na2SO4. The solvent was evaporated in vacuo. The 
crude reaction mixture was purified by column chromatography (gradient: 
CH2Cl2:hexanes, 0:1 to CH2Cl2:hexanes, 1:4 then EtOAc:hexanes, 1:4) to recover (R)-tert-
butyloctahydro-BINOL (R)-209, which was reused in subsequent reactions, and to afford 
(R)-hydroxy ynoate (R)-166 as a light yellow oil (2.51 g, 14.9 mmol, 71%, 98:2 er).  
[α]D = – 9.640 (c = 1.06, CHCl3) 
IR υmax (film): 3412, 3079, 2953, 2236, 1713, 1641, 1435, 1245, 1057, 1023, 999, 914, 
804, 750, 628, 557 cm-1.  
1H NMR; 13C NMR; HR-MS (m/z): see (±)-166 (page 75) 
 
(R)-Iodo Ketone ((R)-196): 
A 250 mL flame-dried flask was charged with (R)-iodocyclohexanol (R)-
195 (2.15 g, 6.28 mmol, 1.0 equiv, 98:2 er), CH2Cl2 (125 mL), and Dess-
Martin periodinane120 (2.8 g, 6.60 mmol, 1.05 equiv). The reaction was 
monitored for completion by TLC. After stirring at room temperature for 2 h, the reaction 
was quenched with saturated NaHCO3 (125 mL) and saturated sodium thiosulfate (125 
mL) and stirred until both aqueous and organic layers were transparent. After extracting 
with CH2Cl2, the combined organic phases were washed with brine and dried over Na2SO4. 
The solvent was concentrated in vacuo. The crude product was purified by column 
chromatography (EtOAc:CH2Cl2, 1:0) to afford (R)-iodo ketone (R)-196 as a pale yellow 
solid (2.0 g, 5.88 mmol, 94%, 97:3 er).  
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m.p. decomposition (EtOAc) 
[α]D = + 36.723 (c = 1.23, CHCl3) 
IR υmax (film); 1H NMR; 13C NMR; HR-MS (m/z): see (±)-196 (page 82) 
 
(R)-Monomethoxy Ketone ((R)-201): 
A 500 mL flame-dried flask was charged with 1,3-dihydroxy-5-
methoxybenzene 102 (1.48 g, 10.5 mmol, 2.0 equiv) and acetone (50 mL). 
The solution was degassed with an argon balloon. To this, K3PO4 (1.69 g, 
7.94 mmol, 1.5 equiv) and DABCO (59 mg, 529 μmol, 0.1 equiv) were 
added, and the reaction was stirred at room temperature for 0.5 h. Then (R)-iodo ketone 
(R)-196 (4.50 g, 13.23 mmol, 1.0 equiv) dissolved in CH2Cl2 (150 mL) was added to the 
heterogeneous reaction mixture, and a reflux condenser was attached. The reaction was 
heated at 40 °C and monitored for completion by TLC. After stirring at 40 °C for 72 h,  the 
reaction was cooled to room temperature, diluted with CH2Cl2 (100 mL), quenched with 
saturated NH4Cl solution (75 mL), and extracted with EtOAc (3x). The combined organic 
phases were washed with brine and dried over Na2SO4. The solvent was concentrated in 
vacuo. The crude product was purified by column chromatography (gradient: 
EtOAc:hexanes, 0:1, to EtOAc:hexanes, 2:5) to afford (R)-monomethoxy ketone (R)-201 
as an orange amorphous solid (1.03 g, 2.92 mmol, 55%).                  
[α]D = + 184.417 (c = 1.07, CHCl3) 
IR υmax (film); 1H NMR; 13C NMR; HR-MS (m/z): see (±)-201 (page 86 – 87) 
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2.7.6 Select NMR Spectra 
 
1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
 
 
  
106 
 
1H NMR (500 MHz, CDCl3) 
 
 13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, (CD3)2 SO) 
 
 
13C NMR (100 MHz, (CD3)2 SO) 
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1H NMR (500 MHz, (CD3)2 SO) 
 
 
NOESY (400 MHz, (CD3)2 SO, mixing time = 600 ms, relaxation time = 1 s) 
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1H NMR (500 MHz, (CD3)2 SO) 
 
 
NOESY (400 MHz, (CD3)2 SO, mixing time = 600 ms, relaxation time = 1 s) 
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3)
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, (CD3)2CO) 
 
13C NMR (125 MHz, (CD3)2CO) 
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1H NMR (500 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (500 MHz, CDCl3) 
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1H NMR (500 MHz, CD3OD) 
 
13C NMR (125 MHz, CD3OD)
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1H NMR (500 MHz, CD3OD) 
 
 
13C NMR (125 MHz, CD3OD) 
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1H NMR (500 MHz, CD3Cl) 
 
13C NMR (125 MHz, CD3Cl) 
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1H NMR (500 MHz, CD3Cl) 
13C NMR (125 MHz, CD3Cl) 
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2.7.7 Chiral HPLC Traces 
Chiral HPLC conditions for separating the enantiomers of hydroxyl ynoate 164: 
Chiralcel®OD (Chiral Technologies Inc., 250 x 4.6 mm I.D.) column; 99:1, 
hexanes:isopropanol; flow rate = 1.0 mL/min; UV detector, λ = 214 nm.  
Retention times: 22.09 min and 25.76 min. 
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Chiral HPLC conditions for separating the enantiomers of iodo ketone 196: 
ChiralPak®AD (150 x 4.6 mm I.D.) column; 99:1, hexanes:isopropanol; flow rate = 1.0 
mL/min; UV detector, λ = 254 nm. 
Retention times: 26.89 min and 30.72 min. 
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2.7.8  X-Ray Crystallography Data 
cis-monomethoxy cyclohexanol (cis-104): 
 
Crystals of cis-monomethoxy cyclohexanol cis-104 for X-ray analysis were obtained by 
slow evaporation from chloroform and 2,2,4-trimethylpentane. 
Crystal Data: 
 C17H22O8 F(000) = 752 
Mr = 354.34 Dx = 1.373 Mg m-3 
Monoclinic, P21/c Cu Ka radiation, l = 1.54178 Å 
a = 13.8284 (5) Å Cell parameters from 9976 reflections 
b = 10.9393 (4) Å q = 3.2–66.5° 
c = 11.3395 (4) Å m = 0.93 mm-1 
b = 92.077 (3)° T = 100 K 
V = 1714.23 (11)  Å3 Prism, colorless 
Z = 4 0.17 × 0.10 × 0.07 mm 
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Data Collection: 
Bruker X8 Proteum-R  
diffractometer 
3005 independent reflections 
Radiation source: rotating anode 2561 reflections with I > 2(I) 
Montel monochromator Rint = 0.087 
/w and /f scans max = 66.7°, min = 3.2° 
Absorption correction: multi-scan  
SADABS (Krause et al., 2015) 
h = -1616 
Tmin = 0.656, Tmax = 0.753 k = -138 
21105 measured reflections l = -1213 
 
Refinement: 
Refinement on F2 Primary atom site location: dual 
Least-squares matrix: full Hydrogen site location: mixed 
R[F2 > 2(F2)] = 0.046 H atoms treated by a mixture of independent 
and constrained refinement 
wR(F2) = 0.127  w = 1/[2(Fo2) + (0.056P)2 + 1.135P]   
where P = (Fo2 + 2Fc2)/3 
S = 1.05 (/)max < 0.001 
3005 reflections max = 0.42 e Å-3 
235 parameters min = -0.27 e Å-3 
0 restraints  
 
Special Detail: 
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes)  are estimated using the 
full covariance matrix.  The cell esds are taken  into account individually in the estimation of esds in 
distances, angles  and torsion angles; correlations between esds in cell parameters are only  used when they 
are defined by crystal symmetry.  An approximate (isotropic)  treatment of cell esds is used for estimating 
esds involving l.s. planes. 
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Fractional atomic coordinates and isotropic or equivalent isotropic displacement 
parameters (Å2): 
 x y z Uiso*/Ueq 
O5 0.60530 (9) 0.26613 (12) 0.57222 (11) 0.0217 (3) 
O4 0.50179 (9) 0.31146 (12) 0.42192 (11) 0.0212 (3) 
O3 0.32189 (9) 0.34853 (12) 0.51143 (11) 0.0206 (3) 
O6 0.60851 (9) 0.50069 (12) 0.68539 (12) 0.0222 (3) 
H6 0.5835 (17) 0.563 (2) 0.645 (2) 0.033* 
O7 0.28194 (9) 0.55657 (12) 0.67374 (12) 0.0242 (3) 
O2 0.22063 (10) -0.02559 (13) 0.69438 (13) 0.0290 (3) 
H2 0.277 (2) -0.011 (2) 0.735 (2) 0.043* 
O8 0.12023 (10) 0.52370 (14) 0.61368 (14) 0.0368 (4) 
O1 0.04524 (11) 0.12731 (15) 0.36584 (15) 0.0399 (4) 
C10 0.52516 (12) 0.31813 (16) 0.52605 (16) 0.0172 (4) 
C9 0.46993 (13) 0.38087 (16) 0.61847 (15) 0.0171 (4) 
C8 0.37316 (13) 0.38586 (16) 0.61190 (16) 0.0182 (4) 
C4 0.25898 (13) 0.25071 (17) 0.52291 (16) 0.0192 (4) 
C12 0.52798 (13) 0.43066 (16) 0.72406 (16) 0.0185 (4) 
H12 0.5548 0.3590 0.7692 0.022* 
C5 0.27449 (13) 0.16318 (17) 0.60914 (16) 0.0191 (4) 
H5 0.3270 0.1700 0.6651 0.023* 
C15 0.31249 (13) 0.43546 (16) 0.70853 (16) 0.0200 (4) 
H15 0.2543 0.3823 0.7170 0.024* 
C14 0.37030 (14) 0.43906 (17) 0.82465 (16) 0.0216 (4) 
H14A 0.3822 0.3547 0.8534 0.026* 
H14B 0.3333 0.4832 0.8844 0.026* 
C13 0.46633 (14) 0.50347 (17) 0.80734 (16) 0.0211 (4) 
H13A 0.4542 0.5861 0.7744 0.025* 
H13B 0.5014 0.5127 0.8845 0.025* 
C6 0.21045 (13) 0.06376 (18) 0.61174 (17) 0.0232 (4) 
C3 0.18378 (13) 0.24457 (18) 0.43836 (17) 0.0229 (4) 
H3 0.1750 0.3061 0.3798 0.027* 
C2 0.12197 (14) 0.14466 (19) 0.44303 (19) 0.0278 (5) 
C11 0.66497 (14) 0.20391 (18) 0.48858 (17) 0.0243 (4) 
H11A 0.6741 0.2569 0.4202 0.036* 
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H11B 0.6331 0.1280 0.4627 0.036* 
H11C 0.7280 0.1848 0.5263 0.036* 
C7 0.13454 (14) 0.05413 (19) 0.52912 (19) 0.0301 (5) 
H7 0.0914 -0.0134 0.5310 0.036* 
C16 0.18377 (14) 0.5817 (2) 0.6945 (2) 0.0303 (5) 
H16A 0.1691 0.5547 0.7753 0.036* 
H16B 0.1731 0.6711 0.6902 0.036* 
C1 0.03000 (16) 0.2146 (2) 0.2731 (2) 0.0366 (5) 
H1A 0.0856 0.2141 0.2219 0.055* 
H1B 0.0226 0.2963 0.3071 0.055* 
H1C -0.0287 0.1933 0.2266 0.055* 
C17 0.12707 (19) 0.5706 (2) 0.4965 (2) 0.0462 (6) 
H17A 0.0809 0.5277 0.4436 0.069* 
H17B 0.1928 0.5580 0.4695 0.069* 
H17C 0.1122 0.6582 0.4961 0.069* 
 
Atomic displacement parameters (Å2): 
 U11 U22 U33 U12 U13 U23 
O5 0.0244 (7) 0.0197 (7) 0.0208 (7) 0.0039 (5) -0.0019 (5) 0.0008 (5) 
O4 0.0275 (7) 0.0195 (7) 0.0164 (7) 0.0000 (5) -0.0015 (5) -0.0001 (5) 
O3 0.0214 (7) 0.0245 (7) 0.0157 (6) -0.0057 (5) -0.0033 (5) 0.0021 (5) 
O6 0.0242 (7) 0.0208 (7) 0.0212 (7) -0.0024 (5) -0.0044 (5) 0.0020 (5) 
O7 0.0249 (7) 0.0180 (7) 0.0295 (7) 0.0036 (5) -0.0007 (5) 0.0046 (6) 
O2 0.0274 (8) 0.0250 (8) 0.0338 (8) -0.0059 (6) -0.0074 (6) 0.0079 (6) 
O8 0.0284 (8) 0.0368 (9) 0.0447 (9) -0.0002 (6) -0.0077 (7) 0.0073 (7) 
O1 0.0312 (8) 0.0435 (10) 0.0436 (9) -0.0100 (7) -0.0203 (7) 0.0082 (8) 
C10 0.0208 (9) 0.0107 (8) 0.0200 (10) -0.0036 (7) -0.0025 (7) 0.0027 (7) 
C9 0.0258 (10) 0.0121 (8) 0.0134 (8) -0.0021 (7) -0.0012 (7) 0.0032 (7) 
C8 0.0254 (10) 0.0141 (9) 0.0148 (9) -0.0022 (7) -0.0024 (7) 0.0030 (7) 
C4 0.0178 (9) 0.0215 (10) 0.0185 (9) -0.0014 (7) 0.0029 (7) -0.0034 (7) 
C12 0.0219 (9) 0.0172 (9) 0.0162 (9) -0.0017 (7) -0.0027 (7) 0.0016 (7) 
C5 0.0169 (9) 0.0211 (10) 0.0191 (9) 0.0010 (7) -0.0011 (7) -0.0036 (7) 
C15 0.0233 (9) 0.0164 (9) 0.0202 (10) -0.0005 (7) 0.0008 (7) 0.0026 (7) 
C14 0.0296 (10) 0.0192 (10) 0.0162 (9) 0.0020 (7) 0.0024 (7) 0.0000 (7) 
C13 0.0271 (10) 0.0208 (10) 0.0151 (9) 0.0006 (7) -0.0035 (7) -0.0010 (7) 
C6 0.0215 (10) 0.0221 (10) 0.0260 (10) 0.0000 (7) 0.0013 (8) 0.0006 (8) 
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C3 0.0217 (10) 0.0266 (10) 0.0202 (10) 0.0027 (7) -0.0025 (7) 0.0014 (8) 
C2 0.0206 (10) 0.0308 (11) 0.0313 (11) -0.0019 (8) -0.0080 (8) -0.0025 (9) 
C11 0.0274 (10) 0.0192 (10) 0.0263 (10) 0.0046 (7) 0.0032 (8) 0.0009 (8) 
C7 0.0234 (10) 0.0272 (11) 0.0391 (12) -0.0070 (8) -0.0065 (9) 0.0033 (9) 
C16 0.0262 (11) 0.0294 (11) 0.0352 (12) 0.0057 (8) -0.0011 (9) 0.0014 (9) 
C1 0.0302 (11) 0.0403 (13) 0.0380 (13) 0.0026 (9) -0.0158 (9) -0.0007 (10) 
C17 0.0471 (15) 0.0440 (15) 0.0459 (15) -0.0013 (11) -0.0187 (11) 0.0101 (12) 
 
Geometric parameters (Å, °): 
O5—C10 1.335 (2) C5—C6 1.403 (3) 
O5—C11 1.449 (2) C15—H15 1.0000 
O4—C10 1.215 (2) C15—C14 1.516 (3) 
O3—C8 1.382 (2) C14—H14A 0.9900 
O3—C4 1.388 (2) C14—H14B 0.9900 
O6—H6 0.88 (3) C14—C13 1.522 (3) 
O6—C12 1.433 (2) C13—H13A 0.9900 
O7—C15 1.441 (2) C13—H13B 0.9900 
O7—C16 1.413 (2) C6—C7 1.386 (3) 
O2—H2 0.90 (3) C3—H3 0.9500 
O2—C6 1.358 (2) C3—C2 1.390 (3) 
O8—C16 1.399 (3) C2—C7 1.397 (3) 
O8—C17 1.431 (3) C11—H11A 0.9800 
O1—C2 1.364 (2) C11—H11B 0.9800 
O1—C1 1.431 (3) C11—H11C 0.9800 
C10—C9 1.487 (3) C7—H7 0.9500 
C9—C8 1.339 (3) C16—H16A 0.9900 
C9—C12 1.518 (2) C16—H16B 0.9900 
C8—C15 1.505 (3) C1—H1A 0.9800 
C4—C5 1.380 (3) C1—H1B 0.9800 
C4—C3 1.390 (3) C1—H1C 0.9800 
C12—H12 1.0000 C17—H17A 0.9800 
C12—C13 1.520 (3) C17—H17B 0.9800 
C5—H5 0.9500 C17—H17C 0.9800 
    
C10—O5—C11 115.31 (14) C12—C13—H13A 109.6 
C8—O3—C4 117.07 (14) C12—C13—H13B 109.6 
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C12—O6—H6 105.9 (16) C14—C13—H13A 109.6 
C16—O7—C15 114.02 (15) C14—C13—H13B 109.6 
C6—O2—H2 106.9 (17) H13A—C13—H13B 108.1 
C16—O8—C17 112.64 (17) O2—C6—C5 121.51 (17) 
C2—O1—C1 117.99 (17) O2—C6—C7 117.97 (17) 
O5—C10—C9 111.13 (15) C7—C6—C5 120.52 (18) 
O4—C10—O5 122.89 (17) C4—C3—H3 121.4 
O4—C10—C9 125.96 (16) C2—C3—C4 117.22 (18) 
C10—C9—C12 116.81 (15) C2—C3—H3 121.4 
C8—C9—C10 121.17 (16) O1—C2—C3 123.38 (19) 
C8—C9—C12 121.89 (16) O1—C2—C7 115.08 (18) 
O3—C8—C15 115.09 (15) C3—C2—C7 121.54 (18) 
C9—C8—O3 121.06 (16) O5—C11—H11A 109.5 
C9—C8—C15 123.82 (16) O5—C11—H11B 109.5 
O3—C4—C3 115.35 (16) O5—C11—H11C 109.5 
C5—C4—O3 121.31 (16) H11A—C11—H11B 109.5 
C5—C4—C3 123.25 (17) H11A—C11—H11C 109.5 
O6—C12—C9 110.18 (14) H11B—C11—H11C 109.5 
O6—C12—H12 107.3 C6—C7—C2 119.38 (18) 
O6—C12—C13 111.68 (15) C6—C7—H7 120.3 
C9—C12—H12 107.3 C2—C7—H7 120.3 
C9—C12—C13 112.67 (15) O7—C16—H16A 109.0 
C13—C12—H12 107.3 O7—C16—H16B 109.0 
C4—C5—H5 121.0 O8—C16—O7 112.74 (17) 
C4—C5—C6 118.08 (17) O8—C16—H16A 109.0 
C6—C5—H5 121.0 O8—C16—H16B 109.0 
O7—C15—C8 107.32 (14) H16A—C16—H16B 107.8 
O7—C15—H15 109.4 O1—C1—H1A 109.5 
O7—C15—C14 110.73 (15) O1—C1—H1B 109.5 
C8—C15—H15 109.4 O1—C1—H1C 109.5 
C8—C15—C14 110.57 (15) H1A—C1—H1B 109.5 
C14—C15—H15 109.4 H1A—C1—H1C 109.5 
C15—C14—H14A 109.8 H1B—C1—H1C 109.5 
C15—C14—H14B 109.8 O8—C17—H17A 109.5 
C15—C14—C13 109.58 (15) O8—C17—H17B 109.5 
H14A—C14—H14B 108.2 O8—C17—H17C 109.5 
C13—C14—H14A 109.8 H17A—C17—H17B 109.5 
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C13—C14—H14B 109.8 H17A—C17—H17C 109.5 
C12—C13—C14 110.43 (15) H17B—C17—H17C 109.5 
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CHAPTER 3 
Synthetic Studies Toward Puniceaside B Aglycon 
 
3.1  Overview and Introduction 
This chapter describes our efforts toward the synthesis of the heterodimeric core of 
puniceaside B (2). Our synthetic plan consisted of exploring the reactivity of a quinone 
monoketal xanthone coupling partner (252) with tetrahydroxanthone core 251 (Figure 
3.1). The precursor to this proposed xanthone quinone monoketal 252 would be xanthone 
253.  
 
Figure 3.1   Proposed Coupling Partners Toward Puniceaside B Aglycon 
The proposed oxidized xanthone 252 was inspired by the quinone monoketal 
arylation strategy employed by the Porco group in their syntheses of the kibdelones 
(Scheme 1.3).64 We wanted to see if we could expand the substrate scope of this arylation 
methodology (Scheme 3.1). We hypothesized that the monoketal moiety would allow for 
the correct biaryl linkage on the electrophilic coupling partner. To favor the biaryl linkage 
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on the ortho position in tetrahydroxanthone 251, we proposed to use a bulky TBDPS group 
on the phenol meta to C-1. A potential issue for the nucleophilic reacting partner could be 
the lack of electron density in the aromatic ring due to the tetrahydroxanthone carbonyl. 
Nevertheless, we were excited about our synthetic proposal as it would contribute to the 
established arylation methodology developed by Porco and coworkers65 and should allow 
us to access puniceaside B aglycon 250 quickly and efficiently.  
Scheme 3.1   Proposed Reactivity of Quinone Monoketal Xanthone  
 
Before we could explore the arylation chemistry, we would need to synthesize 
xanthone precursor 253 to the proposed xanthone quinone monoketal 252. Herein, we 
report our key efforts to synthesize xanthone 253. 
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3.2  Previous Syntheses of Xanthones 
The synthesis of xanthones5,6 have been published and studied more frequently in 
the literature than that of tetrahydroxanthones. In fact, the first reported synthesis of a 
polycyclic xanthone natural product was that of cervinomycin A1 and A2 by Kelley and 
coworkers in 1989.121 Soon after, Mehta and coworkers also published their synthetic 
efforts toward cervinomycin A1- and A2-methyl ether122 as did Rao and coworkers in 
1991.123 Several recent synthetic studies of xanthones and xanthone containing natural 
products will be discussed.   
3.2.1  Suzuki Group’s Synthesis of FD-594 Aglycon  
In 2009, Suzuki and coworkers published the first synthesis of the core of FD-594, 
a glycosylated xanthone that was isolated from Streptomyces sp. TA-0256 (Scheme 3.2).124 
The authors planned to set the chiral diol stereocenters via a chirality-transfer pinacol 
cyclization of an axially chiral biaryl aldehyde (257). The dialdehyde 259 would come 
from a Bringmann-type asymmetric cleavage of lactone 261 using a chiral nucleophile. 
This lactone intermediate 261 could be derived from a Pd-catalyzed cyclization of iodo 
ester 262.  
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Scheme 3.2   Suzuki Group’s Retrosynthetic Analysis of FD-594 Aglycon  
 
To access their iodo ester intermediate 262, the authors needed to synthesize the 
two coupling partners: lactone 263 and xanthone 264 (Scheme 3.3). The Suzuki group’s 
synthesis of xanthone 264 is detailed below. An oxidation of diester 265 using NCS led to 
hydroquinone 266 in 87% yield. Then, a mono-reduction of the methyl ester to the alcohol 
using NaBH4, acetal protection, bromination, methylation, and finally the acidic removal 
of the acetal moiety and oxidation led to bromobenzene 268 in 66% over 6 steps. 
Benzylation followed by the addition of dioxole 269 (deprotonated with n-BuLi) led to 
benzophenone precursor 270 in 85% yield. Finally, an IBX oxidation and MOM 
deprotection gave benzophenone 271 in 97% yield over 2 steps.  
 
 
  
149 
Scheme 3.3   Suzuki Group’s Synthesis of a DEF-Ring Precursor 
 
Suzuki and coworkers then employed a Cs2CO3-mediated SNAr reaction in 
cyclohexane to access xanthone 272 in 84% yield (Scheme 3.4). The authors found that 
the solvent was very important for this SNAr reaction. Using MeOH gave a 1:1 mixture of 
the desired compound 272 and byproduct 273, where the OBn group is displaced by the 
phenoxide. Employing DMF as the solvent improved the ratio of 272/273 to 3:1. 
Cyclohexane proved to be the optimal solvent for the desired xanthone 272 giving a 23:1 
mixture which was re-precipitated in petroleum ether/chloroform (3:1). The methyl ester 
272 was then saponified to carboxylic acid 264, which was then coupled with the lactone 
263 and further elaborated very elegantly to the FD-594 Aglycon (258).124  
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Scheme 3.4   Suzuki Group’s SNAr Reaction to Xanthone Coupling Partner 
 
3.2.2  Martin Group’s Synthesis of 1,4-Dioxygenated Xanthones  
Martin and coworkers reported a synthesis of 1,4-dioxygenated xanthones125,126 
using their previously developed127 novel application of the Moore cyclization (Scheme 
3.5). The authors heated ketone 274a in toluene to generate a ketene in situ which 
underwent the Moore cyclization (Scheme 3.5 a.) and rearrangement to afforded benzyl 
alcohol 276a in 78% yield (Scheme 3.5 b.). A Jones oxidation then gave benzophenone 
279a in 96% yield. 
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Scheme 3.5   Martin Group’s Novel Application of Moore Cyclization  
 Xanthone 281a was synthesized by stirring 279a in dichloromethane with TFA at 
room temperature (Scheme 3.6). The authors then synthesized 8 other xanthones (281b-i) 
by employing this synthetic strategy. For compounds 279f-i, a mixture of the desired 
xanthone 281f-i and spiro ketone 280f-i were obtained after stirring in TFA. Fortunately, 
the authors were able to treat the spiro ketones 280f-i with K2CO3 in acetone to effect 
conversion to xanthones 280f-I in 60-83% yields. 
Martin and coworkers then applied this strategy to the synthesis of the aglycon of 
IB-00208 (283)128,129 and the pentacyclic core of citreamicin η (284),130 both of which are 
polycyclic 1,4-dioxygenated xanthone natural products (Figure 3.2). 
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Scheme 3.6   Martin Group’s Synthesis of Xanthones via Moore Cyclization 
 
The authors completed their synthesis of the aglycon core of IB-00208 283 as 
follows (Scheme 3.7). Coupling of bromobenzene 285 with vinyl cyclobutenone 286 
afforded intermediate 287 in 64% yield. A Grubbs II-catalyzed ring closing metathesis led 
to ketone 289 which was then alkynylated via Grignard addition and coupled with aldehyde 
288 to afford alkyne 290 in 70% yield over 2 steps.  
 
Figure 3.2   IB-00208 and Citreamicin η  
Alkyne 290 was then heated in at 100 °C in DMSO to afford the Moore cyclization 
product 291 in 54% yield. From here, a series of oxidations followed by desilylation 
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afforded spiro compound 292 in 52% yield over 3 steps. Compounds 290-293 were used 
as a mixture of diastereomers as the next step made the stereocenters obsolete.  
Scheme 3.7   Martin Group’s Synthesis of the Aglycon of IB-00208 
 
After deprotecting the hemiacetal and oxidizing to lactone 293, the authors found 
that thermolysis of 232 in the microwave at 180 °C induced a retro oxa–Michael/oxa–
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Michael addition to afford xanthone 294 as a mixture of the hydroquinone (294a) and 
quinone (294b). Hydroquinone 294a could be reoxidized to 294b via heating in the 
microwave at 180 °C after stirring under O2 overnight in 79% yield. Finally, a TMSBr 
mediated deprotection of the MOM group led to an inseparable mixture of the algycon of 
IB 00208 (283) and its oxidized isomer 295. 
Martin and coworkers also recently applied their methodology toward the synthesis 
of citreamicin η (Scheme 3.8). Benzaldehyde 296 was transformed to silyl ether 297 via a 
Grignard addition of acetylene and silyl protection with di-tert-butylsilyltriflate. Coupling 
297 with cyclobutenone 301 afforded alkyne 298 in 90% yield.  
Scheme 3.8   Martin Group’s Synthesis of the Pentacyclic Core of Citreamicin η 
 
Then, an acid-mediated Moore cyclization transformed 298 to xanthone precursor 
299 in 41% yield. A byproduct of this step was cyclopentanedione 300. The latter 
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compound arose from a Moore reaarangement. Desilylation and oxidation of 299 led to the 
pentacyclic core 284 in 32% over 2 steps.  
3.2.3  Recent Regioselective Syntheses of Xanthones 
The regioselective syntheses of xanthones that can be derived from benzene 
substrates has been reported in the literature employing a variety of carboxylic acid 
promoters. Below are just two recent examples (Scheme 3.9). Liu and coworkers131 used 
Eaton’s reagent to synthesize xanthone 305 from commercially available reagents 
phloroglucinol (303) and 2,4,6-trihydroxybenzoic acid (304) in 36% yield. Similarly, Chen 
and coworkers132 reported the regioselective syntheses of a number of oxygenated 
xanthones 308a-h using ZnCl2 and POCl3 from phenols 306 or salicylic acids 307 in 72-
98% yields.  
Scheme 3.9   Recent Regioselective Syntheses of Xanthones 
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3.2.4  Wagner Group’s Synthesis of Xanthones  
 Unfortunately, our desired xanthone 253 could not be derived regioselectively from 
symmetric benzene coupling partners. Thus, the most exciting literature precedent of the 
synthesis of xanthones we found was an article published in 1985 by Wagner and 
coworkers.133 The authors conducted a one-pot oxidation of 2,5-dihydroxymethylbenzoate 
(309) using Ag2O followed by oxa-Michael addition of phenol 161 using 2-
methoxypyridine and finally cyclization on the methyl ester to give xanthone 310 albeit in 
moderate yield (Scheme 3.10). We found this literature precedent exciting as it differed 
from other literature examples of reactions with quinoesters or quinoflavones which 
typically form C-C bonds via Diels-Alder or conjugate addition pathways.134–136  
Scheme 3.10  Wagner Group’s Synthesis of an Oxygenated Xanthone  
 
 
3.3   Quinone Ester Strategy  
We began our studies toward xanthone 253 by attempting to reproduce the results 
reported by Wagner and coworkers.133 Oxidizing hydroquinone 309 and then directly 
reacting it with phenol 163 gave us poor yields (<10%). Thus, we isolated and 
characterized quinone 311. We then reacted 311 and phenol 163 with 2-methoxypyridine 
(Scheme 3.11). Unfortunately, we realized that the major product we obtained from this 
reaction was actually coumarin 312 based on the diagnostic 13C NMR shifts (see 
Experimental Section page 180). Wagner and coworkers reported the carbonyl signal of 
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their compound to be at δ 178.5 ppm ((CD3)2SO). The most downfield signal in the 13C 
NMR spectrum of our compound 312 was at δ 165.2 ((CD3)2SO).  
We found that using pyridine instead of 2-methoxypyridine in toluene only 
increased the yield of the undesired coumarin byproduct. In addition, use of inorganic bases 
such as K3PO4 and Cs2CO3 in toluene also afforded either the coumarin or polymerized 
quinone 311. 
Scheme 3.11  Attempts to Reproduce Results from Wagner and Coworkers 
 
We then screened a number of Brønsted bases and Lewis acids with bis-TIPS 
phloroglucinol (171). Our hope was that the bulky TIPS groups would block the two ortho 
positions and allow the phenol to act as the nucleophile in order to afford an ether linkage 
rather than a biaryl linkage (Scheme 3.12).  Unfortunately, neither desired ether 313 nor 
xanthone 314 were observed in screens with Lewis acids and Brønsted bases in polar 
aprotic and nonpolar solvents. Instead, we observed biaryl compounds 315 and 317 and 
coumarin 316 or polymerization of quinone 311. A summary of conditions is listed in 
Table 3.1. 
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Scheme 3.12  Desired Ether Linkage versus Observed Biaryl Linkage 
 
Conditions conducted in dichloromethane or toluene led to either biaryl 315, 
coumarin 316, or a mixture of both compounds (Table 3.1, Entries 1-3). Polar protic 
solvents such as DMF and DMSO only led to polymerization of quinone 311. Interestingly, 
when Lewis acids were used in acetonitrile, the biaryl compound arising from para 
addition (317) was the major product (Table 3.1, Entry 7). With these results in hand, we 
decided to employ a different synthetic route to the desired xanthone 253. 
Table 3.1   Representative Conditions Screened for Synthesizing Ether Linkage 
Entry Brønsted Base Lewis Acid Solvent 
Temp 
(°C) 
Ratio of Products 
315:316:317 
1 -- -- 
CH2Cl2 or  
toluene 
40 1:0:0 
2 
K3PO4, Cs2CO3, 
or TEA 
-- 
CH2Cl2 or  
toluene 
23 0:1:0 
3 -- 
M(OTf)3 
M = La, Mg, Yb, Zn 
CH2Cl2 23 1:0:0 
4 
K3PO4, Cs2CO3, 
or TEA 
-- 
DMF, 
DMSO 
23 
Recovered 169; 
decomposition of 311 
5 -- -- CH3CN 23 1:0:0 
6 
K3PO4, Cs2CO3, 
or TEA 
-- CH3CN 23 
1:0:0 or 
~1:1:0 
7 -- 
M(OTf)3 
M = La, Mg, Yb, In, 
Ce; Al(OiPr)3 
CH3CN 23 
~1:1:1 or 
~1:1:3 
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3.4   SNAr Strategy 
Our synthesis of methylated tetraoxygenated xanthone employing an SNAr strategy 
is described herein. Protecting 2,5-dibromobenzaldehyde (318) with 1,3-propanediol led 
to acetal 319 in quantitative yield (Scheme 3.13). Deprotonation of 319 with n-BuLi 
followed by quenching with 1,2-dibromotetrachloroethane (DBTCE) afforded 
bromobenzene 320 in 62% yield. The hexanes, benzene, and THF solvent mixture was 
fundamental in this transformation. Deprotection of acetal 320 gave bromobenzaldehyde 
321 in 96% yield.  
In order to access benzophenone precursor 323, we decided to protect 3,5-
dimethoxyphenol (163) with a TIPS group to access benzene 322 in 83% yield. 
Deprotonation of 322 with n-BuLi and addition to aldehyde 321 led to the benzophenone 
precursor 323, which could be triturated from the crude reaction mixture in 75% yield 
(Scheme 3.13). 
Scheme 3.13  Synthesis of a Benzophenone Precursor 
 Oxidation of 323 with IBX in EtOAc afforded benzophenone 324 in 89% yield. We 
then screened conditions for selective demethylation in hopes of obtaining benzophenone 
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325, wherein the C-3 phenol remained methylated while at least one of C-8/C-12 phenols 
was demethylated to enable the subsequent SNAr cyclization.    
Scheme 3.13  Oxidation and Proposed Demethylation 
 
 Fortunately, we found that utilizing MgI2 afforded demethylated benzophenone 326 
in 73-99% yield (Table 3.2). We found that MgI2 from 2 different vendors (Sigma Aldrich 
and Oakwood) and MgI2•OEt2 (synthesized from Mg and I2) gave different mixtures of 
demethylated products (326-328) regardless of the equivalents and reaction times (Table 
3.2, Entries 1-4). We hypothesized that the bottle of MgI2 that consistently gave the 
monodemethylated benzophenone 326 was contaminated with water. Gratifyingly, when 5 
equivalents of water were added to the reaction with dry MgI2, only compound 326 was 
obtained in similar yields (Table 3.2, Entries 6-8).   
A possible mechanism for this selective demethylation is as follows. MgI2 and 
water may react to form a hydrated MgI2 species which could coordinate with the carbonyl 
and one of the ortho methoxy groups in the phloroglucinol ring, priming the methyl group 
for attack by the iodide. We propose that the bromobenzene ring is bisected to the carbonyl 
and phloroglucinol ring due to the larger steric hindrance of the bromine group. 
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Table 3.2   Representative Conditions for Selective Demethylation by MgI2 
 
Entry 
MgI2 
(equiv) 
Additive 
Temp 
(°C) 
Time 
(h) 
Yield 
Ratio of Products 
326:327:328 
1 2.2a -- 105 4 41% 1.3:1.0:0 
2 2.2a -- 105 16 65% 1.9:5.3:1.0 
3 1.0a -- 105 16 -- 1.2:2.7:1.0 
4 1.0b -- 105 16 -- 1.0:3.4:1.15 
5 1.0c -- 105 16 -- Only 326 
6 1.0c -- 105 4 48 mg, 99% Only 326 
7 1.0c -- 105 16 540 mg, 78% Only 326 
8 1.1a H2O (5 equiv) 105 16 96 mg, 73% Only 326 
a. from Sigma Aldrich; b. MgI2•OEt2 synthesized from Mg
0 and I2; c. from Oakwood 
 
Scheme 3.14  Proposed Mechanism for Selective Demethylation 
 
With a scalable route to benzophenone 326, we then screened a number of inorganic 
bases, solvents, and temperature to induce the desired SNAr reaction to access xanthone 
331 (Scheme 3.15). Gratifyingly we found that heating 326 with 10 equivalents of KOH 
in water and dioxane (1:1) at 140 °C afforded the desired xanthone 331 albeit in <10% 
yield. The major product obtained was the desilylated benzophenone 330. Fortunately, 
when 330 was stirred in dioxane/water (1:1) with KOH at 140 °C, xanthone 331 was 
isolated in 27% yield (46% brsm). The TIPS group could be removed from benzophenone 
327 with NBu4OH in water to give 330 in 97% yield. 
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Scheme 3.15  Synthesis of Methylated Xanthone via SNAr  
 
 
3.5   Future Work 
With a scalable route to methylated xanthone 331, future work will focus on 
demethylating the two ortho methoxy groups and oxidizing to the quinone monoketal 
xanthone 252 (Scheme 3.16) to explore its reactivity in the context of synthesizing 
puniceaside B aglycon 250 via arylation with tetrahydroxanthone 251 (Figure 3.1). To the 
best of our knowledge, the use of such a quinone monoketal xanthone 252 as an arylation 
partner has not been reported in the literature. Currently, there are ongoing studies in the 
Porco research group regarding the quinone monoketal arylation.ii We hope that xanthone 
331 can be useful in further exploring the scope of this chemistry.  
 
 
 
 
                                                        
ii Synthetic efforts being pursued by Chun Chen in the Porco lab 
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Scheme 3.16  Future Work on the Chemistry of a Quinone Monoketal Xanthone  
 
3.6  Conclusion 
In summary, we have presented key results from two of our strategies toward the 
synthesis of a tetraoxygenated xanthone. We explored the possibility of an oxa–Michael 
addition of a bis-TIPS phloroglucinol into a quinone ester and found that the reactivity led 
selectively to carbon-carbon biaryl bond formation. Additionally, we developed a scalable 
route to a benzophenone precursor to a desired oxygenated xanthone via an SNAr reaction. 
Further studies to synthesize our proposed quinone monoketal xanthone are ongoing in our 
continued efforts to synthesize puniceaside B aglycon.   
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3.7  Experimental Section  
3.7.1  General Information 
The Scilligence ELN Reaction Planner (Scilligence Corp.) was used for 
experimental procedure planning. All reactions were performed in round-bottomed flasks 
under argon or nitrogen atmosphere, unless otherwise noted. Thermolyses were conducted 
in Teflon® capped, heavy wall sealed vials (Chemglass CG-1880) to minimize 
solvent/reagent evaporation. Stainless steel needles (Chemglass CG-3075) and Norm-
Ject™ syringes were used to transfer air-sensitive reagents. Analytical thin layer 
chromatography (TLC) was performed using 0.25 mm silica gel 60-F plates (Silicycle, 
Inc.). Ozonolysis was conducted with a Welsbach T-series ozonator (6 psi stream of 
oxygen; 60 volts). Flash chromatography was performed using 200-400 mesh silica gel 
(Sorbent Technologies, Inc.). Preparative HPLC was performed on a Gilson PLC2020 
using a Waters SunFire™ Prep C18 OBD™ 5µm 19X50 mm column. Yields refer to 
chromatographically and spectroscopically pure compounds, unless otherwise stated.   
All 1H NMR spectra were recorded at 400 or 500 MHz at ambient temperature with 
CDCl3 (Cambridge Isotope Laboratories, Inc.) as the solvent, unless otherwise stated. All 
13C NMR spectra were recorded at 100 or 125 MHz at ambient temperature with CDCl3 as 
the solvent, unless otherwise stated. Chemical shifts are reported in parts per million 
relative to CDCl3 (
1H, δ 7.26; 13C, δ 77.1), CD3OD (1H, δ 3.31; 13C, δ 49.0), or (CD3)2SO 
(1H, δ 2.50; 13C, δ 39.5), unless otherwise stated.  
Data for 1H NMR are reported as follows: chemical shift, multiplicity (s = singlet; 
d = doublet; t = triplet; q = quartet; m = multiplet; br = broad; ovrlp = overlapping), 
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coupling constants (J values), and integration. All 13C NMR spectra were recorded with 
complete proton decoupling.  
Infrared spectra were recorded on a Bruker ALPHA FT-IR spectrometer. High-
resolution mass spectra were obtained at the Boston University Chemical Instrumentation 
Center using a Waters Q-TOF mass spectrometer. Melting points were recorded on a Mel-
temp apparatus (Laboratory Devices). Analytical LCMS was performed on a Waters 
Acquity UPLC (Ultra Performance Liquid Chromatography (Waters MassLynx Version 
4.1) with a Binary solvent manager, SQ mass spectrometer, Water 2996 PDA (PhotoDiode 
Array) detector, and ELSD (Evaporative Light Scattering Detector). An Acquity UPLC 
BEH C18 1.7μm column was used for analytical UPLC-MS. Optical rotations were 
recorded on an AUTOPOL III digital polarimeter at 589 nm, and specific rotations are 
given [α]D (concentration in grams/100 mL solvent). Chiral HPLC analysis of 
enantioenriched compounds was performed using a Waters 1525 Binary HPLC Pump with 
a Waters 2487 diode array detector.  
HPLC grade tetrahydrofuran, methylene chloride, diethyl ether, toluene, 
acetonitrile, and benzene were purchased from Fisher and VWR and were purified and 
dried by passing through a PURE SOLV® solvent purification system (Innovative 
Technology, Inc.). Anhydrous dimethoxyethane from Sigma Aldrich was degassed using 
freeze-pump-thaw. Reagents were purchased from Strem, Sigma Aldrich, Acros, TCI, Alfa 
Aesar, and Oakwood, and they were used as received unless otherwise noted.   
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3.7.2  Experimental Section: Quinone Ester 
Quinone Ester (311):133 
A flame-dried flask was charged with methyl 2,5-dihydroxybenzoate (5.0 g, 
29.74 mmol, 1.0 equiv), Na2SO4 (6.3 g, 44.61 mmol, 1.5 equiv), and Et2O 
(200 mL). To this was added Ag2O (16.5 g, 71.38 mmol, 2.4 equiv). After stirring at room 
temperature for 24 h, the reaction was filtered through celite while eluting with Et2O. 
Quinone ester 311 was isolated as an orange solid (4.8 g, 28.77 mmol, 97%).   
m.p.: decomposition (Et2O) 
IR υmax (film): 3485, 3065, 2954, 2868, 1743, 1664, 1600, 1493, 1436, 1380, 1347, 1265, 
1205, 1161, 1105, 1046, 922, 842, 425 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 7.12 (dd, J = 1.9, 0.6 Hz, 1H), 6.84 (ovrlp, 1H), 6.83 (ovrlp, 
1H), 3.92 (s, 3H). 
13C NMR: (125 MHz, CDCl3) δ 186.9, 183.0, 163.24, 137.1, 137.0, 136.6, 136.2, 53.2. 
LR-MS (m/z): [C8H6O4+H]
+ calculated: 167.0344; found: 167.03 (Low Resolution). 
 
Dimethyl Coumarin (312): 
 A flame-dried flask was charged with quinone ester 311 (270 mg, 1.63 
mmol, 1.0 equiv), 3,5-dimethoxyphenol 163 (276 mg, 1.79 mmol, 1.1 
equiv), and CH2Cl2 (30 mL). To this was added pyridine (0.3 mL, 3.72 
mmol, 2.3 equiv). The reaction was stirred at 40 °C and monitored for completion by TLC. 
After stirring at 40 °C for 48 h, the reaction was quenched with a saturated NH4Cl solution 
and extracted with CH2Cl2. The combined organic phases were washed with brine and 
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dried over Na2SO4. The solvent was concentrated in vacuo. The crude product was eluted 
through silica with EtOAc:hexanes (1:1) to afford dimethyl coumarin 312 as a yellow solid 
(451 mg, 1.56 mmol, 96%).  
m.p.: 163 – 165 °C (EtOAc) 
IR υmax (film): 3274, 1680, 1619, 1606, 1461, 1435, 1344, 1312, 1286, 1230, 1205, 1157, 
1125, 1104, 1047, 997, 826 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 11.21 (s, 1H), 8.77 (s, 1H), 7.31 (d, J = 9.0 Hz, 1H), 7.00 
(d, J = 9.0 Hz, 1H), 6.58 (d, J = 2.6 Hz, 1H), 6.50 (d, J = 2.6 Hz, 1H), 4.05 (s, 3H), 3.86 
(s, 3H). 
13C NMR: (125 MHz, CDCl3) δ 165.6, 161.1, 156.9, 154.9, 152.3, 145.0, 129.5, 118.6, 
117.9, 105.1, 102.5, 98.2, 96.1, 58.1, 56.0. 
HR-MS (m/z): [C15H12O6+H]
+ calculated: 289.712; found: 289.0709 (– 1.0378 ppm).  
 
Biaryl Ester (315): 
 
 
 
m.p.: > 200 °C (EtOAc) 
IR υmax (film): 3436, 3419, 3383, 2947, 2891, 2867, 1731, 1669, 1611, 1461, 1437, 1291, 
1196, 1172, 1085, 882, 829, 688 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 10.67 (br s, 1H), 7.16 (d, J = 9.0 Hz, 1H), 6.97 (d, J = 9.0 
Hz, 1H), 6.22 (d, J = 2.1 Hz, 1H), 6.09 (d, J = 2.1 Hz, 1H), 4.97 (br s, 1H), 3.53 (s, 3H), 
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1.31 – 1.22 (m, 3H), 1.13 (s, 9H), 1.12 (s, 9H), 1.03 – 0.97 (m, 3H), 0.91 (s, 9H), 0.88 (s, 
9H). 
13C NMR: (125 MHz, CDCl3) δ 171.2, 158.0, 156.7, 154.9, 154.5, 147.5, 123.5, 119.5, 
118.1, 113.0, 106.3, 103.4, 101.0, 52.2, 17.8, 17.7, 12.9, 12.8.  
HR-MS (m/z): [C32H52O7Si2+H]
+ calculated: 605.3330; found: 605.3318 (– 1.9824 ppm).  
 
Bis-TIPS Coumarin (316): 
  
 
 
m.p.: > 200 °C (EtOAc) 
IR υmax (film): 2980, 2971, 2890, 2867, 1651, 1624, 1462, 1433, 1385, 1235, 1207, 1180, 
1162, 1083, 952, 819 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 11.07 (s, 1H), 8.72 (s, 1H), 7.33 (d, J = 9.0 Hz, 1H), 7.02 
(d, J = 9.0 Hz, 1H), 6.64 (d, J = 2.5 Hz, 1H), 6.49 (d, J = 2.5 Hz, 1H), 1.29 (ovrlp, 6H), 
1.13 (s, 9H), 1.12 (s, 9H), 1.04 (s, 9H), 1.02 (s, 9H). 
13C NMR: (125 MHz, CDCl3) δ 165.6, 157.5, 156.4, 151.8, 151.5, 145.1, 129.0, 119.1, 
117.7, 109.2, 107.3, 105.1, 103.5, 17.8, 17.7, 12.6, 12.6. 
HR-MS (m/z): [C31H48O6Si2+H]
+ calculated: 573.2887; found: 573.3069 (+ 0.1744 ppm).  
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para-Biaryl Ester (317): 
  
m.p.: 175 – 177 °C (EtOAc) 
IR υmax (film): 3501, 3372, 2945, 2892, 2866, 1662, 1588, 1440, 1328, 1195, 1159, 1016, 
881, 800, 737, 680, 651, 563 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 10.67 (s, 1H), 7.09 (d, J = 8.9 Hz, 1H), 6.89 (d, J = 8.9 Hz, 
1H), 6.07 (s, 2H), 5.08 (s, 1H), 4.96 (s, 1H), 3.51 (s, 3H), 1.13 – 1.04 (m, 6H), 0.91 (ovrlp, 
36H). 
13C NMR: (125 MHz, CDCl3) δ 171.7, 156.6, 156.1, 155.1, 147.0, 123.3, 122.0, 117.7, 
113.0, 111.3, 99.4, 51.8, 17.8, 17.7, 12.9. 
HR-MS (m/z): [C32H52O7Si2+H]
+ calculated: 605.3149; found: 605.3337 (– 1.1564 ppm). 
3.7.3  Experimental Section: SNAr Strategy 
2-(2,5-dimethoxyphenyl)-1,3-dioxane (319): 
A 500 mL flask was charged with 2,5-dimethoxybenzaldehyde 318 (15.7 g, 
94.48 mmol, 1.0 equiv), (±)-CSA (1.1 g, 4.72 mmol, 0.05 equiv), 1,3-
propanediol (13.5 mL, 188.96 mmol, 2.0 equiv), and benzene (250 mL). A Dean-Stark 
apparatus and reflux condenser were attached, and the flask was heated at 100 °C for 48 
hours. The reaction was then cooled to room temperature and diluted with EtOAc then 
washed with brine. The organic phase was dried over Na2SO4, and the solvent was 
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concentrated in vacuo. 2-(2,5-dimethoxyphenyl)-1,3-dioxane 319 was isolated as a yellow 
oil (20.9 g, 93.20 mmol, 99%) and was used in the next step without further purification.                  
(1H NMR spectra matched reported spectra)137 
1H NMR (500 MHz, CDCl3): δ 7.20 (d, J = 3.0 Hz, 1H), 6.85 (dd, J = 8.9, 3.0 Hz, 1H), 
6.81 (d, J = 8.9 Hz, 1H), 5.85 (s, 1H), 4.29 – 4.21 (m, 2H), 4.04 – 3.98 (m, 2H), 3.80 (s, 
3H), 3.79 (s, 3H), 2.29 – 2.20 (m, 1H), 1.45 – 1.41 (m, 1H). 
 
Bromo Acetal (320):138 
A 1 L flame-dried flask was charged with acetal 319 (12 g, 53.51 mmol, 1.0 
equiv), hexanes (360 mL), and benzene (123 mL). The solution was degassed 
with an argon balloon for 30 minutes. To this was added n-BuLi (2.5 M 
solution in hexanes, 27.8 mL, 69.56 mmol, 1.3 equiv) at -25 °C. The reaction was stirred 
at -25 °C for 2.5 h. The reaction was a red, heterogeneous mixture. To this, 1,2-
dibromotetrachloroethane (16.7 g, 51.37 mmol, 0.96 equiv) dissolved in THF (123 mL) 
was carefully cannulated. The reaction immediately turned pale yellow and became 
homogeneous. The reaction was then warmed to ambient temperature and stirred for 1 h. 
Finally, the reaction was quenched with a saturated NH4Cl solution (250 mL) and extracted 
with EtOAc. The combined organic phases were washed with brine and dried over Na2SO4. 
The solvent was concentrated in vacuo. The crude product was purified by column 
chromatography using a EtOAc:hexanes gradient (0:1 to 1:4) to afford bromo acetal 320 
as an off-white solid (10 g, 32.99 mmol, 62%).        
  
171 
IR υmax (film): 3468, 2960, 2840, 2734, 1726, 1577, 1477, 1463, 1377, 1151, 1101, 1073, 
1033, 839, 764 cm-1.  
1H NMR: (500 MHz, CDCl3) δ 6.86 (d, J = 0.9 Hz, 2H), 6.22 (s, 1H), 4.29 (ddd, J = 12.0, 
5.0, 1.5 Hz, 2H), 3.97 (ddd, J = 12.3, 12.0, 2.3 Hz, 2H), 3.83 (s, 3H), 3.82 (s, 3H), 2.35 (m, 
1H), 1.40 (m, 1H). 
13C NMR: (125 MHz, CDCl3) δ 152.7, 150.9, 127.1, 114.0, 113.2, 112.1, 99.7, 67.8, 57.2, 
57.2, 25.7. 
HR-MS (m/z): [C12H15BrO4+H]
+ calculated: 303.0232; found: 303.0231 (– 0.3300 ppm). 
 
Bromobenzaldehyde 321:138 
A flask was charged with bromo acetal 320 (8.4 g, 27.71 mmol, 1.0 equiv) and 
THF (250 mL). To this was added 3M HCl (200 mL). The reaction was 
monitored for completion by UPLC. After stirring at room temperature for 1 h, 
the reaction was quenched with saturated NaHCO3 (400 mL) and extracted with EtOAc. 
The combined organic layers were washed with brine and dried over Na2SO4. The solvent 
was concentrated in vacuo. Bromobenzaldehyde 321 was isolated as an off-white solid (6.5 
g, 26.52 mmol, 96%) and used without further purification.  
m.p.: 94 – 95 °C (EtOAc) 
IR υmax (film): 2957, 2838, 1693, 1594, 1566, 1472, 1433, 1397, 1289, 1259, 1190, 1152, 
1063, 1027, 800, 717 538 cm-1. 
1H NMR (500 MHz, CDCl3): δ 10.37 (s, 1H), 7.04 (d, J = 9.1 Hz, 1H), 6.90 (d, J = 9.1 
Hz, 1H), 3.85 (s, 3H), 3.84 (s, 3H). 
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13C NMR (125 MHz, CDCl3): δ 190.9, 155.5, 150.5, 117.2, 114.7, 111.6, 57.2, 56.7.  
HR-MS (m/z): [C9H9BrO3+Na]
+ calculated: 266.9633; found: 266.9626 (– 2.6221 ppm). 
 
Dimethoxy Silane 322: 
A flame-dried flask was charged with 3,5-dimethoxyphenol 163 (27.0 g, 
175.14 mmol, 1.0 equiv), CH2Cl2 (300 mL), and trimethylamine (48.6 
mL, 350.28 mmol, 2.0 equiv). To this was added triisopropylchlorosilane (41.2 mL, 192.65 
mmol, 1.1 equiv). The reaction was monitored for completion by TLC. After stirring at 
room temperature for 48 h, the reaction was then quenched with a saturated NH4Cl solution 
and extracted with CH2Cl2 (3x). The combined organic phases were washed with brine and 
dried over Na2SO4. The solvent was concentrated in vacuo. The crude material was eluted 
through silica with 2% EtOAc/Hexanes. The triisopropylsilanol was distilled off under 
reduced pressure. Dimethoxy silane 322 was isolated as a pale yellow oil (44.9 g, 144.61 
mmol, 83%).   
IR υmax (film): 2944, 2892, 2866, 1591, 1460, 1443, 1259, 1191, 1148, 1055, 1008, 990, 
881, 829, 788, 680 cm-1. 
1H NMR (500 MHz, CDCl3): δ 6.09 (dd, J = 2.2, 2.2 Hz, 1H), 6.07 (d, J = 2.2 Hz, 2H), 
3.75 (s, 6H), 1.26 (h, J = 7.4 Hz, 3H), 1.11 (d, J = 7.4 Hz, 18 H). 
13C NMR: (125 MHz, CDCl3) δ 161.4, 157.9, 98.9, 93.5, 55.4, 18.1, 12.8.  
HR-MS (m/z): [C17H30O3Si+H]
+ calculated: 311.2042; found: 311.2055 (+ 4.1773 ppm). 
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Diphenyl Methanol 323: 
A 500 mL flame-dried flask was charged with dimethoxy silane 
322 (8.65 g, 27.86 mmol, 1.05 equiv) and THF (250 mL). The 
solution was degassed with an argon balloon. To this was added 
n-BuLi (2.5 M in hexanes, 10.6 mL, 26.53 mmol, 1.0 equiv) at -78 °C. The solution was 
then warmed to room temperature and stirred for 2 hours then cooled back to -78 °C.  
A 1 L flame-dried flask was charged with bromobenzaldehyde 321 (6.5 g, 26.53 mmol, 1.0 
equiv) and THF (150 mL). The solution was degassed with an argon balloon. To this was 
added the reaction mixture from above at -78 °C, dropwise. After complete addition of the 
dimethoxy silane mixture, the reaction was warmed to room temperature. After stirring at 
room temperature for 2 hours, the reaction was quenched with saturated NH4Cl and 
extracted with EtOAc. The combined organic phases were washed with brine and dried 
over Na2SO4. The solvent was concentrated in vacuo. Benzophenone precursor 323 was 
purified by trituration using hexanes as an off-white solid (11.1 g, 19.98 mmol, 75%). 
m.p.: 129 – 132 °C (EtOAc) 
IR υmax (film): 3339, 2951, 2865, 2837, 1727, 1648, 1607, 1475, 1259, 1216, 1103, 1069, 
1029, 921, 797, 762 cm-1.  
1H NMR: (500 MHz, CDCl3) δ 6.78 (d, J = 8.9 Hz, 1H), 6.74 (d, J = 8.9 Hz, 1H), 6.57 (d, 
J = 9.9 Hz, 1H), 6.08 (s, 2H), 5.66 (d, J = 9.9 Hz, 1H), 3.83 (s, 3H), 3.70 (s, 6H), 3.67 (s, 
3H), 1.24 (m, 3H), 1.10 (s, 9H), 1.09 (s, 9H). 
13C NMR: (125 MHz, CDCl3) δ 159.0, 156.6, 153.5, 150.4, 134.0, 115.1, 112.1, 111.3, 
110.3, 97.3, 71.3, 57.0, 56.6, 56.0, 18.0, 12.8.  
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HR-MS (m/z): [C26H39BrO6Si+Na]
+ calculated: 577.1597; found: 577.1599 (+ 0.3465 
ppm). 
 
Benzophenone (325): 
A Teflon® cap, heavy wall sealed vessel was charged with 
benzophenone precursor 324 (4.6 g, 7.74 mmol, 1.0 equiv), IBX 
(2.17 g, 7.74 mmol, 1.0 equiv), and EtOAc (60 mL). The vessel 
was then capped and heated to 85 °C. After stirring for 36 hours, the reaction was cooled 
to room temperature and eluted through a pad of celite washing with EtOAc. The solvent 
was concentrated in vacuo. The crude red oil was purified by column chromatography 
(EtOAc:hexanes (1:3)) to afford benzophenone 325 as a light orange solid (3.8 g, 6.86 
mmol, 89%).  
m.p.: 114 – 116 °C (EtOAc)           
IR υmax (film): 2944, 2866, 2838, 1674, 1595, 1575, 1462, 1432, 1410, 1346, 1297, 1267, 
1234, 1165, 1015, 827, 688 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 6.81 (s, 2H), 6.06 (s, 2H), 3.85 (s, 3H), 3.67 (s, 3H), 3.64 
(s, 6H), 1.31 – 1.21 (m, 3H), 1.12 (s, 9H), 1.10 (s, 9H).  
13C NMR: (125 MHz, CDCl3) δ 191.0, 161.7, 161.0, 151.8, 150.2, 136.8, 113.0, 111.8, 
111.5, 109.7, 97.0, 57.3, 57.1, 56.2, 18.0, 12.8. 
HR-MS (m/z): [C26H37BrO6Si+H]
+ calculated: 553.1621; found: 553.1614 (– 1.2655 
ppm). 
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Demethylated Benzophenone (327): 
 Method A: A Teflon® cap, heavy wall sealed vessel was 
charged with benzophenone 325 (710 mg, 1.28 mmol, 1.0 equiv), 
MgI2iii (2.17 g, 7.74 mmol, 1.0 equiv), and toluene (35 mL). The 
vessel was then capped and heated to 105 °C. After stirring for 24 hours, the reaction was 
cooled to room temperature, quenched with saturated NH4Cl, and extracted with EtOAc. 
The combined organic phases were washed with brine, dried over sodium sulfate, and 
concentrated in vacuo. The crude oil was purified by column chromatography 
(EtOAc:hexanes, 1:3) to afford demethylated benzophenone 327 as a pale yellow solid 
(540 mg, 692 μmol, 78%). 
Method B: A Teflon® cap, heavy wall sealed vessel was charged with benzophenone 325 
(135 mg, 244 μmol, 1.0 equiv), MgI2iv (80 mg, 288 μmol, 1.2 equiv), water (22 μL, 1.22 
mmol, 5.0 equiv), and toluene (2.0 mL). The vessel was then capped and heated to 110 °C. 
After stirring for 24 hours, the reaction was cooled to room temperature, quenched with 
1N HCl, and extracted with EtOAc. The combined organic phases were washed with brine, 
dried over sodium sulfate, and concentrated in vacuo. The crude product was isolated as a 
yellow solid (121 mg) and a mixture of only starting material 325 and demethylated 
benzophenone 327 (1:7). The yield was calculated by 1H NMR integration (96 mg, 178 
μmol, 73%).  
m.p.: 164 – 165 °C (EtOAc)         
                                                        
iii From Oakwood Chemical (Item #099350) 
iv From Sigma Aldrich (Item #394599)  
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IR υmax (film): 3001, 2991, 2945, 2903, 2867, 2822, 1619, 1583, 1479, 1462, 1415, 1290, 
1260, 1212, 1174, 1116, 1038, 794 cm-1. 
1H NMR: (500 MHz, CDCl3) δ 13.32 (s, 1H), 6.84 (s, 2H), 6.10 (d, J = 2.2 Hz, 1H), 5.78 
(d, J = 2.2 Hz, 1H), 3.87 (s, 3H), 3.72 (s, 3H), 3.37 (s, 3H), 1.33 – 1.25 (m, 3H), 1.12 (s, 
9H), 1.11 (s, 9H). 
13C NMR: (125 MHz, CDCl3) δ 195.8, 167.5, 164.8, 163.3, 150.4, 150.3, 136.1, 111.4, 
110.8, 108.5, 106.9, 100.9, 95.5, 57.2, 57.0, 56.0, 18.0, 12.9.  
HR-MS (m/z): [C25H35BrO6Si+H]
+ calculated: 539.1465; found: 539.1484 (+3.5241 ppm). 
 
Dihydroxy Benzophenone 330: 
A heavy wall sealed vessel was charged with demethylated 
benzophenone 327 (729 mg, 1.35 mmol, 1.0 equiv), 
tetrabutylammonium hydroxide (40% w/w in H2O, 2.6 mL, 4.05 
mmol, 3.0 equiv), and water (4 mL). The vessel was then capped and heated in the 
microwave at 120 °C for 1 h. The reaction was then quenched with 1N HCl solution and 
extracted with EtOAc. The combined organic phases were washed with brine, dried over 
Na2SO4, and concentrated in vacuo. The crude product was eluted through silica with 
EtOAc:hexanes (1:1) to afford dihydroxy benzophenone 330 as a yellow solid (500 mg, 
1.30 mmol, 97%). 
m.p.: 104 – 106 °C (EtOAc)        
IR υmax (film): 3649, 3635, 3619, 3605, 3558, 3531, 3471, 3165, 3000, 2944, 2293, 2253, 
1633, 1442, 1375, 1038, 918, 749 cm-1. 
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1H NMR: (500 MHz, CDCl3) δ 13.45 (s, 1H), 6.82 (s, 2H), 6.01 (d, J = 2.2 Hz, 1H), 5.76 
(d, J = 2.2 Hz, 1H), 3.85 (s, 3H), 3.69 (s, 3H), 3.35 (s, 3H), 2.09 (s, 1H). 
13C NMR: (125 MHz, CDCl3) δ 167.7, 165.2, 165.2, 163.8, 150.2, 150.2, 135.8, 111.6, 
110.9, 108.4, 106.2, 96.7, 91.5, 57.2, 56.9, 56.0. 
 
Methylated Xanthone 331: 
 A heavy wall sealed vessel was charged with dihydroxy benzophenone 
330 (300 mg, 782 μmol, 1.0 equiv), KOH (439 mg, 7.83 mmol, 10.0 
equiv), dioxane (2 mL), and water (4 mL). The vessel was then capped 
and heated at 140 °C for 24 h. The reaction was then quenched with 1N HCl and extracted 
with EtOAc. The crude product sonicated in CH2Cl2 and then filtered to afford methylated 
xanthone 331 as a pale yellow solid (65 mg, 215 μmol, 27%, 47% brsm).   
m.p.: 149 – 150 °C (EtOAc)           
IR υmax (film): 3650, 3634, 3586, 3541, 3165, 2995, 2981, 2944, 2293, 2253, 1632, 1442, 
1375, 1039, 918, 748 cm-1. 
1H NMR: (500 MHz, (CD3)2SO) δ 10.73 (br s, 1H), 7.28 (d, J = 9.0 Hz, 1H), 6.79 (d, J = 
9.0 Hz, 1H), 6.35 (d, J = 2.1 Hz, 1H), 6.33 (d, J = 2.1 Hz, 1H), 3.87 (s, 3H), 3.80 (s, 3H), 
3.77 (s, 3H).  
13C NMR: (125 MHz, (CD3)2SO) δ 173.1, 162.9, 161.3, 157.6, 152.4, 145.6, 141.3, 115.8, 
113.8, 106.5, 105.7, 95.8, 94.4, 56.4, 56.2, 55.8. 
HR-MS (m/z): [C16H14O6+Na]
+ calculated: 325.0688; found: 325.0679 (– 2.7686 ppm). 
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3.7.4  Select NMR Spectra 
 
1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, (CD3)2SO) 
 
 
13C NMR (125 MHz, (CD3)2SO) 
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3)
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1H NMR (500 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3)
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
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1H NMR (500 MHz, CDCl3) 
13C NMR (125 MHz, CDCl3) 
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HMQC (500 MHz, CDCl3) for compound 326 
 
 
 
 
gHMBC (500 MHz, CDCl3) for compound 326 
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1H NMR (500 MHz, CDCl3) 
 
13C NMR (125 MHz, CDCl3) 
 
 
  
193 
 
1H NMR (500 MHz, (CD3)2SO) 
 
 
13C NMR (125 MHz, (CD3)2SO) 
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